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Abstract
Knowledge o f the mechanisms by which Mycobacterium tuberculosis regulates 
its defence against oxidative stress will aid in the development o f drugs and vaccines to 
combat the extensive morbidity and mortality caused by tuberculosis.
In this thesis I have investigated the SenX3-RegX3 two component signal 
transduction system, one of 12 such systems in M. tuberculosis, which is essential for 
virulence in a mouse model and is similar to systems in other organisms that are involved 
in sensing oxygen. By complementing the attenuated growth o f the senX3 and regX3 null 
mutants in mice I have shown that this phenotype is truly due to the targeted mutations in 
these strains. In vitro assays of oxygen stress have shown the senX3 and regX3 null 
mutants to be less sensitive than the wild-type to superoxide and organic hydroperoxide 
stresses.
Microarray analysis of mutants in the SenX3-RegX3 system after growth in 
microaerobic conditions suggested some functions for RegX3; but there was little overlap 
between strains. However, microarray comparison of a strain overproducing regX3 
transcript demonstrated control of genes such as ahpC and cydB, indicating that this 
system may indeed play a role in the resistance of M. tuberculosis to oxidative stress.
RegX3 was expressed and purified in E. coli and used to examine the interaction 
of this protein to different promoters, including that of senX3.
Two further genes, which are probable one component regulators of oxidative 
stress in M. tuberculosis, Rv0465c and Rvl049, as judged by similarity to proteins in 
other organisms, were analysed through the isolation of null mutations. In vitro analysis 
suggests that Rvl049 is necessary for resistance to organic hydroperoxide stress,
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although neither the Rv0465c nor the Rvl049 null mutants were attenuated 
macrophage or murine intravenous injection models of infection.
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1 Introduction
1.1 Tuberculosis: disease and developments
Mycobacterium tuberculosis is the causative agent o f tuberculosis, a disease 
which infects around one third of the world’s population and is the cause of death of 
between two and three million people every year (Kochi 1991). Although tuberculosis 
can infect any part o f the body, it typically attacks the lungs and throat. Whereas most 
foreign organisms that enter the body by this route are trapped and killed by the innate 
immune system, M. tuberculosis is able to survive and will usually grow until it is 
contained within a granulatomous lesion. The granuloma is an immune defence that is 
thought to control the replication of M. tuberculosis through limiting the oxygen and 
nutrients available to the bacterium. Despite this, the bacteria are able to survive in the 
host for long periods of time in a state of metabolic dormancy. If the host later becomes 
immunocompromised through, for example, malnutrition or immunodeficiency caused by 
HIV (Hopewell 1992), then he or she is no longer able to contain the growth of the M. 
tuberculosis and the lesion reactivates. Death typically occurs when the lesions caused 
by the mycobacteria erode the bronchial lining and cause the lungs to fill with blood.
There have been a number of trends in the incidence of tuberculosis in the last 
decade. Firstly, the high levels of M. tuberculosis-infected individuals in developing 
countries and the increasing presence o f HIV in these countries means that there has been 
a growing trend for co-infection with both M. tuberculosis and HIV. It seems that these 
two diseases are synergistic, with death occurring within a matter o f months in co­
infected individuals. Secondly, more virulent strains of M. tuberculosis have been 
appearing in the Far East, such as the W, or Beijing, strain (Bifani et al. 2002). These 
isolates are characterised by a far higher infectivity index than other strains of M
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tuberculosis. Infection by the Beijing strains also proceeds more rapidly, and the bacteria 
are more likely to be multiply drug resistant -  bringing us to the third trend. Drug 
resistance in M. tuberculosis has been a problem since the first antibiotic was invented to 
treat the disease, however due to poor adherence to treatment regimens and a dearth of 
new antibiotics the incidence of multiply drug resistant (MDR) tuberculosis is increasing. 
Combined with the increase in world travel and an often complacent attitude to the risks 
of tuberculosis infection in developed countries, this means that there has been a growing 
number of M. tuberculosis outbreaks in cities in developed countries where first-line 
antibiotics such as isoniazid have not been effective.
In recent years the World Health Organisation has had success at controlling 
tuberculosis infections with the DOTS (directly-observed therapy, short-course) 
treatment strategy (WHO, 2004), which involves the simultaneous administration of four 
antibiotics to which the isolate has proved to be sensitive. It is hoped that investigation 
of the molecular interactions within M. tuberculosis may allow the design of new 
antimicrobials to signalling or metabolic pathways of the bacterium, perhaps even to 
target M. tuberculosis during the latent stages o f M. tuberculosis infection.
1.1.1 Vaccine use in the prophylactic treatment of M. tuberculosis
The Bacille Chalmette-Guerin (BCG) vaccine has been used prophylactically in 
the UK for several generations. It is a live attenuated strain of M. bovis that was grown 
on potato agar for an extended period of time until it lost its ability to create a progressive 
infection. See Oettinger et al. (1999) for a review. After its initial isolation in the 1920s 
the strain was distributed to a number of different laboratories around the world. The
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BCG vaccine is highly variable in efficacy as a prophylactic vaccination against adult 
tuberculosis, where it is typically given during the teenage years. Although used widely 
in the UK, it has never been shown to be effective in adults in the developing world (Fine 
1988; Roche et al. 1995; Fine 1996), and was of such limited efficacy in the US that it 
was decided to rely on selective application of drugs alone as a prophylactic measure in 
an outbreak. This also removed problems connected with the antigenic masking effect of 
the BCG vaccine since until very recently been difficult to distinguish vaccinated from 
infected individuals by serology due to the similarity between the BCG and M. 
tuberculosis bacteria. More recent genotyping of the BCG strains that were originally 
distributed to laboratories has shown that the original strain acquired a large deletion 
encompassing a number of genes now thought to encode parts o f a secretory system 
involved in the virulence of M. tuberculosis. The distributed isolates, however, acquired 
a range of other large deletions and these may be in part responsible for the variable 
efficacy of the vaccine; see Behr (2002) for a review on this subject.
Other factors influencing the efficacy o f the BCG vaccine are the underlying 
nutritional status of the population, and pre-existing immunity acquired from exposure to 
environmental mycobacteria. Despite the vaccine’s variable protective efficacy in adults, 
it has been relatively successful as a neonatal vaccination protecting against childhood 
forms o f the disease (Clarke & Rudd 1992). Furthermore, the antigenicity and widely 
accepted safety record make it an ideal candidate as a vector for the delivery of foreign, 
i.e., non-mycobacterial, antigens to protect against other diseases requiring strong 
intracellular immune responses.
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Of greatest prophylactic use would be a live attenuated strain of M. tuberculosis 
to use as a vaccine that had been minimally modified in order to maintain its wild-type 
immunological profile. As more is understood about the dormant stages of M. 
tuberculosis, it may also be possible to design vaccines that are effective after infection, 
able to produce sterilising immunity in those with latent tuberculosis. Progress towards a 
modem vaccine for tuberculosis, as well as targeted antimicrobials, will rely on the 
elucidation of the genetic and molecular interactions o f M. tuberculosis at all stages of 
the infection process.
1.1.2 Drug treatment for tuberculosis
The current treatment for tuberculosis is the widely-adopted WHO DOTS 
(directly-observed treatment, short-term) strategy. This involved the supervised 
treatment of patients with isoniazid, rifampicin, pyrazinamide and ethambutol for two 
months, followed by treatment with isoniazid and rifampicin alone for four further 
months. DOTS plus is used for cases o f multi-drug resistant (MDR) tuberculosis, where 
second-line antimicrobials are included in the treatment regimen, and the period of the 
treatment is extended to 24 months.
There are several problems with the current use of antimicrobials to treat TB. It is 
difficult to find drugs that will penetrate caseous granulomas to come into contact with 
the bacteria. It is also difficult to find antimicrobials that have a sterilising ability, and 
this is of particular relevance to HIV-TB coinfected individuals whose immune systems 
will have trouble supporting a bacteriostatic antimicrobial attack on the bacilli. 
Furthermore, the majority o f antimicrobials will have no effect on M. tuberculosis if  it
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has entered a latent or nonreplicating state, meaning that it is very difficult to treat 
patients with latent tuberculosis. Please see Zhang (2005) for a review.
1.1.2.1 Current anti-tuberculosis drugs, their mechanisms of action and their 
targets.
The key antimicrobials for tuberculosis therapy predominantly act as inhibitors of 
cell wall synthesis, and inhibitors of nucleic acid synthesis. They rely on interaction with 
components of the bacterial cell preferentially over components o f the host cells, and an 
ability to cause bacteriostasis or bacteriocidal activity in the bacterial population. In the 
case of bacteriostatic drugs, or if  bactericidal activity has not been total, then the 
administration of these drugs attempts to control bacteria pathogenesis and replication to 
the extent where the immune system can ‘mop up’ the remaining bacteria.
1.1.2.2 Inhibitors of cell wall synthesis
Isoniazid, for example, is a prodrug that is activated by the katG gene product to 
produce reactive oxygen intermediates. One product is the isonicotinic acyl radical, 
which inhibits enoyl ACP reductase (encoded by inhA), an enzyme involved in mycolic 
acid biosynthesis. Resistance in clinical isolates is usually due to the inactivation of 
katG, preventing activation o f the prodrug. Ethambutol, as another example of cell wall 
synthesis inhibitors, prevents the polymerisation of arabinogalactan and 
lipoarabinomannan, probably by inhibiting arabinsyl transferase (encoded by embB). 
Mutations in embB seem to be the primary form of resistance seen clinically.
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1.1.2.3 Inhibitors of nucleic acid synthesis
Inhibitors of nucleic acid synthesis include rifampicin and the fluoroquinolones. 
Rifampicin binds to the DNA-dependant RNA polymerase /3-subunit encoded by rpoB, 
mutations in which cause resistance to rifampicin. The fluoroquinolones, including 
ciprofloxacin and ofloxacin, inhibit DNA synthesis by binding to the A and B subunits of 
the DNA gyrase. Inhibition o f nucleic acid sythesis effectively paralyses the cell; 
however removal of these drugs may allow growth to continue. Rifampicin is 
particularly important since it has activity against both growing and non-growing 
bacteria.
1.1.2.4 Design of new antimicrobials against M. tuberculosis
The design of new drugs, to new targets in M. tuberculosis, avoids problems with 
cross-resistance that may occur when existing drugs are sequentially modified for 
improvements. Furthermore, the addition of novel drugs to existing multidrug therapies 
may prevent the development of resistance to the new drugs altogether. Ideally these 
new antimicrobials would target essential aspects of mycobacterial growth, be 
bactericidal, and would have the ability to be modified to give good pharmacokinetic 
properties. Certainly it may be possible to target those key aspects of mycobacterial 
growth and virulence that we know are sufficiently different to eukaryotic systems as to 
minimise problems of toxicity to the host. The regulatory systems of M. tuberculosis are 
likely to fit this category: for example, the histidine-aspartate phosphotransfer that occurs 
in two-component systems is rare in eukaryotes, and may represent a good target for 
inhibition by a designed small molecule (Stephenson & Hoch 2004). PAS domains may
31
have sufficiently specific structure to allow the selective inhibition of ligand-binding or 
sensor activation. Any genes that have been designated as essential for growth, for 
example by high-density mutagenesis (Sassetti et al. 2003), can be screened for utility as 
a drug target. This can be done by screening libraries o f compounds for inhibitory 
effects, or a lifting o f repression o f inhibitory effects, against mutant strains of the 
bacteria; isolation of natural chemical partners of mycobacterial proteins and synthesis of 
toxic analogues; or by the use o f crystallographic data to specifically design inhibitory 
molecules.
1.13 Immunological responses to TB infection
The study of the immune responses to M. tuberculosis is a very active and 
complex field. In the majority of infections the mycobacteria initially contact the innate 
immune response consisting of the alveolar macrophages lining the lungs. If these 
macrophages are unactivated, it may be possible for the bacteria to enter without 
stimulating the oxidative burst, using TACO protein amongst others (see Pieters & 
Gatfield (2002) for a review). It is known that mycobacteria can be seen to reside in 
phagosomes after macrophage infection, and these are prevented by the bacteria from 
fusing with lysosomes (Armstrong & Hart 1971). There is also evidence that the bacteria 
can escape the phagosomes and reside within the cytoplasm. Certainly, the bacteria can 
survive the innate immune response in immunocompetent hosts.
In terms of the acquired immune response, M. tuberculosis elicits both Thl and 
Th2 responses. The latter tend to be reactions to the secreted antigens of M. tuberculosis, 
and although this response may be useful in diagnosis o f infected individuals it is not
32
thought to be protective of the host. As a predominantly intracellular pathogen, much of 
the inflammatory pathology o f the M. tuberculosis granuloma is produced by the Thl arm 
of the acquired immune response, to which the secretion of the cytokine interferon-y is 
involved. Stimulation of the Thl response may also occur due to the interaction of M. 
tuberculosis secreted proteins with pattem-recognitions receptors, such as the toll-like 
receptor proteins, as part of the innate immune response. A great deal of M. tuberculosis 
pathology is caused by the host immune responses to the bacterium, and there is a great 
deal of evidence for M. tuberculosis components such as lipoarabinomannan being able 
to modulate the immune response, reviewed in Flynn & Chan (2003).
As the bacteria multiply, a large variety o f cells build up around the focus of 
infection, including activated macrophages, CD4+ and CD8+ T-lymphocytes and multi­
nucleated giant cells. As the inflammatory response continues, a granuloma forms 
around the focus of infection and the tissue within the granuloma becomes necrotic, 
forming a caseous, ‘cheesy’ lesion. If the bacteria are contained, then the granuloma will 
eventually calcify unless the disease later reactivates. If the bacteria and the lesion 
continue to grow however, then death may eventually occur when the lesion erodes the 
lining o f a major artery.
1.1.4 The M. tuberculosis genome
In a landmark paper, Cole et al. (1998)described the sequence of the M  
tuberculosis genome. The M. tuberculosis genome has a very high GC content, and 
contains a large number of genes encoding proteins involved in lipid metabolism as well 
as a series o f genes encoding glycine-rich proteins that have been designated as the PE
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and PPE families that may be involved in antigenic variation. Approximately half of the 
open reading frames (ORFs) identified coded for proteins that bear little homology to 
those identified in other organisms.
The publishing of the M. tuberculosis sequence allowed genetic manipulation of 
the bacterium on a much larger scale than before, and attracted a large amount of 
attention to a field that had been considered stagnant due to a lack of tools to allow 
genetic manipulation o f the mycobacteria. The new genetic information made it easier to 
create targeted gene knockouts, and polymerase chain reaction (PCR) amplification of 
sections of each ORF identified in the sequencing project allowed the construction of an 
M. tuberculosis microarray. The ability to create targeted gene mutations using reverse 
genetics meant that it was possible to create strains without a phenotype. This was 
particularly important since M. tuberculosis is difficult to grow, in terms of requiring 
category III containment and having a very slow generation time, which meant that 
traditional methods of inducing mutation in the bacteria and selecting for phenotypes was 
not an attractive option for generating mutants in M. tuberculosis.
1.1.4.1 Types of regulatory mechanism in M. tuberculosis
In order to respond efficiently to changes in their environment, bacteria use a 
number of different protein-based systems to sense stimuli and co-ordinately regulate 
gene expression. Generally considered the most important of these are the two- 
component signal transduction systems, although these are outnumbered numerically by 
the one-component signal transduction systems, a review of which can be seen in Ulrich 
et al. (2005).
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One component signal transduction systems consist of a single protein with both a 
sensory domain and a DNA-binding domain. These are activated directly or indirectly by 
a signal, and either repress or activate transcription of genes. As such they are 
cytoplasmic proteins. Two component signal transduction systems consist of a sensor 
protein that contains a signal input domain and a histidine kinase domain, which 
phosphorylates a response regulator that contains a DNA binding domain. Activation of 
the sensor protein, which is usually membrane-anchored, causes it to autophosphorylate 
on a histidine residue, followed by phosphotransfer to an aspartate residue on the 
response regulator. Phosphorylation o f the response regulator alters its DNA binding 
activity and allows it to activate or repress the translation of other genes. For a review 
see Hoch (2000). Since the phosphorylation of histidine residues in two-component 
systems, is specific for bacteria, they represent a potential target for the design of novel 
antibacterial agents (Stephenson & Hoch 2004).
Sigma factors are another mechanism of protein-level regulatory control in 
bacteria. Sigma factors form part of the RNA polymerase holoenzyme and provide 
recognition of sequences upstream of genes, allowing transcriptional control o f these 
genes. Whereas in E. coli sigma factor F has a role as a general sigma factor, in M. 
tuberculosis there are 11 sigma factors (Gomez et al. 1997; Cole et al. 1998; Wu et al. 
2004), with sigma factor A being considered as the major sigma factor since it has so far 
been impossible to create null mutants for this gene (Gomez et al. 1998). Use of different 
sigma factors is likely to influence the response of the bacterium to environmental signals 
and influence the transcriptome of the organism; and current knowledge suggests that the 
sigma factors of M. tuberculosis have a great deal of regulatory overlap, producing a
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complex system o f regulation (reviewed in Manganelli et al, (2004)). Of particular 
relevance to the oxidative stress defence of M. tuberculosis is sigma factor H, SigH, 
mutants o f which are more susceptible than the wild-type to the superoxide stress and 
heat stress, which may itself cause oxidative stress of the cells (Raman et al. 2001).
Unusually, the genome sequence of M. tuberculosis appears to encode 11 
eukaryotic-like serine-threonine protein kinases (Cole et al. 1998). These have a variety 
of proposed regulatory roles, from membrane transport to cell division (reviewed in Av- 
Gay & Everett (2000)) and at least one serine-threonine protein kinase is required for 
growth of M. tuberculosis in vivo (Curry et al. 2005). Although serine-threonine protein 
kinases are an interesting class o f regulator in M. tuberculosis, there are currently no roles 
for them described for defence against oxidative stress.
1.2 Oxygen and metabolic sensing in bacteria
Many of the mechanisms that bacteria use to sense their environments have been 
elucidated in E. coli, and it is hoped that systems discovered in M. tuberculosis will allow 
comparison by homology and similarities of regulons in an effort to accelerate our 
understanding of M. tuberculosis pathogenesis. In E. coli much of the machinery for 
sensing the presence of oxygen and other metabolites is also utilised for detoxification of 
ROI and RNI used in host defence; it is difficult to separate the two in E. colU let alone 
M. tuberculosis where many o f the regulatory systems are still to be defined. The 
following sections describe our current knowledge of relevant systems in E. coli, and 
comparisons have then been drawn with data produced from studies in M. tuberculosis.
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1.2.1 The role of bacterial metabolic sensory systems
In bacteria there are often several layers of regulation governing the expression of 
genes involved in metabolism and redox states (Green & Paget 2004). The existence of a 
dynamic network o f interactions between these systems means that bacteria can ‘fine 
tune’ their energy metabolism to give them the maximum possible energy yield for a 
given energetic outlay. This is done by deploying components of the aerobic, anaerobic 
and fermentative metabolism, such as cytochrome oxidases and nitrate reductases, to 
maximise the potential difference between electron donors and the terminal electron 
acceptors o f the electron transport chain. Oxygen is the preferred electron donor, with an 
redox potential midpoint o f Elo= +820mV, followed by nitrate (Elo+ +430mV) and 
finally organic molecules such as fumarate (Elo= +30mV) that are used in the 
fermentative metabolism. The use of oxygen and nitrogen as terminal electron acceptors 
means that, in contrast to fermentation, redox balance does not have to be maintained in 
the cell. The regulation of the electron transport chain is also linked to glycolysis and the 
TCA cycle, where absence of oxygen will induce the formation of the glyoxylate shunt 
pathway, enabling the bacterium to derive energy from pyruvate as a metabolic product 
of fatty acid degradation. The manipulation of these regulatory mechanisms in M 
tuberculosis would be likely to aid its survival in nutrient or oxygen starvation 
conditions.
The utilisation of the high-redox potential oxygen in energy metabolism however 
does have a cost. Molecular oxygen degrades to a free radical state comparatively easily, 
since its two unpaired electrons have parallel spin and occupy separate orbitals in the gas, 
giving the molecule a paramagnetic nature. Unless both of these electrons pair with
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electrons of the complementary spin at the same time, a one-electron reduction will take 
place yielding the superoxide radical, 02*'; see Demple (1991) for a review. Bacteria can 
detoxify superoxide to hydrogen peroxide using the enzyme superoxide dismutase to 
produce the relatively unreactive hydrogen peroxide; however if the hydrogen peroxide is 
not reduced further by catalase to yield water and molecular oxygen it forms the highly 
reactive hydroxyl radical in the presence of transition metals such as Fe2+ (Imlay & Linn 
1988). Organic hydroperoxides may form organic peroxide radicals, which are 
analogous to hydrogen peroxide and must be reduced by alkyl hydroperoxidases. 
Hydroxyl radicals will attack almost all biological macromolecules, including DNA and 
lipids. Superoxide radicals are also produced by the enzyme phagocyte oxidase in host 
cells as a bactericidal mechanism during an infection, in which case the detoxification 
mechanisms o f the bacteria are induced as a method of surviving within the host. 
Furthermore, in the absence of carbohydrate sources or oxygen, as is hypothesised to 
occur in human M. tuberculosis granuloma environments, the bacterium would be at a 
greater advantage if it were able to switch off the then unnecessary and potentially 
deleterious aerobic metabolism and its concomitant superoxide production (reviewed in 
Nystrom (1999)). Reactive nitrogen intermediates may also be formed by a variety of 
mechanisms and may combine with reactive oxygen intermediates to further damage the 
cell. See Figure 1.1 (adapted from Nathan & Shiloh (2000)) for a schematic diagram of 
the reactive oxygen and nitrogen intermediates involved in causing cellular damage.
A number of global regulatory pathways interact to control the bacterial response 
to oxidative stress. These have been principally studied in Gram-negative bacteria such
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as E. coli, in which the SoxS, Fnr, OxyR, NarL and ArcB-ArcA systems respond to 
changes in redox; and Fur and Crp sense iron concentration and catabolites, respectively. 
See Figure 1.2 ( adapted from Iuchi & Weiner (1996)) for a diagram of the mechanisms 
of action of the four principal oxygen-sensing systems.
1.2.1.1 ArcB-ArcA
One system that may be relevant when considering a role for the SenX3-RegX3 
two component signal transduction system is the ArcB-ArcA two component signal 
transduction system of E. coli.
ArcB is a membrane-bound sensor protein in E. coli whose ability to 
autophosphorylate is inhibited by oxidation of two critical cysteine residues (Malpica et 
a l  2004) caused by the presence of a large pool of oxidised quinone electron carriers 
(Georgellis et al. 2001). Under microaerobic conditions the pool of oxidised quinones 
decreases, enabling autophosphorylation of ArcB, subsequent phosphorylation of ArcA 
and modulation o f the bacterium’s transcriptional activity. ArcB is constitutively 
synthesised in E. coli; however arcA is expressed approximately four-fold higher 
anaerobically (Iuchi & Lin 1992). The kinase activity of ArcB can be enhanced by the 
presence of other metabolic intermediates such as D-lactate (Rodriguez et al. 2004), 
suggesting at least two levels o f control for this system. There are several transcriptional 
start sites in the ArcA promoter, one of which is dependant on Fnr for activity (Compan 
& Touati 1994), and promoter studies using ArcA itself showed that ArcA displays high 
affinity for a 141 bp region downstream of the pyruvate formate-lyase promoter
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Figure 1.2: The four principle oxygen sensing systems of E. coli. Black arrows represent 
metabolic interactions, purple arrows and bars represent stimulation and inhibition, 
respectively. Adapted from Iuchi & Weiner (1996).
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(Drapal & Sawers 1995). A 65 bp region o f the sodA promoter was protected by lysate 
o f cells overproducing ArcA (Tardat & Touati 1993). Iuchi & Weiner, in their review 
(1996), suggest that this is indicative of ArcA binding as an oligomer, or a monomer that 
recognises multiple sites.
It is thought that M. tuberculosis can adapt to nutrient starvation (Nyka 1974) and, 
despite its inability to survive sudden anaerobiasis (Loebel et a l 1933), can survive 
anaerobiasis if  subjected to incrementally decreasing levels of oxygen (Wayne 1977). 
These are conditions hypothesised to exist within the human granuloma, and metabolic 
shutdown o f M. tuberculosis is likely to be the cause o f the latent phenotype seen in 
clinical infection. In other organisms, viz E. coli, the ArcB-ArcA system is responsible 
for the shutdown of the aerobic carbon metabolism as the bacterium enters stationary 
phase (Iuchi & Lin 1988). This prevents the free radicals produced by the aerobic 
metabolism damaging the proteins of the cell (Benov & Fridovich 1995; Dukan & 
Nystrom 1998) when it is not needed, especially during a time of decreased protein 
turnover. Mutants of ArcA lose viability more than the wild-type in stationary phase 
induced by carbon starvation (Nystrom et al. 1996). Activity of the OxyR system also 
plays a role in survival of E. coli to stationary-phase survival (Dukan & Nystrom 1999), 
however OxyR is present as a pseudogene in M. tuberculosis (Deretic et al. 1997) and 
there are no clear homologues that may be performing its function in this organism to 
which adaptation to and survival in a latent form is critical.
1.2.1.2 Fnr
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Fnr senses oxygen directly in E. coli, and was discovered by mutations that 
produced strains deficient in nitrate, nitrite and fumarate reductases. Sensing occurs by 
reduction of an iron-sulphur cluster in the presence of oxygen, upon which the protein’s 
DNA binding activity alters, causing up- and down-regulation of a number of operons, 
although it is predominantly a transcriptional activator of operons involved in anaerobic 
metabolism. Key operons regulated by Fnr are pyruvate formate lyase, and the 
cytochrome oxidases o and d. Fnr also repressed its own synthesis under anaerobic 
conditions (Spiro & Guest 1987) and has strong homology to Crp (catabolite repressor 
protein) (Guest 1992), which extends to the similarity of their DNA-binding sequences 
and gave rise to the Crp-Fnr family of transcriptional regulators (Shaw et al. 1983).
1.2.1.3 OxyR
OxyR was discovered as a result of the study of E. coli and S. typhimurium 
mutants resistant to high levels o f hydrogen peroxide, which showed high levels of 
catalase and alkyl hydroperoxide reductases that are critical in the response of the 
bacterium to oxidative stress (Demple & Halbrook 1983; Christman et al. 1985). OxyR 
was subsequently shown to bind to the catalase I (katG) promoter under oxidising, but 
not reducing conditions (Toledano et al. 1994). In E. coli OxyR is constitutively 
expressed but becomes active after oxygen exposure. It appears to bind to a motif o f four 
ATAG motifs in adjacent major grooves on one face of the DNA helix (Toledano et al. 
1994).
1.2.1.4 SoxR
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SoxR (superoxide resistance) was originally identified as a mutant that conferred 
resistance to superoxide generating agents (Greenberg et al. 1990). Upon oxidation of its 
two iron-sulphur clusters it upregulates transcription of SoxS, which then regulates 
transcription of a number o f genes including sodA (Hidalgo & Demple 1994; Hidalgo et 
al. 1995; Wu et al. 1995). Although this system contains two components, one being a 
sensor and another being a regulator, it does not constitute a bona fide two component 
signal transduction system since interaction between the two proteins does not occur at 
the phosphorylation level. It is likely that SoxR does not sense superoxide directly, since 
the system can also be activated by nitric oxide (Nunoshiba et al. 1993). SoxS can also 
interact with its own promoter, causing a two-fold decrease in expression (Nunoshiba et 
al. 1993).
1.2.1.5 Fur and Crp
Neither Fur (ferric uptake regulator) nor Crp respond to oxygen; however these 
proteins serve to sense the nutrient levels in the external environment and can modify the 
responses o f the bacterium to other agents. Fur homologues in other organisms such as S. 
typhimurium use iron availability as an indicator of their presence inside another 
organism, and upregulate the production of siderophores and a number of other virulence 
factors in preparation for their encounter with the innate immune response. Fur exhibits a 
level o f interaction with the more direct agents of the oxidative stress response, as 
discussed below.
Crp functions to sense the levels of cyclic AMP, which is a direct measure of 
energy levels within the cell (Pastan & Perlman 1970). Crp regulates the transcription of
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over 100 operons, and analysis o f the functions of the Crp-Fnr family of regulators shows 
that they govern diverse responses within the cell, including responses to oxidative and 
nitrosative stress, and redox sensing. For a review see Komer et al. (2003).
1.2.2 Interactions between the global regulators of E. coli
The key regulators of the oxidative stress responses of E. coli are well connected, 
offering a dynamic and broad response to diverse stimuli. The major elements of the 
oxidative stress response therefore are often controlled by a number of different 
regulators that may synergise or antagonise each other depending on the environmental 
stimuli and the nutrients available.
Cytochrome d oxidase, for example, is expressed maximally in E. coli at 
microaerobic levels in the presence of activated ArcA, minimal aerobic repression by the 
histone-like protein H-NS and minimal anaerobic repression by Fnr (Govantes et a l
2000). sodA expression is controlled by at least six different regulatory proteins, 
including Fur , ArcA, SoxS, SoxQ, Fnr and IHF (Compan & Touati 1993), where SoxS 
and SoxQ increase expression of sodA and the other proteins act as repressors of sodA 
transcription. This has the effect of linking the expression of sodA to iron availability 
(Fur), and the level of oxygen in the environment (ArcA) (Tardat & Touati 1991). 
Consistent with these results, the binding sites for ArcA and Fur overlap (Tardat & 
Touati 1993). At other levels the presence of intracellular iron, which activates Fur, also 
increases the rate at which reactive oxygen intermediates form, stimulating a number of 
other pathways.
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Fnr is required for maximal ArcA expression, and can weakly induce transcription 
of ArcA under anaerobic conditions (Compan & Touati 1994). ArcA also recognises the 
metabolic conditions controlled by members of the Crp and Fnr regulons, creating 
another level o f interaction.
It can be seen from these two examples that the response of E. coli to oxidative or 
nitrosative stress, and its metabolic state, are closely linked and it has been possible to 
elucidate many of these mechanisms due to the comparative ease by which E. coli can be 
manipulated in the laboratory.
13 Oxidative stress responses of M. tuberculosis
In contrast to the increasingly detailed understanding of the oxidative stress 
responses in E. coli and some other gram-negative bacteria, the molecular basis for 
resistance to oxidative stress in M. tuberculosis is relatively poorly understood. 
Furthermore, due to the considerable evolutionary differences between the mycobacteria 
and the gram-negatives, and the strikingly different lifestyles of the pathogenic slow- 
growing mycobacteria, it is conceivable that the approach that M. tuberculosis takes to 
oxidative stress defence is broadly different to that of E. coli. Nevertheless, our 
understanding of the regulatory systems of E. coli allows certain assumptions to be made 
of apparently similar systems in M. tuberculosis, which may subsequently decrease 
research time and discount unlikely hypotheses.
13.1 Homology of the M. tuberculosis oxidative stress responses to those of E. coli
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Many of the well characterised key regulators in E. coli, such as SoxR, OxyR and 
Fnr either have no clear homologues in M. tuberculosis, or are present as pseudogenes 
(Deretic et al. 1995). In M. tuberculosis OxyR is a pseudogene (Deretic et al. 1995). In 
M. smegmatis and the Gram-negative bacteria OxyR controls the response to low doses 
of hydrogen peroxide that protects the bacteria against subsequent high-dose challenges 
with the same agent. In M. tuberculosis however, this response is limited to the induction 
of a single catalase, KatG (Sherman et al. 1995). KatG is a determinant o f isoniazid 
sensitivity, and is non-functional in all clinical, isoniazid-resistant strains. These KatG 
mutant strains have acquired secondary site mutations that cause overexpression of AhpC 
(Sherman et al. 1996) which may compensate for the absence of KatG in the 
detoxification o f organic peroxides.
AhpC was not initially seen to be produced at detectable levels in M. tuberculosis 
in vitro during aerobic growth, even though it is present as an unmutated gene 
(Dhandayuthapani et al. 1996; Zhang et al. 1996), and although it is possible that this is 
due to the loss of OxyR (Dhandayuthapani et al. 1997), other reports (Springer et al.
2001) have shown AhpC of M. tuberculosis to be expressed in statically grown cultures 
and in macrophages but not aerobically grown cultures, pointing to a second level of 
regulation for AhpC. AhpC was subsequently shown to have a role in peroxynitrite 
resistance and survival of M. tuberculosis in macrophages (Master et al. 2002), and this 
remains consistent with previous work on AhpC with other reactive oxygen intermediates 
when one considers that peroxynitrite is a product of reactive oxygen intermediate 
breakdown and may be one of the most damaging products o f oxidative and nitrosative 
stress.
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Other possible homologues of global regulatory proteins in E. coli in M. 
tuberculosis are Fur, which is divergently transcribed with katG (Pagan-Ramos et a l 
1998) and two potential Crp homologues, Rv3676 (Rickman et a l  2005) and Rv1675c 
(A. Blockley, personal communication). The ArcB-ArcA two component signal 
transduction system of E. coli may have a homologue in the SenX3-RegX3 two 
component signal transduction system o f M. tuberculosis; this was examined this thesis, 
and a publication arising from work partially contained within this thesis (Rickman et a l 
2004).
1.3.2 Two component signal transduction systems
Two component systems in bacteria, as typified by the ArcB/A system of E. coli, 
often respond to signals from the external environment, and in pathogenic bacteria will 
increase the bacterium’s chance of survival during infection (Cheung et a l  2004). As 
such, it is possible to see that bacteria that ordinarily encounter diverse environments tend 
to have a greater number of two-component systems encoded in their genome. E. coli 
and B. subtilis, for example, contain between 30 and 50 two component systems. M. 
tuberculosis contains 11 two-component systems, perhaps as a reflection of the fact that it 
exists almost entirely within a host. It is possible, however, that M. tuberculosis can 
‘compensate’ its lack of two-component signal transduction systems with the serine- 
threonine protein kinases (Galperin & Gomelsky 2005).
The M. tuberculosis two-component systems, then, could be assumed to respond 
to the host environment that it encounters in the human body. M. leprae has an even 
more limited environmental range than M. tuberculosis, in that it can only infect a few
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different tissues in the human body. M. leprae is considered to have evolved from M. 
tuberculosis by reductive evolution (Monot et al. 2005), and although its genome is 
approximately the same size as that of M. tuberculosis, it codes for approximately half 
the functional genes that are encoded in the M. tuberculosis genome (Cole et al. 2001). 
The remainder of the genes encoded in M. tuberculosis are present as pseudogenes or are 
deleted in M. leprae, giving rise to the assumption that the genes still remaining in M. 
leprae reflect the minimum geneset necessary for the mycobacterial intracellular lifestyle.
1.3.2.1 The SenX3-RegX3 two component signal transduction system of M. 
tuberculosis.
One of the 11 two component systems of M. tuberculosis, and one of the four two 
component systems conserved in M. leprae, is the SenX3-RegX3 two component signal 
transduction system. Previous in silico analysis of this system by R. Buxton and J. Millar 
(NIMR) used BLAST searches to identify RegX3 as a possible orthologue of ArcA 
(Drury & Buxton 1985; Iuchi & Lin 1988) o f E. coli, and SenX3 as a possible orthologue 
of Mak2p (Buck et al. 2001) of Schizosaccharomyces pombe (Buck et al. 2001; Rickman 
et al. 2004). ArcA is part o f the PAS-domain containing ArcB-ArcA two component 
system o f E. coli that is involved in the shutdown of aerobic metabolism genes when the 
bacterium enters a microaerobic environment (Compan & Touati 1994; Alexeeva et al. 
2003; Levanon et al. 2005). Mak2p is a PAS-domain containing histidine kinase that is 
important in the defence of S. pombe to peroxide damage.
An isogenic mutant of the regX3 gene of M. tuberculosis (called Tame 15) was 
made contemporaneously with this study and was shown to be attenuated in a variety of
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macrophage and macrophage-like infection assays, and immunocompetent and 
immunodeficient mice (Parish et al. 2003). It should be noted that in this study that 
Tame 15 did not grow normally in vitro, which may be responsible for the apparent 
attenuation of the strain when compared to the growth of the wild-type in the infection 
models. The authors did not, however, complement Tame 15 with the wild-type allele. It 
seems that the deleted region of Tame 15 included part of the region between senX3 and 
regX3 that contains three mycobacterial interspersed repeat units (MIRUs) (T. Parish, 
personal communication). MIRUs are used for typing strains o f mycobacteria and may 
have a regulatory function (Supply et al. 1997).
13.2.2 The DosR-DosS two component signal transduction system of M. 
tuberculosis.
It is entirely plausible that the oxidative stress responses of M. tuberculosis are at 
least partially governed by systems that have no equivalent in E. coli or other Gram- 
negative bacteria. One of the few two component signal transduction systems of M. 
tuberculosis o f which we have a clear understanding of the stimulus and potential 
relevance to the oxidative stress responses of M. tuberculosis is the DosR-DosS system. 
The DosRS two-component system is likely to be involved in the sensing of oxygen, 
although probably not directly (Park et al. 2003).
DosR is a response regulator of M. tuberculosis controlled by two sensor histidine 
kinases, DosS and DosT (Roberts et al. 2004) that is required for dormancy survival of 
M. tuberculosis in an in vitro model o f oxygen starvation-induced metabolic shutdown
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(Boon & Dick 2002) and is expressed in standing shallow broth cultures and in vivo 
granuloma models (Florczyk et a l  2003; Karakousis et al. 2004; Kendall et al. 2004).
It is likely that DosR is involved in the adaptation of M. tuberculosis to stationary 
phase (Voskuil et al. 2004); however a study of the transcription of the two-component 
systems of M. tuberculosis during infection of human peripheral blood monocyte-derived 
macrophages shows that the SenX3-RegX3 two component signal transduction system is 
induced partially at 18 hours post infection and strongly at 48 hours post infection; yet 
disappears entirely by the time DosR is induced at 110 hours post infection (Haydel & 
Clark-Curtiss 2004). This suggests that a role for DosR in stationary-phase adaptation 
does not preclude a role for the SenX3-RegX3 two component signal transduction system 
in oxygen sensing, and raises the possibility that the two systems may be acting in 
concert. In addition to the DosR system, it has been suggested that a universal stress 
protein (USP) response may be implicated in the adaptation of M. tuberculosis to low- 
oxygen conditions, and may play a role in latency (see OToole & Williams (2003) for a 
review o f USPs).
Work on a DosR mutant has shown them to be hypervirulent (Parish et al. 2003), 
which may be due to disregulation of the alpha-crystallin gene (Hu et al. 2005). A DosR 
homologue, DevR, exists in M. smegmatis where it is required for adaptation to oxygen 
heat stress resistance (OToole et al. 2003), indicating that this organisms may simplify 
the study of the DosR response in M. tuberculosis.
13.3 Two component systems of other bacteria
1.3.3.1 FixL of Rhodobacter spheroides
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FixL homologues are found in the bacteria Rhizobium meliloti, Bradyrhizobium 
japonicum and Azorhizobium caulinodans, and in these organisms forms part of a 
hierarchy of regulatory genes, constituting one half of a two-component signal 
transduction system (along with FixJ) that responds to environmental nitrogen and 
oxygen conditions, controlling nitrogenase synthesis and the transcription of genes when 
the bacterium encounters microaerobic environments. Nitrogenase is the principle 
method by which nitrogen is fixed to ammonia in these bacteria, and needs to be tightly 
regulated.
FixL is a membrane-bound haem-containing protein that is able to phosphorylate 
the FixJ response regulator. It has three domains; one N-terminal membrane anchor, a 
haem-binding central domain and a C-terminal domain with autophosphorylation and 
kinase activity. The haem prosthetic group in the central domain is associated with a 
PAS domain, operates to sense oxygen conditions, and controls the kinase and 
phosphatase activity of the c-terminal domain (Gong et al. (1998).
Under low oxygen conditions, the kinase activity of the N-terminal domain of 
FixL is increased, resulting in a larger proportion of phosphorylated FixJ, probably at its 
N-terminal domain. The C-terminal DNA-binding domain of FixJ then allows it to 
initiate transcription of target genes. When oxygen levels increase, the level of 
phosphorylated FixJ is decreased as the phosphatase activity of the N-terminal domain of 
FixL increases. For reviews please see Fischer (1994) and Gilles-Gonzalez & Gonzalez 
(2004).
1.3.3.1 NifL of Azotobacter vinlandii
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NifL has been studied as a regulatory protein of Azotobacter vinlandii and 
Klebsiella pneumoniae. It may also be part of a two-component signal transduction 
system with NifA, and also controls regulation of the fixation of atmospheric nitrogen to 
ammonia in plant root nodules under conditions of nitrogen deprivation. NifL responds 
to oxygen and fixed nitrogen by means o f either one or two (depending on the organism) 
PAS domains, one of which contains flavin adenine dinucleotide as a prosthetic group. 
NifL is hypothesised to regulate NifA by a number of methods. The transcriptional 
activator NifA is constitutively active in both A. vinlandii and K. pneumoniae, and its 
activity is lessened when NifL is present. For a review please see Martinez-Ardudo et a l 
(2004).
13.4 PAS domains of sensory proteins in M. tuberculosis
PAS domains are sensory input domains first identified as a motif in the 
Drosophila melanogaster period clock protein, the E. coli aerotaxis receptor, and the D. 
melanogasler single-minded protein (Huang et al. 1993) that typically sense light, 
oxygen and redox potential (Hefti et al. 2004). Although PAS domains are always 
located on the inside of the cell, it is possible to monitor changes in external stimuli 
through, for example, alterations in the concentration of metabolites arising from the 
electron transport chain, as is the case for ArcB (Georgellis et al. 2001; Malpica et al. 
2004). Interestingly, the ArcB sensor from Haemophilus influenzae is able to signal 
redox states even after its PAS domain has been removed (Georgellis et al. 2001).
PAS domains often do not have a conserved primary structure and are difficult to 
identify by sequence alone. For reviews see Taylor & Zhulin (1999) and Gilles-Gonzalez
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& Gonzalez (2004). Given the homology of SenX3 to other protein containing PAS 
domains, J. Saldanha (Mathematical Biology, NIMR) used structural modelling to find 
that SenX3 contains an atypical, or PAS-like, domain towards the membrane-anchored 
N-terminus of the protein with homology to the PAS domain of FixL (Miyatake et al.
2000), a nitrogen fixation protein from Rhizobium meliloti that regulates genes that allow 
the utilisation of nitrogen as a terminal electron acceptor in the absence of oxygen 
(Figures 1.2 and 1.4). The PAS domain of FixL senses oxygen concentration through 
association with a haem prosthetic group, and bears strong homology to a recently-solved 
PAS domain in the E. coli direct oxygen sensor, Dos (Park et al. 2004). Dos has a role in 
mediating the transition of E. coli from aerobic to anaerobic metabolism (Delgado-Nixon 
et al. 2000). The homology of the SenX3 PAS domain to the PAS domains in other 
oxygen-sensing systems further supports a hypothesis for the SenX3-RegX3 two 
component signal transduction system in oxygen sensing. Attempts have been made by 
C. Joseph and A. Pastore (Division of Molecular Structure, NIMR) to purify both SenX3 
and the SenX3 PAS domain in isolation in soluble form but were unsuccessful, although 
it has been shown to be possible to express and purify two-component sensory proteins 
from other organisms (Potter et al. 2002).
No definite sensor domains have been proved for DosS, the cogent histidine 
kinase for DosR, however two potential GAF domains have been identified through 
homology searching, although the N-terminal GAF domain may in fact be a PAS domain 
(N. Stoker, personal communication). Recently, two orphan (i.e. not adjacent) gene 
products have been shown to be able to transphosphorylate, and may be a twelfth two
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Figure 1.3: The PAS domain of Rhizobium meliloti FixL (A), and the predicted PAS 
domain of SenX3 (B). Secondary structure is coloured red for helices and yellow for 
strands, and labelled according to the sequence alignment in Figure 1.4. Note the loss of 
helices aD and aE leading to a more open structure in the modelled SenX3 PAS domain. 
Adapted from Rickman et al. (2004).
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Figure 1.4: Alignment of the PAS domain regions of SenX3 from M. tuberculosis, M. 
leprae, M. bovis, M. smegmatis, NifL from Azotobacter vinlandii and FixL from R. 
meliloti. a-helices, dark shading; /3-strands, light shading; A-I, PAS domain region. The 
structure of the PAS domain of FixL has been solved (Miyatake et a l 2000) and 
represents the actual secondary structure of the domain; secondary structure of the other 
PAS domains was predicted. Note the missing o-helical elements aD and aE in the 
mycobacterial PAS domains. Adapted from Rickman et al. (2004).
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component system o f M. tuberculosis (Morth et al. 2005). The putative sensor protein, 
encoded by Rv3220c, contains both a PAS and a GAF domain.
13.5 M. tuberculosis can avoid the normal bactericidal mechanisms of the host
After infection of a host the bacterium is engulfed by alveolar macrophages. 
Generally with phagocytes, engulfed bacteria are destroyed by acidification of the 
phagosome in which it resides, fusion of the phagosome with lysosomes and exposure to 
reactive oxygen and nitrogen radicals in the oxidative burst. Later in the infection other 
mechanisms act on the bacteria such as oxygen limitation and nutrient starvation within 
the granuloma, where surviving bacteria encounter low oxygen and carbon levels.
Live tuberculous bacilli have mechanisms that allow them to survive and replicate 
within the alveolar macrophages that are designed to protect against infection. The first 
mechanism o f mycobacterial immune evasion to be discovered was the ability of the 
bacillus to prevent phagosome-lysosome fusion (Armstrong & Hart 1971). M. 
tuberculosis can also enter macrophages without activating them, avoiding some or all of 
the potential damage from the oxidative burst that is stimulated by normal phagocytosis 
of bacteria. For reviews of the entry mechanisms of M. tuberculosis into macrophages 
and the avoidance of phagosome-lysosome fusion, including recent advances in the field, 
please see Vergne et al. (2004), Pieters & Gatfield (2002) and Pieters (2001).
1.4 The role of oxidative stress during tuberculosis infection
During the later stages of infection M. tuberculosis is able to enter a period of 
metabolic shutdown in this environment, which allows it to remain viable for later
61
reactivation disease and transmission (Wayne & Sohaskey 2001). There are also 
suggestions that exposure to low-oxygen conditions increases the virulence of M  
tuberculosis during infection (Bacon et al. 2004).
1.4.3 Oxidative and nitrosative stress in the macrophage
The occurrence of oxidative stress in the macrophage environment can be divided 
into two broad categories: i) events immediately after infection of the macrophage and ii) 
late-stage oxidative stress resulting from a multi-cellular response to the infected 
macrophage. A cartoon representation of the events may be seen as Figure 1.5.
1.4.3.1 Events that occur immediately after infection
The events that occur immediately after infection form the oxidative burst, 
consisting o f short-lived oxygen and nitrogen radicals that primarily damage structures 
on the surface o f the bacterium. The response of the mycobacterium to these agents is 
critical to its ability to create a productive infection. For an in-depth review of this 
subject see Nathan & Shiloh (2000).
The cell-wall associated macrophage protein phagocyte oxidase (Phox) is capable of 
generating the superoxide radical O2* that can also form reactive oxygen intermediates 
such as hydrogen peroxide radicals (H2O2) and hydroxyl radicals (OH*), which interact 
with organic molecules (often on the bacterial cell surface) to create the highly damaging 
organic hydroperoxides. The highly charged superoxide radical cannot pass the cell wall 
and may only damage surface structures when released in the oxidative burst, whereas
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Figure 1.5: Diagram illustrating stresses that occur within the macrophage after infection 
by M. tuberculosis.
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some of its polar breakdown products can diffuse into the bacterium and degrade the 
cellular machinery.
Macrophages also rely on the cytoplasmic protein inducible nitric oxide synthase 
(iNOS) to create the nitroxide radical (NO*). The nitroxide radical will also damage 
structures at the bacterial cell surface, and may combine with the superoxide radical to 
form peroxynitrite, which is a highly damaging reactive oxygen intermediate that is very 
short lived and can also diffuse across the bacterial membrane to damage structures 
inside the cell.
1.4.3.2 Events that occur later in the infection process
Late-stage events in the macrophage occur when the infected macrophages have 
been unable to kill or control the replication of the mycobacteria. Immune cells 
aggregate around the focus of infection and form a granuloma. It is thought that nutrients 
and oxygen are limited in this environment, in an effort to kill the bacteria by siege 
tactics. The granuloma also has the function of sealing the focus o f infection and 
preventing further spread, and may eventually calcify into a hard, impenetrable node. It 
is also prudent to consider the role of oxygen and nitrogen radicals to bacterial in this 
situation.
The tricarboxilic acid (TCA) cycle of bacteria is the favoured source of energy 
liberation during aerobic growth on carbon sources, since it provides the most efficient 
yield o f energy; however it produces a large amount of superoxide radicals as a 
byproduct. The damaging effect o f the superoxide radicals and their intermediates on the 
proteinaceous cellular machinery can be fixed by a number of specialised enzymes such
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as methionine sulphoxide reductase (Nathan & Shiloh 2000), but is also mitigated by the 
high turnover of proteins in the rapidly dividing cells. Clearly, if the ability to use this 
method of energy liberation is not available, through either lack of carbon sources or lack 
of oxygen to use as a terminal electron acceptor, then the bacterial will grow more slowly 
and alternative metabolic pathways used. Although an obligate anaerobe, M. tuberculosis 
is able to survive oxygen withdrawal in a nonreplicative state (Wayne & Lin 1982). 
Interestingly, the fermentation pathway is conserved in M. tuberculosis (Cole et a l
1998), hinting that the bacillus may have methods of generating energy in the absence of 
oxygen. The alternative routes to the electron transport chain produce fewer radicals, and 
since the slower growth of the bacteria means that the protein turnover is lower and there 
is less energy available for protein fixing, it is important for the bacteria to switch off the 
TCA cycle, otherwise it will gradually lose viability under these conditions. For a review 
of this subject please see Nystrom (1998; 2002).
The mycobacteria are also able to evade the late-stage responses by entering a 
state of latency, of which very little is known in vivo. During this time the bacteria are 
hypothesised to be in a period of metabolic shutdown that has been referred to as “viable 
but non-culturable”. For a review of nonreplicating persistence in M. tuberculosis please 
see Wayne & Sohaskey (2001).
This form of persistence accounts for much of the great burden of tuberculosis on 
the world population, since around two billion people are infected by M. tuberculosis by 
skin test and yet only a small fraction of these have active tuberculous disease (WHO
2001). Latent tuberculosis may reactivate to spread and cause disease if  the individual
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carrying latent tuberculosis becomes immunosupressed in some way, such as through 
HIV infection, malnutrition or immunosupressive cancer therapy.
The specific macrophage-like agents will now be discussed as they apply to the in 
vitro assessment of M  tuberculosis.
1.433 Low oxygen
One method of discovering whether the SenX3 and RegX3 proteins are acting like 
ArcA-like is to assess their growth in oxygen-limited culture. Ordinarily, given excess 
oxygen, the bacteria will grow until all of the available nutrients in the media are 
exhausted and the byproducts of the metabolism have built up to toxic levels. In rolling 
bottles this will typically occur at an OD600 o f four to six. However if the bacteria are 
maintained in standing cultures with little air included (low headspace ratio, or HSR), 
then the bacteria will enter stationary phase at a much lower optical density due to a lack 
of oxygen. For a review of the E. coli adaptations to stationary phase please see (Spiro & 
Guest 1991)
It is possible to hypothesise that if  the senX3 and regX3 null mutants are acting 
like the ArcA-B system of E. coli, then they will be unable to shut down their TCA cycle, 
despite the lack of oxygen. In E. coli, bacteria lacking the ArcA-B system are unable to 
shut down their TCA cycle and gradually lose viability when forced to shift to stationary 
phase by anaerobic growth or carbon starvation (Nystrom et al. 1996), and a similar 
phenotype is seen in E. coli lacking superoxide dismutase A (Spiro & Guest 1991; 
Nystrom et al. 1996; Dukan & Nystrom 1999). If superoxide radicals are building up in 
the senX3 and regX3 null mutants of M. tuberculosis more than the wild-type as they
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enter stationary phase due to oxygen starvation, then one would expect to see slower 
growth as the bacteria become damaged.
1.4.3.4 Nutrient starvation
Another method of inducing a phenotype in an ArcA mutant o f E. coli is to 
withdraw its carbon source and in that way limit aerobic respiration (Nystrom et a l 
1996). Mutants of arcA in E. coli dramatically lose viability more than the wild-type 
after prolonged incubation without nutrients, as the bacteria are no longer replicating 
quickly and the internal structure of the cells becomes progressively damaged by 
oxidative stress generated by the still-active TCA cycle. A review of this concept can be 
seen in Nystrom (1999). The same technique can be applied to the senX3 and regX3 null 
mutant strains of M. tuberculosis, in which one would expect the mutants to lose viability 
more than the wild-type after washing and prolonged incubation in phosphate-buffered 
saline.
1.4.3.5 Superoxide stress
The most commonly used superoxide generator is paraquat, also known as methyl 
viologen, gramoxone and 1,1 -dimethyl-4,4 '-bipyridinium dichloride. This is dissolved in 
water and added to liquid cultures of M. tuberculosis, where it attacks the outside of the 
cell. Due to its charge it cannot cross the membrane, but it may be reduced further to the 
whole variety of reactive oxygen intermediates and therefore represents a very broad 
attack on the oxidative stress defences o f the bacterium. Previous work at NIMR has 
shown that M. tuberculosis exposed to a final concentration of 50mM for 24 hours will
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cause a 60-80% drop in the viability o f the culture (L. Rand, personal communication). 
Like most stressing agents, lower concentrations can be used to study the effect on 
transcription without the large drop in culture viability.
The effect of superoxide on the senX3 and regX3 null mutants of M. tuberculosis 
can be studied to see if there is any difference in the ability of either of these strains to 
resist the stress more than the wild-type. Any difference can be taken as an indication 
that the gene products have a role in either sensing or coordinating the response to 
damage by superoxide or its breakdown products and downstream effects.
1.4.3.6 Nitrosative stress
Although there is no strong evidence for the involvement of the SenX3/RegX3 
system of M. tuberculosis in the direct sensing and response to nitroxide radicals, it is 
possible to hypothesise that the mutants would be more susceptible to damage by 
nitroxide radicals if the SenX3/RegX3 system were acting like ArcA of E. coli, 
overproducing superoxide which then interacted with the nitroxide radicals to form 
peroxynitrite which damaged the cells. The effects of nitrosative stress are thought to be 
particularly important in M. tuberculosis, data for which is reviewed in (Nathan & Shiloh 
2000). One way of assessing the ability of the senX3 and regX3 null mutants to resist 
nitrosative stress is to add silver nitrite to bacteria in acidified media to a final 
concentration of 3mM. Although the bacteria can be grown in normal liquid media, they 
must be washed and resuspended in media adjusted to pH5.5 to allow the silver nitrite to 
become labile and release nitrogen.
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Assuming the senX3 and regX3 gene products do not specifically interact with the 
reactive oxygen intermediate protection mechanisms (such as superoxide dismutase) then 
there would be no reason to expect to see a phenotype difference in normal aerobic 
growth of the senX3 and regX3 null mutants. During normal aerobic growth the wild- 
type, and strains that may hypothetically be deficient in TCA cycle shutdown, would 
generate the normal amount of superoxide radicals. When nitroxide radicals were added, 
some o f the superoxide radicals from the TCA cycle would be detoxified, and some 
would combine with nitroxide radicals to damage the cells.
However, after microaerobic growth in which the wild-type had shut down its 
TCA cycle, mutants deficient in this ability would be expected to generate more internal 
oxidative stress than the wild-type if  the system were acting like ArcA of E. coli 
(Nystrom et al. 1996). Excess superoxide radicals would combine with the nitroxide 
radicals to produce the highly damaging peroxynitrite that would damage the senX3 and 
regX3 null mutants more than the wild-type. Therefore it could be hypothesised that the 
senX3 and regX3 null mutants, if  they are generating larger amounts of internal oxidative 
stress than the wild-type under microaerobic conditions, would be more susceptible to 
damage by nitrosative stress than the wild-type after microaerobic growth.
1.4.3.7 Organic hydroperoxide stress
The products of the oxidative burst will ultimately combine with organic 
molecules of the bacteria to form the highly-damaging organic hydroperoxides. The 
addition of tert-butyl hydroperoxide to cultures of M. tuberculosis seeks to replicate this 
end-stage effect of free radical damage. Although the general pathway of cellular
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damage is maintained by this method, in other bacteria there are specific responses and 
regulators that react to these particular methods of damage (Fuangthong et a l 2001; 
Sukchawalit et a l 2001; Fuangthong & Helmann 2002; Mongkolsuk et a l 2002; 
Panmanee et a l 2002). If SenX3 or RegX3 could be acting in this way then it would be 
expected for the senX3 and regX3 null mutants of M. tuberculosis to be more susceptible 
to damage by tert-butyl hydroperoxide than the wild-type.
There are a number of other reagents that form organic hydroperoxides, such as 
cumene hydroperoxide and plumbagin. tert-butyl hydroperoxide is soluble in water at 
most concentrations, and relatively easy to work with. Cumene hydroperoxide, for 
example, is supplied dissolved in an organic solvent (cumene) that may itself damage the 
bacteria. Cumene hydroperoxide is also insoluble in water at the concentrations needed 
for bactericidal levels against M. tuberculosis.
1.4.4 Measurement of stress studies
To look at the growth of a culture after stress it is necessary to take viable counts 
or optical density readings of stressed cultures, and also of unstressed controls. Paired 
cultures are used to eliminate problems caused by inherent generation time differences 
between strains and experiments are performed in triplicate to gain an idea of the 
reliability of the results.
Taking viable counts involves making ten-fold dilutions of an aliquot of the 
culture, spreading of samples on agar plates and counting the colonies that grow. 
Measuring the optical densities o f the cultures can also give an indication of the 
bactericidal level of an agent against a particular strain of M. tuberculosis but it is not
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possible to tell whether the bacteria are dead or in bacteriostasis unless the cell have 
lysed, thus lowering the optical density of the culture. Furthermore, some documented 
responses of M. tuberculosis to stress conditions include a thickening of the cell wall 
(Cunningham & Spreadbury 1998), in which case the optical density o f the culture would 
rise giving the appearance o f growth, when in fact bacterial numbers may have stayed 
stable.
It is important in these types o f study to use an appropriate concentration of the 
damaging agent, enough to cause a reliable drop in the viability of wild-type cultures. 
Often this can be ascertained by reading the previous literature for the appropriate 
organism, or by protocols acquired from other workers.
It is also important to ensure that all strains are at the same phase of growth since 
it is possible that two strains, although at the same optical density, will be at different 
growth phases and will react differently to the stress. For example, if one culture had 
recently been diluted from stationary phase then there would be likely to be a large 
quantity of bacteria in that culture that are still in stationary phase, or that are shifting out 
of stationary phase and are not growing evenly. This population of bacteria will respond 
differently to another culture that has grown from a small inoculum to the same optical 
density but is genuinely in exponential-phase growth. All of the experiments with 
aerobic cultures of M. tuberculosis in this thesis have been performed with early 
exponential-phase cells.
Although it is often possible to simply add the damaging reagent to the stressed 
cultures and leave the unstressed controls unmolested, the unstressed controls should 
properly have the solvent used to dilute the damaging agent added at an equal volume to
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that of the stressed cultures. Whereas adding a few hundred microlitres of water to a 
100ml culture of M. tuberculosis would be expected to make little difference to the 
viability of the control cultures, some damaging agents are soluble only in organic 
solvents, such as cumene or ethanol. These solvents would be expected to make a 
contribution to the growth or viability o f the cultures, and must strictly be added to the 
control cultures.
It is desirable to try and keep the volumes of added reagent similar in an 
experiment. For example, with a titration of damaging agent against multiple cultures of 
the same strain, the concentrations of stocks should be adjusted so that equal volumes are 
added to cultures to give the appropriate range of final concentrations.
1.4.5 Growth of mycobacteria in mouse models of infection
The mouse model of infection is a stalwart of studies of M. tuberculosis, enabling 
screening of strains for virulence. The use of mice allows sufficiently large populations 
of animals to be housed in a laboratory, both through cost and space considerations. This 
means that it is possible for a single experiment to easily contain enough animals to allow 
it statistical validity. Mice are easier to work with than guinea pigs or primates, and are 
sufficiently inbred to allow consistency of results. Mice are also unable to cough, 
reducing the potential hazard from the release of airborne M. tuberculosis when working 
with these animals.
The murine immune system and physiology has been the subject of extensive 
research, which makes the model attractive to those studying pathogenesis and the 
immunology of M. tuberculosis infection. Knockout mice are also available to allow
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assessment of mycobacterial virulence in, for example, a mouse deficient in the nitric 
oxide synthesis pathway.
The early cataloguing of the growth of M. tuberculosis in mice was performed by 
(Pierce et al. 1953), who showed that virulent strains o f M. tuberculosis grow 
preferentially in the lungs independently of the route of infection. A review o f the mouse 
model of M. tuberculosis infection can be seen by Orme & Collins (1994). The infection 
process as considered by the author follows.
Infection in the system used at NIMR is typically though intravenous injection 
into the tail vein, after which the mycobacteria disseminate through the murine vascular 
system to the organs. After 24 hours the bacteria disappear from the bloodstream, having 
been removed principally by the reticuloendothelial system. Large numbers of bacteria 
enter the spleen, since it has a high exposure to blood-borne particles and large quantities 
of phagocytes in which the mycobacteria can replicate. Bacteria also find their way to 
the lungs, where they replicate rapidly due the high oxygen levels present in lung tissue. 
Eventually the mice develop loose, poorly structured granulomas in the lung. Some mice 
are more susceptible to infection by M. tuberculosis than others; Balb/c and C57/B16 are 
commonly used, where Balb/C are generally resistant to infection displaying a Thl-type 
intracellular response to the infection.
Like all models of infection there are a number of factors to be considered when 
interpreting results.
i) Mice do not develop tight granulomas as seen in human infection. In fact, 
there is evidence to suggest that the predominant form of mycobacterial 
control in mice is exposure of the mycobacteria to nitric oxide (Chan & Flynn
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1999), whereas in humans it is considered that oxygen and nutrient limitation 
control mycobacterial spread as a function of the dense granulomas that form 
around the focus o f infection.
The wild-type strains of M. tuberculosis used in the laboratory and for mouse 
infection were originally isolated from human infections (Steenken & Gardner 
1946). They were chosen as laboratory reference strains due to their 
maintenance of colony morphology during repeated passage, something that 
was unusual amongst the clinical strains of M. tuberculosis examined for this 
purpose. Many laboratories routinely passage their reference strains through 
mice so that they retain virulence in this model, although it is likely that the 
genomic structure of the bacterium in changing somewhat.
Human infection by M. tuberculosis is predominantly by aerosol infection, 
whereas mice are usually experimentally infected by the intravenous route. 
Several groups are making efforts to create reliable aerosol infection models 
for mice, but the size, expense and safety considerations of the necessary 
equipment means that this model is not routinely used. It is also worth 
bearing in mind that M. tuberculosis given to mice by the aerosol route are 
more virulent than when given intravenously (North 1995).
Mice are typically infected intravenously with much larger doses of 
mycobacteria than a normal human aerosol infection; at least hundreds and 
frequently orders o f magnitude more than that. Humans, however, may have 
an infectious dose of just a few mycobacteria inhaled from the environment.
This may have implications for the pathogenesis and host response to the 
bacilli.
Although the murine model of infection is not a perfect mirror of human tuberculosis, 
it is necessary, and adequate, for initial screening of mutants of M. tuberculosis for 
hypervirulence or attenuation.
1.4.6 Macrophage models of M. tuberculosis Infection
Macrophage infections act a fast, convenient assay for screening strains of M. 
tuberculosis for attenuation, virulence or other in vivo phenotypes when there is not the 
time, space or desire to set up a long-running mouse infection. Macrophage infections 
can use any one of a variety of cells.
Ideally macrophages would be isolated from human lung tissue by alveolar 
lavage; these cells would be responding to tuberculosis infection in the most natural way 
although they would still be isolated from other compartments of the immune system, 
such as components of the acquired immune response. Unfortunately human alveolar 
macrophages obtained by lavage are difficult to get hold of and one would expect cells 
from different individuals to have different responses. Alternately macrophages can be 
isolated from the periphery by taking blood samples, but this may not yield a satisfactory 
number of cells and is likely to suffer from the same person-to-person variation in 
response.
The use of cell lines is a convenient method of obtaining large numbers of 
macrophage-like cells at low cost. They are available from human and mouse 
backgrounds, and cell lines are available that are deficient in various biosynthesis and
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immunological pathways. These knockout cell lines enable very specific questions to be 
asked of the interaction between the eukaryotic cell and the mycobacterium. The 
downside of using cell lines is that they do not represent a good model of infection. The 
cells have usually been through multiple passages, and may not have had the 
developmental cues necessary to allow them to form a proper response to infection. 
Furthermore, some cell lines are multinucleate or have abnormal numbers of 
chromosomes as a result of transformation, and will not act like their mortal parent cell 
types.
A compromise between convenience and likeness to a true infection can be 
reached by using primary cells from mice. Large numbers of cells can be recovered from 
the thigh bones of mice and cultured to enrich them for macrophages. These cells will 
have a normal genetic background and respond largely in the same way as they would in 
vivo.
However, since they are derived from the thigh of the mouse they may not be 
fully developed into the sort of cell that would encounter a macrophage in vivo. In 
addition, they are still removed from the acquired immune response and may lack some 
of the infection cues that would be necessary for completely normal in vz'vo-like 
reactions. Cell layers also do not develop granulomas, so it is unlikely that any infecting 
mycobacteria would encounter oxygen stress. The infection is short-lived as bone 
marrow derived macrophages seldom survive more than two weeks in vitro. The latter 
two points mean that the bacteria would not experience events that occurred later on in 
the infection.
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Due consideration is seldom given to the activation state of these macrophages -  
whether they can be activated in the normal way following their liberation from the thigh 
bones and possible immaturity, and whether the extensive physical manipulation of the 
macrophage population could cause them to activate or move them into an anergic state.
However for the purposes of initial screening for attenuation of mutant phenotypes 
this system is perfectly adequate as long as one remembers that certain phenotypic 
defects may be missed. If a null mutant of M tuberculosis is known to be attenuated in 
macrophage models of infection, then this form of experiment is a convenient assay for 
complementation and allows further, detailed examination of the interaction between the 
mycobacteria and the host cell.
1.5 Allelic exchange
Genetics relies on the study of the function of genes through the isolation of 
mutants. Traditional methods of disrupting genes in bacteria relied on mutagenisis of the 
chromosome by chemicals or transposons and analysing for the desired phenotypes 
amongst the pool of heterogeneous bacteria. The discovery ways o f using homologous 
recombination for alleleic exchange meant that genes could selectively be ‘knocked out’ 
genes to create stable mutant strains. Current techniques made possible by whole- 
genome sequencing allow the use of ‘reverse genetics’, where the sequence of the gene to 
be knocked out is known and the mutants do not need to be ‘selected’ in random screens. 
This allows isolation of strains carrying mutations in genes that do not present a 
selectable phenotype. The sequencing of the genome of M. tuberculosis, in conjuction 
with the development of powerful selective markers for use in the mycobacteria, now
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allow knockouts to be made to study the contribution of particular genes. This was not 
possible before with M. tuberculosis since the organism grows too slowly for the 
traditional genetic methods to be used, and selective markers were not identified until 
fairly late. Even in E. coli, using traditional genetic approaches, it was only possible to 
identify ~30% of the genes using traditional mutant screens.
1.5.1 Homologous recombination
Homologous recombination can occur when a cell is diploid for two identical 
copies of a stretch of DNA. It is an extension of the DNA damage repair mechanisms of 
bacteria, where damaged alleles are replaced with functional copies. Some species such 
as Streptococcus pneumoniae use the mechanism to develop a kind of ‘community gene 
pool* where certain virulence factors are flanked by highly homologous regions and the 
bacteria are naturally competent.
In molecular cloning homologous recombination is used to exchange the normal 
chromosomal allele of a cell for one chosen by the investigator. The replacement allele 
may have been disrupted, mutagenised, marked in some way or may be a functional allele 
to complement a gene that has already been knocked out. In its simplest form, 
homologous recombination is a single cross-over event mediated by an assortment of 
enzymes. The cell will now be diploid for the region introduced to the cell, with the two 
alleles adjacent to each other on the chromosome and both reading in the same direction 
(Figure 1.6). To be of greatest use to the investigator, however, a second cross-over 
event will allow allelic exchange to take place.
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Figure 1.6: Diagram representing genotypic changes of the chromosome of M.
tuberculosis during selection of an allelic exchange mutant
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1.5.2 Development of allelic exchange in the mycobacteria
There are three major barriers to the development of routine allelic exchange in an 
organism: the difficulty of introducing foreign DNA into the host cell, the existence of 
vectors that will allow ease of manipulation and the existence of appropriate marker 
genes that will allow selection of recombinants at the various stages in the process.
1.5.3 Transfection of mycobacteria
The foreign DNA must first be introduced into the cell, a process notoriously 
difficult in the mycobacteria. Successful strategies developed through the 1990s were 
transfection by spheroplasty and electroporation. Spheroplasty was the earliest method 
used for studies of DNA introduction into M. smegmatis, and involves the gentle 
digestion o f the mycobacterial cell wall with lipase and lysozyme. The DNA of choice is 
encapsulated in synthetic protoplasts and mixed with the bacterial protoplast in the 
presence of agents such as PEG that will encourage the membranes of the protoplast and 
spheroplast to meet. Once the transfected bacterial spheroplasts are placed in a recovery 
medium the cell walls spontaneously reform.
Electoporation is a highly efficient and straightforward transfection mechanism 
that was first used for M. tuberculosis and M. bovis BCG several years after competency 
had been demonstrated in M. smegmatis. The bacteria are incubated with glycine to 
permeablise the cell wall, then washed and resuspended in 10% glycerol. The foreign 
DNA is then mixed with the cells and an electrical current passed through the DNA-cell
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mix. After a recovery period the transformants may be selected by use of the appropriate 
markers.
1.5.4 Development of systems for genetic manipulation of alleles in the 
mycobacteria
Effective tools for genetic manipulation of alleles for gene replacement in the 
mycobacteria must be able to replicate in E. coli. Much of the early work on DNA 
introduction into mycobacteria focussed on the expression of antigens in M. bovis BCG, 
and required a mycobacterial origin of replication in addition to that of the E. coli origin 
of replication (Jacobs et al. 1987; Snapper et al. 1988). This work drove the development 
of markers for genetic manipulation in the mycobacteria. Allelic exchange on the other 
hand does not require a mycobacterial origin of replication, although such systems have 
recently been developed (Pashley et al. 2003), but the development of the allelic 
exchange vectors did rely very much upon the discoveries made with the shuttle vectors.
The first vectors for alleleic exchange in the mycobacteria were very simple 
plasmids that had few cloning sites and markers borrowed from the shuttle expression 
vectors (Marklund et a l 1995; Reyrat et a l 1995). In theory a vector for allelic exchange 
can be very simple -  it requires an E. coli origin of replication, a cloning site that allows a 
marked allele to be inserted and a counterselectable marker elsewhere on the plasmid. 
Selective pressure will allow only plasmids that have integrated into the chromosome of 
the mycobacteria to grow, and remaining episomal DNA will be lost from the progeny.
The early successful reports of allelic exchange in the mycobacteria used custom- 
made plasmids for each occasion, and often relied on the auxotrophic effects of the
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mutation being studied, such as in Husson et al. (1990). The development of a cloning 
system by Parish & Stoker (2000) was one example o f a rational approach that allowed 
the process of making knockouts of M. tuberculosis to become more routine. The 
flexibility it offered also simplified the process of exchange with unmarked alleles, where 
in-frame deletions could be made on the mycobacterial chromosome that did not abolish 
transcription of downstream genes in an operon.
The key feature of the pNIL system developed by Parish & Stoker (2000)was that 
the manipulation of the alleles was separated from the cloning of marker genes, which 
could be added later in the process from a series of pre-prepared plasmid cassettes. 
Multiple cloning sites allowed a wide choice of restriction enzymes to be used, 
eliminating problems with restriction sites in the cloned M. tuberculosis sequences and 
allowing directional cloning of fragments as a matter of course. The negative marker 
genes were designed to be added last to the construct and were cloned into a Pacl site, for 
which no recognition sequences exist in M. tuberculosis.
The two-step selection strategy allowed the isolation of mutants with no obvious 
phenotype and increased the likelihood of generating a second cross-over. With a two- 
step strategy only one colony with a single cross-over was necessary for clonal 
amplification and selection for the second cross-over event. By this stage the various 
markers used in early experiments had been verified and optimised by the addition of, for 
example, strong mycobacterial promoters.
1.5.5 Marker genes used in generating gene knockouts in M. tuberculosis
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In making a mutation of M. tuberculosis, both positive and negative selective 
markers are used. In a marked mutation, an antibiotic resistance gene is cloned in 
between amplified fragments up- and downstream of the gene to be knocked out to create 
a mutant allele that contains both the antibiotic resistance gene and portion of the vector 
sequence. Hygromycin and gentamycin resistanc cassettes are often used for this purpose 
and can easily be obtained commercially or from other plasmids. Kanamycin resistance 
markers should not be used for creating marked mutations of M. tuberculosis since the 
background level of mutation to kanamycin resistance is quite high in mycobacteria and 
would be likely to obscure rare recombination events.
The counterselective markers used for assessing the elimination of the vector after 
the second recombination event are inserted into the plasmid away from the cloning sites. 
An example is the sacBtlacZ fragment from pGOAL17 where both genes are cloned into 
the final vector simultaneously. sacB is a gene from Bacillus subtilis coding for 
levansucrase, which catalyses sucrose hydrolysis and levan synthesis and is also capable 
of adding fructosyl residues to a variety of other molecules (Dedonder 1966). Expression 
of levansucrase causes a lethal phenotype in the presence of sucrose and this allele has 
been fused to the Hsp60 promoter, which is a strong constitutive promoter in M. 
tuberculosis.
lacZ codes for the /3-galactosidase gene of E. coli, which cleaves the colourless 
substrate X-gal (5-bromo-4-chloro-3-indolyl-j8-galactopyranoside) into galactose and an 
insoluble blue product that gives expressing bacterial colonies an intense blue colour. A 
lacZ homologue is not present in the chromosome of M. tuberculosis, which would 
preclude its use as a marker in this organism. The lacZ gene in the pGOAL system has
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the mycobacterial antigen 85 promoter to drive its expression, since the native E. coli 
promoter is non-functional in M. tuberculosis.
1.5.6 The knockout process in practice
Making allelic exchange mutants is an extremely long process, and it is important 
to be diligent throughout the process. The use of a viable strain of M. tuberculosis and 
certainty of the plasmid structure prevent any additional loss of time, as does careful 
planning during the selection process, the freezing of colonies at all stages and the careful 
and thorough analysis of potential alleleic exchange mutants at the end of the process. It 
is important to add supplements that might be necessary in the media to allow growth of a 
potential alleleic exchange mutant. For example, a lysine auxotroph would require 
supplementary lysine in minimal media otherwise it will be impossible to isolate alleleic 
exchange mutants. By the same reasoning deletion mutants of genes essential for the 
growth of M. tuberculosis will be impossible to isolate, although high-density 
mutagenesis experiments on M. tuberculosis allow this to be predicted in advance.
The process described here is specific for generating allelic exchange mutants by 
the p2NIL two-step strategy, although it is roughly applicable for other knockout systems 
of M. tuberculosis and one-step allelic exchange strategies. It may be helpful to refer to 
Figure 1.6.
1.5.7 Electroporation of the vector into M. tuberculosis.
The plasmid construct is prepared as appropriate (see above), and then sequenced 
at the cloned regions to confirm the orientation and identity of the inserts. A high-quality
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DNA prep, such as a maxiprep (Qiagen), is then made of the plasmid since 
transformation and selection for knockouts has shown greatly reduced efficiency with 
vector DNA purified by small-scale preparation.
The wild-type M. tuberculosis is grown from a single colony obtained from 
stocks, and made electrocompetent (see 2.1.1.4.8). The wild-type M. tuberculosis used 
for constructing new mutants was the fully sequenced H37Rv strain, obtained directly 
from Dr. S. Cole at the Institut Pasteur (Paris). See figure 1.7 for reference.
Once the vector DNA and competent M. tuberculosis are prepared, the M. 
tuberculosis cell suspension is mixed with plasmid DNA and electroporated. The 
transformed cells are then allowed to recover overnight, before plating on agar plates 
containing hygromycin and X-gal. This selection should allow the growth of all cells that 
have undergone homologous recombination, either by one or two recombination events.
1.5.8 Selection for recombinants
After four to six weeks blue and white colonies are present. The blue colonies 
carry the integrated plasmid as a result of one homologous recombination event, meaning 
that they are sucrose sensitive, kanamycin and hygromycin resistant and metabolise X- 
gal. Although kanamycin could also be used as a selective agent at this stage, its use 
would prohibit the growth of colonies that have undergone two recombination events and 
resulted in allelic exchange. The white colonies are either a) spontaneous mutants in the
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Figure 1.7: Diagram representing the physical process of selection of alleleic exchange 
mutants in M. tuberculosis. Selection usually occurs in two stages, unless double cross­
over mutants have arisen at the first stage of selection. H, hygromycin, K, kanamycin, S, 
sucrose resistant, X, blue colonies on X-gal agar plates.
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wild-type M. tuberculosis that have resulted in a hygromycin-resistant phenotype and do 
not have any plasmid sequence present, or b) allelic exchange mutants that have rapidly 
undergone two recombination events. The blue and white colonies are treated differently 
for the next few rounds of selection, and represent two different potential sources of 
allelic exchange mutants.
Blue colonies are streaked out on agar plates without selection, which allows a second 
homologous recombination event to occur. After four to six weeks the colonies are likely 
to be genotypically heterogeneous, where the following may have occurred:
i) a second recombination event has occurred in the same region as the first, 
resulting in excision of the plasmid sequence and a return to the wild-type 
genotype;
ii) a second recombination event has occurred on the opposite side of the mutated 
allele as before, resulting in allelic exchange;
iii) no further recombination events have occurred.
One or two blue colonies are picked into liquid media and homogenised to break the 
cell clumps apart. The cell mix is then serially diluted and aliquots plated onto agar 
plates with hygromycin, sucrose and X-gal.
After four to six weeks clones that have developed as per situation (i) above will 
not have grown as they have lost the hygromycin resistance allele, although some may 
grow that have developed spontaneous mutations that result in hygromycin resistance. 
Clones that have developed after situation (ii) will grow as white colonies, whereas 
clones that have developed at situation (iii) will not be able to grow as they contain the 
counterselection gene for sucrose sensitivity. It is also possible that clones from scenario
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(i) and (iii) have developed spontaneous mutations for hygromycin resistance in the case 
of (i) and (iii) and/or sucrose resistance, kanamycin sensitivity and lacZ activity in the 
case of situation (iii).
Colonies that appear to display the correct phenotype arising from situation (ii) 
are checked by streaking on separate agar plates containing either hygromycin, X-gal and 
sucrose or kanamycin alone. True allelic exchange mutants should grow as white 
colonies on the hygromycin, X-gal and sucrose agar plates and should not grow on the 
kanamycin agar plates. Potential allelic exchange mutants are then examined by 
genotypic methods.
White colonies are assayed directly for allelic exchange by again streaking the 
colonies onto agar plates containing either hygromycin, X-gal and sucrose or kanamycin 
alone. Clones that grow well as white colonies on the first selection plate but not on the 
latter can be assumed to be potential allelic exchange mutants, and are examined further 
by genotypic methods.
It can be seen here that the two-step selection strategy employed with the colonies 
that are blue from the initial screen of transformants represents a more logical and ‘safer’ 
approach to creating allelic exchange mutants. It is however still desirable to examine 
potential spontaneous allelic exchange mutants that appear at the initial screen due to the 
considerable amount of time saved.
1.5.9 Genotypic methods of analysis of potential allelic exchange mutants
1.5.9.1 Polymerase chain reaction
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Potential allelic exchange mutants are first examined by polymerase chain 
reaction (PCR). PCR needs no introduction since its use is widespread and there are 
exhaustive references on the subject. Crude DNA preparations can be made directly from 
the agar plates used to confirm the colony phenotypes using a rapid and inexpensive 
process (Instagene). With well-designed primers to amplify regions of the region in 
which homologous recombination was expected to occur it is possible to use the different 
sizes of the products as a cheap, rapid and effective screen for appropriate genotypes.
1.5.8.2 DNA microarray analysis
Clones that appear to have the correct genotype are grown in liquid media, and 
high-quality DNA preparations are made (see 2.4.1.2). Whole-genome analysis can then 
be carried out using DNA microarrays (see 2.5), where the genomic DNA from the 
potential allelic exchange mutant is labelled using a cyanine dye (Amersham) and 
hybridised on a microarray against wild-type genomic DNA labelled with a 
complementary cyanine dye. The resultant hybridisation levels are then visualised by a 
dual-wavelength laser scanner equipped with appropriate filters and linked to a computer.
If the clone has arisen by allelic exchange then there will be no labelled DNA for 
the exchanged gene, and there will be a striking difference in hybridisation intensities for 
that gene when compared to the wild-type, provided that the DNA probe on the 
microarray hybridises within the deleted region. This will reveal itself as a deviation 
away from one when the relative hybridisation intensities of the wild-type genes are 
compared to those of the potential allelic exchange mutant and normalised to the majority 
of other genes present.
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Clones that have arisen from a single legitimate recombination event will show no 
difference in the hybridisation levels of the target gene when compared to the wild-type, 
but features on the microarray that were present in the M. tuberculosis sequences 
amplified and cloned into the plasmid would be expected to hybridise to the appropriate 
spots on the microarray at twice the level of the wild-type, since the clone is diploid for 
these regions. Clones resulting from single illegitimate recombination events can also be 
distinguished by looking at any diploid regions that appear in the microarray.
Clones that have arisen by spontaneous mutation to the allelic exchange mutant 
phenotype would not be expected to show any significant differences in hybridisation 
intensity for any of the genes when compared to the wild-type, unless the mutation 
abolished hybridisation of the mutant gene cDNA to the appropriate wild-type allele 
probe present on the microarray slide. In either event, these clones would be clearly 
distinguishable from the desired mutant phenotype.
1.5.8.3 Sequencing
The de facto confirmation of an allelic exchange mutant is provided by 
amplifying the exchanged region and sequencing along its length until the conversion of 
wild-type sequence to the vector sequence is found and vice versa. It is possible to use 
sequencing alone to confirm the knockout by beginning the sequencing in regions outside 
of those cloned into the knockout vector, but in practice one also relies on the PCR and 
microarray data to minimise the amount of sequencing needed.
93
Suffice to say, the agreement of PCR, microarray and sequencing data means that 
it is possible to be absolutely certain of a correct allelic exchange mutant genotype, 
should one arise.
1.6 Project aims
The aim of this research project is to examine the oxidative stress responses of M  
tuberculosis through the phenotype and transcriptomic study of mutants in the SenX3- 
RegX3 two component signal transduction system, the interaction of purified 
recombinant RegX3 protein with potential genetic regulatory regions, and the isolation of 
mutants for two other genes thought to be involved in the oxidative stress responses of M. 
tuberculosis, Rv0465c and Rvl049.
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2 Materials and methods
2.1 Strains and growth conditions
2.1.1 M. tuberculosis strains
2.1.1.1 Wild-type M. tuberculosis
The wild-type M. tuberculosis designated H37Rv was isolated from a human 
infection in 1908 and became popular since it did not lose infectivity for mice or colony 
morphology during repeated passage (Steenken & Gardner 1946). Due to subsequent 
divergence of the use of this strain, two variants commonly now used are H37Rv (Paris) 
and Erdman. The H37Rv strain used in this study came from two sources. One strain of 
H37Rv (Paris) has been maintained at the NIMR for several years and was used to 
generate both the senX3 and regX3 null mutants. Experiments using these two strains 
compare them to this parent strain. During 2003 there was concern over the mouse 
infectivity of the wild-type H37Rv (Paris) kept at the NIMR, which was probably due to 
a change in the media used to prepare the strains for infection. A second H37Rv (Paris) 
strain that had been used for the M. tuberculosis sequencing project was obtained directly 
from S. Cole (Institut Pasteur) to act as a parent strain for the generation of knockouts in 
the Rv0465c and Rvl049 genes. Experiments using the Rv0465c and Rvl049 null 
mutants compare them to this wild-type parent strain. No phenotypic differences have 
been seen between the two wild-type H37Rv strains used in this study, although 
differences have been seen by others (A. O’Garra, personal communication). See table 
$$ for a list of mycobacterial strains used in this study.
2.1.1.2 Null mutants and complementing strains
2.1.1.2.1 AsenX3
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Table 2.1 Mycobacterial strains used in this study
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strain genotype reference
H37Rv wild-type Cole et al (1998)*
senX3 null mutant H37Rv AsenX3 Rickman et al (2004)
regX3 null mutant H37Rv AregX3 hyg Rickman et al (2004)
Rv0465c null mutant H37Rv ARv0465c this study
Rvl049 null mutant H37Rv ARvl049 this study
Tamel5 H37Rv AregX3 Parish et al (2003)**
complementing senX3 null mutant H37Rv AsenX3/pDHl2 Rickman et al (2004) and this
study
complementing regX3 null mutant H37Rv AregX3 hyg/pDH 12 Rickman et al (2004) and this 
study
Rv0465c complemented mutant H37Rv ARv0465c/pDH30 this study
Rvl049 complemented mutant H37Rv ARv0465c/pDH31 this study
regX3 overexpression with acetamidase 
promoter
H37Rv AregX3/pDH27 this study
regX3 overexpression with acetamidase 
promoter control strain
H37Rv AregX3/pACE this study
regX3 overexpression with HSP60 
promoter
H37Rv AregX3/pDU\S this study
regX3 overexpression with HSP60 H37Rv AregX3/pMV261 this study
promoter control
* Kindly supplied by S. Cole (Institut Pasteur) **Kindly supplied by T. Parish (Royal London Hospital)
98
A hygromycin-marked senX3 null mutant had been constructed previously (L. 
Rickman, personal communication). In this strain the region from 579333 to 580542 bp 
on the M. tuberculosis genome containing the senX3 coding sequence is replaced by a 
hygromycin resistance cassette that creates a polar mutation in the downstream, co­
transcribed regX3 gene.
2.1.1.2.2 AregX3
An unmarked regX3 null mutant was previously constructed in our laboratory 
(Rickman et al. 2004). In this strain the region from 580658 to 581724 bp on the M. 
tuberculosis genome containing the coding sequence for regX3 and 254 bp of the 3’ end 
of the Rv0492c gene was replaced by around 300 bp of vector sequence creating a gene 
deletion.
2.1.1.2.3 ARv0465c
A hygromycin-marked Rv0465c null mutant is constructed in this study. The 
region between 554896 and 556312 bp on the M. tuberculosis chromosome containing 
the coding sequence of the Rv0465c gene was exchanged with a hygromycin resistance 
cassette.
2.1.1.2.4 ARvl049
A hygromycin-marked Rvl049 null mutant is constructed in this study. The 
region between 1172388 and 1172846 bp on the M. tuberculosis chromosome containing
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the coding sequence of the Rv0465c gene was exchanged with a hygromycin resistance 
cassette.
2.1.1.2.5 Tame 15
Tame 15 is a regX3 null mutant strain of M. tuberculosis created in another 
laboratory (Parish et al. 2003). This strain carried an unmarked deletion that 
encompasses the 3* end of senX3, most of the coding sequence for regX3 and the MIRU 
(Supply et a l 1997) region separating the two genes (Figure 2.1).
2.1.1.3 Overexpressing strains
2.1.13.1 AregX3/Phsp60-«®X3+
To overexpress RegX3 in a regX3 null strain, the coding sequence of regX3 was 
amplified using the primers 152 and 153 (Appendix 3) and the Pfu Ultra enzyme (see
2.3.1) and blunt-end-cloned using the Zero Blunt kit (Invitrogen) into pCR4-TOPO (see 
Table 2.2 Plasmids used in this study The insert was sequenced before being subcloned 
into the BamHl-Clal site of pMV261 to create pDH18. pMV261 is a plasmid that allows 
the strong, constitutive Phsp60-driven expression of foreign genes in mycobacteria (Stover 
et al. 1991, and Table 2.2). pDH18 was then electroporated into the regX3 null strain of 
M. tuberculosis described in 2.1.1.4.8. The plasmid was maintained by growth of the 
strain under kanamycin selection.
2.1.1.3.2 AregX3/Phsp60-re£AT
100
Figure 2.1: Genetic arrangement of the Tamel5 mutant of M. tuberculosis. A represents 
the region of deletion. Adapted from Parish et al. (2003).
101
Rv0488 gpml senX3 regX3 Rv0492c
!► *
102
Table 2.2 Plasmids used in this study
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plasmid genotype reference
pDHl pCR4-TOPO senX3 regX3 L. Rickman
pDH2 pCR4-TOPO + (1619bp 3’ of Rvl049) This study
pDH3 pCR4-TOPO + (1674bp 5’ of Rv0465c) This study
pDH4 pCR4-TOPO + (1601bp 3’ of Rv0465c) This study
pDH5 pCR4-TOPO + (1500bp 5’ of Rvl049) This study
pDH6 1656bp BamHl fragment from pDH3 cloned into the BamHl site of 
p2NIL-H
This study
pDH7 1512bp BamHl fragment of pDH5 cloned into the BamHl site of 
p2NIL-H
This study
pDH9 1609bp Notl fragment from pDH4 cloned into the Notl site of pDH6 This study
pDHIO 1623bp Notl fragment of pDH2 cloned into the Notl site of pDH7 This study
pDH12 attP kanr senX3 regX3 This study
pDH14 pDHIO + lacZsacB Pacl fragment of pGOAL 17 This study
pDH18 pMV261 + regX3 This study
pDH19 pDH9 lacZ sacB {Pad fragment of pGOAL 17) This study
pDH27 pACE regX3 This study
pDH28 pCR4-TOPO Rv0464c Rv0465c This study
pDH29 pCR4-TOPO Rvl049 Rvl050 This study
pDH30 pKPl 86 + (Rv0464c Rv0465c from pDH28) This study
pDH31 pKP186 + (Rvl049 and Rvl050 from pDH29) This study
pKP186 oriE attP kanr K.G.
Papavinasasunderam
pBS-Int int ampr B. Springer
p2NIL-H oriE kanr hygf Parish & Stoker (2000)
pGOAL17 PAg85-lacZ P w s a c B  flanked by Pad  sites, ampr Parish & Stoker (2000)
pACE oriE oriM acetamidase promoter, hyg Triccas et al (1998)
pMV261 oriE, oriM, groEL2 (Hsp60) promoter, kanr Stover etal (1991)
pCR4-TOPO oriE lacZ ccdB kanr ampr Invitrogen
(www.invitrogen.com)
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pET 15b oriE ampr lacl Novagen
(www.emdbiosciences.
com)
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This strain is identical to AregX3/Phsp6o-reg.\3+ but does not contain the coding sequence 
for regX3.
2.1.133 AregX3/PMe-r«gXJ+
To overexpress RegX3 in a regX3 null strain using a different promoter, the 
coding sequence of regX3 was amplified using the primers 151 and 168 (Appendix 3) and 
the Pfu Ultra enzyme (see 23.1) and blunt-end cloned using the Zero Blunt kit 
(Invitrogen) into pCR4-TOPO (Table 2.2), after which the insert was sequence and then 
subcloned into the BamHl-Clal site of pACE to create pDH27. pACE is a plasmid that 
allows acetamide-inducible expression of foreign genes in M. smegmatis (Triccas et a l 
1998) but produces constitutive expression of genes at around half the level of that 
provided by PhSp60 in M. tuberculosis (E. Davis, personal communication). This plasmid 
was electroporated into the regX3 null mutant of M. tuberculosis described in 2.1.1.4.8 
and the plasmid was maintained by growth of this strain under hygromycin selection.
2.1.13.4 AregX3/PaCe-r^gXT
This strain is identical to AregX3/PaCe-7*egAr5+ but does not contain the coding 
sequence for regX3.
2.1.1.4 Media and growth conditions for Af. tuberculosis
2.1.1.4.1 Media
All liquid cultures o f M. tuberculosis strains referred to in this work were grown 
in Dubos broth (Becton Dickinson) supplemented with 4% v/v albumin (Becton
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Dickinson), 0.2% v/v glycerol, 0.05% Tween and selective agents where mentioned. All 
cultures of M. tuberculosis were grown at 37°C whether in liquid culture or on agar 
plates. Growth of M. tuberculosis strains on solid media used Middlebrook 7H11 agar 
(Difco) supplemented with 10% oleic acid, dextrose, catalase and albumin mix (Difco) 
when the molten agar had cooled below 65°C.
2.1.1.4.2 Antibiotics and selective agents
In agar plates and in liquid cultures the following final concentrations for 
selective agents were used: sucrose, 2%; kanamycin, 25/zg/ml; hygromycin, 50/ng/ml; X- 
gal, lOOjLtg/ml. Antibiotics were added to liquid agar once it had cooled below 65°C.
2.1.1.43 Rolling bottles
M. tuberculosis strains were prepared for all experiments in this study by 
inoculation of 100ml aliquots of liquid Dubos media as described above in 2.1.1.4.1 at a 
1/500 dilution from exponential-phase cultures in sterilins (Bibby-Sterilin) to a 1 litre 
polycarbonate bottle (Techmate) and incubation at 37°C at ~2rpm in a Bellco roll-in 
incubator to allow maximum aeration, unless stated otherwise. All experiments, unless 
otherwise stated, were performed in biological triplicate.
Cultures of M. tuberculosis were then incubated until early exponential-phase, at 
which point experiments were started. Typically after 1/500 dilution and growth under 
the conditions described above the cultures would reach an OD600 of 0.3-0.4 after five 
days. The OD600 was checked regularly and cultures were diluted with pre-warmed
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liquid media to keep the strains growing together. Cultures were not diluted within at 
least one generation of the start of the experiment.
2.1.1.4.4 Storage of M. tuberculosis strains as frozen stocks
Exponential-phase liquid cultures, or cultures on agar plates, of M. tuberculosis 
were mixed with freezing mix either by 50:50 dilution of a liquid culture or by the 
homogenisation of a fresh bacterial colony with sterile 2.5-3.5mm glass beads (BDH) in 
lml freezing mix using a vortexer (Labtech) before storage at -80°C. The components of 
freezing mix can be found in Appendix 4.
2.1.1.4.5 Growth of M. tuberculosis strains on agar plates
Strains were streaked or spotted on agar plates and left to dry overnight. The 
plates were then sealed with gas-permeable Nescofilm and incubated upside-down in a 
Bellco roll-in incubator at 37°C for 2-6 weeks.
2.1.1.4.6 Initial growth of M. tuberculosis strains prior to rolling bottle inoculation
To adapt colonies grown on plates to growth in liquid media, and to minimise 
clumping, strains were grown as 5 ml cultures in sterilins (Bibby-Sterilin) before 
inoculation into rolling bottles. A colony was picked from an agar plate and inoculated 
into a sterilin containing 1 ml 2.5-3.5mm sterile glass beads (BDH) and 5ml liquid media. 
The colony was homogenised by vortexing the culture and was left to incubate at 37°C in 
a Swallow incubator until the culture reached exponential phase.
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2.1.1.4.7 Optical density reading of bacterial cultures
Spectrophotometric measurements of microbial biomass were expressed as optical 
densities after measurement of the scattering of 600nm wavelength light through a 1cm 
pathlength transparent plastic cuvette (Elkay) in a Cecil spectrophotometer. The cuvette 
was stoppered for biosafety reasons. Generation (doubling) times of the bacteria were 
established using the formula
G = ___________ t______________
3.3 log (new OD6oo/old OD600)
Any cultures that gave OD600 measurements of over 0.8 were serially diluted 
below this value and then multiplied up to generate the final measurement. This was 
done because most spectrophotometers do not accurately record light scattering at higher 
culture densities.
2.1.1.4.8 Preparation and transformation of competent M. tuberculosis
M. tuberculosis strains were grown as 100ml cultures in rolling bottles (see
2.1.1.4,1) to an OD600 of 1 before the addition of 10ml 2M sterile-filtered glycine 
(Sigma). After a further 24 hours of incubation the cells were pelletted and washed in 
glycerol by repeated centrifugation at 10 OOOrpm in a GSA rotor pre-cooled to 4°C in an 
high speed centrifuge (Sorvall) at 13000rpm, before resuspension in an equal volume of 
10% glycerol (BDH). After three washes the cells were resuspended in 10ml 10% 
glycerol and stored for no more than a week at 4°C before electroporation.
400/d of competent M. tuberculosis was mixed with an appropriate amount of 
plasmid DNA, usually lpg, in a 0.2cm pathlength stoppered electroporation cuvette (Bio-
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Rad). The cuvette was then placed in a Bio-Rad Gene Pulse Controller and 
electroporated at 25/zF, 2.5kV and 10000. The cells were then transferred using a sterile 
needle-nosed pastette to 3.6ml prewarmed liquid media in a sterilin, without antibiotic 
selection, which allows for expression of the marker genes contained on the plasmid. 
After 24 hours the electroporated mycobacteria are diluted as appropriate and spread onto 
agar plates containing selective agents.
2.1.2 E. coli strains
Commercially available strains of E. coli were used throughout this work (see 
Table 2.3). Library efficiency DH5a cells (Invitrogen) were used for routine cloning and 
subcloning of plasmids and supercompetent E. coli (Invitrogen) were used for cloning 
more difficult sources, such as those generated during site-directed mutagenesis (see 
Table 2.3 List of strains and genotypes used in this study . TOP 10 cells (Invitrogen) 
were used for blunt-end cloning PCR products into the vectors from the TOPO cloning 
kit (Invitrogen).
BL21-RIL-codonplus cells (Novagen) were used for protein expression, since 
they are protease negative and contain a plasmid that allow translation of codons rarely 
found in E. coli but common in M. tuberculosis. This is necessary since the E. coli strain 
may not otherwise produce the appropriate amounts of the tRNA for these codons and 
would translate the mycobacterial sequences inefficiently. Strains were manipulated as 
directed by the manufacturers’ supplied protocols.
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Table 2.3 List of strains and genotypes used in this study
strain genotype reference
DH5-<x (DNA F- <|>80/acZAM15 A{lacZYA-argF)\]\69 recAl
manipulation) endAl h sdR n fa , mk+)phoA supE44 thi-l
gyrA96 relAl AT
BL21- E. coli B F- ompT hsdS{x&~ me-) dcm+ Tetr gal X
CodonPlus(DE3)- (DE3) endA Hte [argUproL Canf]
RP (protein 
expression)
TOP 10 F- mcrA A(mrr-hsdRMS-mcrBC) <j)80/acZAM 15
AlacXIA recAl araD\39 A{ara-leu)1691 galU 
galKrpsL (StrR) endAl nupG
Invitrogen
(www.invitrogen.com)
Stratagene
(www.stratagene.com)
Invitrogen
(www.invitrogen.com)
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2.1.2.1 Media and growth conditions for E. coli strains
Luria broth or agar was used to grow all cultures of E. coli according to the 
method in Sambrook et al. (2001). 3ml liquid cultures were grown overnight, and then 
used for small-scale DNA or protein extraction or inoculated into larger vessels 
(Sambrook et al. 2000). Liquid cultures were grown at 37°C with shaking at 300rpm in 
an incubator (New Brunswick Scientific). Agar plates were left to dry before being 
incubated upside-down overnight at 37°C in a Bellco roll-in incubator. OD600 readings 
for E. coli were taken using 1cm pathlength plastic cuvettes (Elkay) and a Unicam 
spectrophotometer.
2.1.2.2 Antibiotics and selective agents for E. coli
Ampicillin, carbenicillin and X-gal were used at 100/xg/ml final concentration, 
and kanamycin and hygromycin at 50/ig/ml and 250/ig/ml final concentrations, 
respectively. IPTG was used at ImM final concentration in liquid cultures to induce 
expression of recombinant polyhistidine-tagged RegX3; alternatively 100/d was spread 
onto the surface of a 90m diameter agar plate and allowed to dry before inoculation with 
E. coli that may be expressing (3-galactosidase.
2.2 Stress experiments
2.2.1 In vitro experiments
2.2.1.1 Stress experiments after aerobic growth
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Strains of M. tuberculosis were grown as 120ml cultures in rolling bottles to an 
OD600 of 0.3-0.4, after which the culture was split into six 20ml aliquots in fresh rolling 
bottles. The stressing agent dissolved in a small volume of solvent was then added to 
three of these and equal volumes of the solvent alone were added to the other three 
cultures as controls. All cultures were then incubated (with rolling at 37°C) for the 
specified amount of time, after which samples were removed from each culture and 
assessed for OD600 and viability. Viability was assessed by plating out aliquots of each 
culture that had been vortexed with 2.5-3.5mm glass beads (BDH) and serially diluted in 
a 1:1 mix of DMEM (Gifco) and foetal calf serum (Sigma). The purpose of the foetal 
calf serum is to buffer the mycobacteria against any stressing agents that may still be 
active in the culture media. Typically 25/il of the 10'2, 10'3, 1CT4 and 10'5 dilutions were 
plated in duplicate onto separate halves of agar plates, and dried before incubation. After 
10-14 days the plates were counted by eye using a strong light source and a dark 
background in order to visualise the colonies. Values for each culture were taken as the 
mean of the duplicate readings at the most appropriate dilution and multiplied by the 
dilution factor.
2.2.1.2 Microaerobic growth of M. tuberculosis strains
Early exponential-phase rolling cultures of M. tuberculosis were inoculated at 
1/10 dilution into 262.5cm volume non-vented tissue culture flasks containing 90ml 
liquid media, to make a final volume of 100ml, and the lids tightened firmly by hand. 
The cultures were then left to stand vertically in an incubator (Swallow) at 37°C until the 
cultures were at the appropriate OD600 as required before being processed as described in
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the relevant experiments. Excess cultures were set up and sacrificed daily to measure the 
approximate increase in ODeoo-
2.2.1.3 Nutrient starvation of M. tuberculosis strains
Early exponential-phase cultures were grown as 100ml cultures in rolling bottles 
after which they were washed three times with equal volumes of sterile PBS by pelleting 
and resuspending using a high speed centrifuge (Sorvall) and a GSA rotor at 10 OOOrpm 
for 20 min. After washing, the pelletted cells were resuspended in a further equal volume 
of PBS and 5 ml aliquots made into sterilin tubes (Bibby-Sterilin) that were incubated at 
37°C without shaking or other disturbance for 43 days, after which the viable counts and 
OD600 measurements were taken and compared to those taken on day one.
2.2.1.4 Growth of M. tuberculosis strains at acid pH
Dubos media was prepared as normal (2.1.1.4.1), however the media was adjusted 
to pH5.5 with hydrochloric acid and a digital pH meter before being autoclaved and 
supplemented with the albumin. A sample of the sterile supplemented media was then 
re-checked to ensure the pH had not changed. Strains were inoculated from early 
exponential-phase cultures into 100ml aliquots of the acidified liquid media and cultured 
aerobically (see 2.1.1.4.3). OD600 was measured throughout the growth of the strains, 
and after the final time point was taken the pH of the media was measured using indicator 
strips (Merck).
2.2.1.5 Agents used for viability studies
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Paraquat dichloride (Sigma) is a superoxide radical generator that was used at 
50mM concentration to cause a bactericidal effect in M. tuberculosis (L. Rand, personal 
communication). The supplied powder was made up to the correct concentration with 
distilled water, before being sterilised by passing through a .22pm filter (Millipore). 
Silver nitrite (Sigma) was supplied as a powder and treated in the same was as the 
paraquat, and added to a final concentration of 3mM to cultures resuspended in media 
acidified to pH 5.5 in order to produce bactericidal levels of nitroxide radicals (L. Rand, 
personal communication), terf-butyl hydroperoxide (Sigma) was supplied as a liquid, 
and diluted to the required concentrations using distilled water before being sterilised by 
passing through a .22pm filter (Millipore). The prepared tert-butyl hydroperoxide was 
added to cultures over a range of concentrations and produced bactericidal levels of 
organic hydroperoxide stress at concentrations over lOOpM (see 3.2.2.3).
2.2.1.6 Statistics for stress experiments
Homoscedastic, two-tailed Student’s t-tests were used to compare the log losses in 
viability of a strain after stress compared to the wild-type. Calculations were made in 
MICROSOFT EXCEL, and graphs plotted in SIGMAPLOT. Error bars for the graphs 
represent standard error of three experiments as calculated by SIGMAPLOT. See 
Appendix 5 for raw data and statistical treatment of all stress experiments mentioned in 
this thesis.
2.2.2 In vivo experiments
2.2.2.1 Isolation and infection of macrophages
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8-month old female Balb/C mice were killed and the thigh bones removed and 
flushed with CCVindependent media (Gibco). After centrifugation of the flushed cells in 
sterilins at 1200rpm for 5 min in a swing-out rotor in a Heraeus megafuge the cell pellet 
was resuspended in complete IMDM media (Gibco) supplemented with 0.0004M j8- 
mercaptoethanol (Sigma), 4mM L-glutamine (Sigma), 5% FCS and 10% MCSF (supplied 
in-house), and aliquoted into Petri dishes (Nunclon). After 2 days incubation at 37°C 
with 5% CO2 in an incubator (LEEC) the cells were washed and the media replaced. 
After a further three days the cells are scraped from the surface of the Petri dish, counted 
using a haemocytometer and 100 000 cells were aliquoted into each well of a 12-well 
tissue culture dish (Nunclon).
After a further 24 hours of incubation to allow the macrophages to adhere to the 
wells, M. tuberculosis cells diluted in DMEM (Gifco) from early-exponential-phase 
cultures were added to the wells containing the macrophages at a multiplicity of infection 
of 1 mycobacterium per every 2 macrophages. After a 5 hour infection period the 
infected macrophages were washed to remove the extracellular bacteria, and saponin 
(Sigma) was added to a 0.1% final concentration to the wells of the first time point, time 
0. After an hour of saponin treatment, lysis of the macrophages was confirmed by 
microscopy and serial dilutions of the supernatant were made in saline. 10/d aliquots of 
the serially diluted supernatant were spotted onto agar plates and the bacteria were left to 
grow at 37°C for 10-20 days before colony numbers were counted.
2.2.2.2 Murine infection experiments
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M. tuberculosis strains were grown in rolling bottles to early-exponential phase, 
were diluted in sterile saline to give a suspension of approximately 106 cfu/ml and 200/il 
of the cell suspension was inoculated intravenously into the tail vein of 6-8 week old 
female BALB/c mice. The infection was monitored by removal of the lungs and spleen 
of groups of 3-5 mice at intervals, followed by homogenisation of the removed organs 
using a Mini-Bead Beater (Biospec Products). Serial 10-fold dilutions of the 
homogenates were made in chilled saline and spotted onto agar plates. After 10-20 days 
the plates were counted and the cfu/g of each tissue calculated. A paired Student’s T-test 
was used to assess the p values of the means of different samples.
2.3 Cloning
23.1 Polymerase chain reaction
A variety of PCR protocols were used throughout the project. Pfu Ultra 
(Stratagene) is a modified high-fidelity proofreading polymerase from Pyrococcus 
furiosus, and was used to amplify regions of M. tuberculosis DNA used for allelic 
exchange and protein expression purposes where it was important not to generate errors 
in the amplified DNA. The disadvantages of Pfu Ultra are its relatively high cost and low 
processivity when compared to other enzymes. Kod Hi-Fi polymerase (Novagen) is a 
modified high-fidelity proofreading polymerase from Thermococcus kodakaraensis that 
is complexed with two monoclonal antibodies that confer hot-start properties on the 
enzyme. It produced consistent results, has very high processivity and is relatively 
cheap; however the accuracy of the enzyme is not as great as that of Pfu Ultra. It was
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predominantly used for amplifying short lengths of DNA for cloning, protein expression 
purposes or sequencing when it was not possible to obtain a product with Pfu Ultra.
When errors in the sequence were less important, i.e. for assessing the presence of 
inserts in a plasmid by the size of the PCR products, HotStart Taq polymerase (Qiagen) 
or Ready-2-Go PCR beads (Amersham) were used. HotStart polymerase is a hot-start 
polymerase that shows increased specificity for the target due to its activation only at the 
first denaturation step of the PCR cycle, for which it requires 15 min incubation at 95°C. 
Ready-2-Go PCR beads contain the majority of the reagents required for PCR in a 
lyophilised bead, to which water, primers and DNA must be added. Ready-2-Go PCR 
beads showed poor specificity for the substrate but were fast and simple to use. 
Components were included in the reactions as described in the manufacturers’ 
instructions.
All amplifications took place in an MWG Primus thermocycler or a Perkin Elmer 
thermocycler, using thin-walled 0.2ml tubes (ABgene) and heated lids. A touchdown 
cycling protocol was used for the majority of amplifications, with the following 
parameters: 95°C denaturation step for 2 min, followed by 10 rounds of synthesis with 
progressively decreasing annealing temperatures (95°C, 45 sec, 72°C-1°C per cycle, 45 
sec, 72°C, 2 min), 25 rounds of synthesis at a lower, constant annealing temperature 
(95°C, 45 sec, 55°C, 45 sec, 72°C, 2 min) and a final extension step at 72°C, after which 
the samples were cooled to 30°C at the end of the reaction. For further details on PCR, 
see Sambrook et al. (2000)
23.2 Reverse transcriptase polymerase chain reaction
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RT-PCR was carried out using the one-step RT-PCR system (Invitrogen)
according to the manufacturer’s directions.
2 3 3  Restriction enzymes
Restriction endonucleases were purchased from Roche and New England Biolabs, 
and were used in accordance with the manufacturers’ directions. Reactions typically took 
place in a 10/xl volume with the appropriate lx  buffer and were incubated for 1 hour at 
37°C before the addition of glycerol running buffer (30% glycerol, 0.5% bromophenol 
blue) and electrophoresis of the samples through an agarose gel (see below at 2.3.4). If 
greater quantities of cut DNA were required the reaction was scaled up to take this into 
account.
23.4 Agarose gel electrophoresis
Separation and visualisation of DNA was performed by electrophoresis through a 
TBE agarose gel (Sigma, molecular biology grade) containing 0.00016mg/ml ethidium 
bromide and visualised and photographed on a UV transilluminator fitted with a digital 
camera (UVP). Gels were prepared at 1% agarose concentration for analysis for most 
purposes or 2% for analysis of DNA fragments smaller than 500 bp.
2.3.5 Ligation of DNA fragments
‘Sticky-ended’ ligations of DNA with compatible overhangs at the 5’ and 3’ ends 
were performed by overnight incubation at room temperature of the ‘cut’ insert and 
vector at a 7:1 ratio with T4 ligase (Promega) in the supplied buffer. Blunt-ended
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ligations were performed using the Zero Blunt TOPO kit from Invitrogen according to
the manufacturer’s instructions.
23.6 Transformation of E. coli strains
Transformations were carried out using commercial strains discussed above 
(Table 2.2) and according to the instructions supplied by the manufacturer. Further 
information on transformation of competent cells can be seen in Sambrook et al. (2000).
23.7 Design and supply of oligonucleotides
Primers for PCR (Appendix 3) were designed using the program PRIMER 
DESIGNER FOR WINDOWS to fit the default parameters specified within that program, 
were checked for the presence of hairpins and runs of single bases, and varied between 
around 17 and 22 bp in length. All primers designed for amplification of M. tuberculosis 
target sequences were checked using the ARTEMIS program (Rutherford et al. 2000) for 
uniqueness. Oligonucleotides were ordered from Oswel-Eurogentec at 0.04M scale 
synthesis and were desalted, or purified by HPLC if they were to be used for 
radiolabelling in electromobility shift assays.
2.4 Nucleic acid extraction
2.4.1 DNA
2.4.1.1 E. coli
DNA was extracted from 3ml cultures E. coli using either Qiagen miniprep or 
maxiprep kits as recommended by the manufacturer. Qiagen plasmid isolation kits rely
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on the adsorption of DNA onto silica membranes after alkaline lysis of the E. coli cells; 
for further information see the Qiagen handbooks (supplied) or Sambrook et al. (2000).
2.4.1.2 M. tuberculosis
For small-scale preparations of M. tuberculosis DNA from cultures grown on 
plates, the Instagene matrix (Biorad) was used according to the manufacturer’s directions. 
The plate-grown mycobacteria were incubated with the Instagene matrix at high 
temperatures causing lysis of the cells. The matrix serves to remove some of the cell 
debris that would otherwise interfere with downstream applications.
For large-scale high quality DNA preparations (protocol supplied by R. Curtis), 
rolling cultures were centrifuged at 10 000 rpm for 20 min at 4°C in a GSA rotor in a 
Sorvall centrifuge. The pellet was washed with 20ml SET solution (see Appendix 4) and 
resuspended in 2ml set solution containing 2mg/ml lysozyme (Sigma) and 2mg/ml lipase 
(Sigma) and was incubated for 30 min at 37°C. 4 volumes of GSE solution were added 
before a further 90 min incubation, after which the nuclaeic acids were isolated using 
chloroform-ethanol precipitation (Sambrook et al. (2000)). The pellet was then dissolved 
in 400/d TE buffer with 2/d RNase (Invitrogen), 20/d of proteinase K (Sigma) at 
lOmg/ml and 20/d of 10% SDS, and incubated overnight at 37°C until dissolved.
2.4.2 RNA
RNA was extracted from cultures of M. tuberculosis by use of the RNA Pro kit 
(Q-Biogene) according to the manufacturer’s directions. The extracted RNA was 
purified by incubation with 2/d 20 000u//d RNAse-free DNAse I (Invitrogen) and two
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rounds of phenol/chloroform extraction (Sambrook et al. (2000)). The quality and 
integrity of the RNA was then analysed by running l/il on a gel and quantified by 
spectrophotometry at 260nm and 280nm in a UV-visible 1cm pathlength disposable 
cuvette (Eppendorf) in a Unicam spectrophotometer, or lpl was analysed on a Nanodrop 
spectrophotometer. Representative samples were also analysed by RT-PCR (see 2.3.2) 
and gel chromatography in an Agilent Bioanalyser (service performed by R. Butler, 
NIMR).
2.5 Microarrays
2.5.1 Microarray construction
cDNA microarrays (TB version 1) covering 98% of the M. tuberculosis predicted 
genes were kindly provided by Dr. J. Hinds at the B/iGS facility, St. George’s Hospital 
Medical School, London. Arrays used in all experiments barring the RegX3 
overexpression experiment (section 4.2.3) were printed on poly-L-lysine coated slides 
prepared in our laboratory according to a protocol from B/iGS; arrays for the RegX3 
overexpression experiment were printed on GAPS amino-sialine coated slides purchased 
from Coming. The poly-L-lysine or GAPS coating gives the slide a positively charged 
surface to which the negatively-charged DNA can bind. All protocols in section 2.5 were 
supplied by or adapted from those supplied by B/iGS, with assistance from J. Hinds 
gratefully received.
2.5.2 Poly-L-Lysine coating
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To prepare slides for microarray printing, standard glass microscope slides were 
placed vertically in metal racks in an appropriately sized chamber. The slides were 
washed with an alkaline wash solution containing 70g NaOH dissolved in 280ml dH20 
and 420ml 95% ethanol for two hours with stirring. The slides were then rinsed five 
times for five minutes per wash with clean dH^O, after which they were coated by 
submersion in a solution containing 70ml 0.1% w/v solution poly-L-lysine (Sigma), 70ml 
lOx PBS and 560ml dfLO. Slides were then given further washes in water, and allowed 
to dry before storage in dust-free boxes at room temperature.
2.5.3 Post-processing
The printed poly-L-lysine slides were hydrated by being held face down over 
boiling water for approximately 2 seconds to create a light vapour coating, after which 
the slides were snap-dried on a 100°C hot plate for approximately 3 seconds. Care was 
taken not to over-hydrate the slides, which causes the spots to run. The slides were then 
exposed to lOOmJ cm' ultraviolet light using a UV crosslinker (Spectronics 
Corporation), after which the slides were chemically blocked using a succinic 
anhydride/sodium borate solution (according to the B/zGS protocol) to minimise non­
specific hybridisation of probe to the poly-L-lysine coating of the slides. The slides were 
then washed for 2 minutes in boiling water with agitation to denature the spotted DNA 
and make it accessible for hybridisation (Eisen & Brown 1999) followed by a 1 minute 
wash in 95% ethanol, after which the slides were dried and stored in the dark at room 
temperature prior to hybridisation.
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2.5.4 Labelling
2.5.4.1 RNA-RNA
RNA-RNA hybridisation experiments are a sensitive means of assessing small 
differences in the transcriptomes of two strains of M. tuberculosis. They consist of the 
hybridisation of labelled cDNA generated from RNA extracted from the wild-type and 
labelled cDNA generated from RNA extracted from a mutant strain on the same slide. 
This results in the analysis of two samples simultaneously. Disadvantages o f this method 
are that batches of the wild-type RNA used to generate labelled cDNA are likely to be 
inconsistant between, or possibly within, experiments making comparisons between 
different biological replicates or experiments difficult. Furthermore, some of the 
software for microarray analysis such as GENESPRING was originally developed with 
one-sample-per-array data in mind, such as that generated by Affymetrix array 
experiments. This can cause difficulties with later analysis when one wants to examine 
the control samples independantly from the test samples. In addition, ‘dye-swapped’ 
technical replicates have to be performed to prevent artefacts in the data arising from the 
inequalities in hybridisation and fluorescence of the Cy3- and Cy5-labelled cDNA. The 
method for RNA-RNA microarray hybridisation is adapted from a protocol provided by 
the B/xGS group (St. George’s Hospital Medical School, London).
cDNA samples of the RNA extracted from the wild-type and a mutant strain are 
generated by reverse transcription of the randomly-primed sample RNA. This is 
achieved by heating 2-5 /xg RNA with 3/xg random hexameric primers (Invitrogen) in an 
11 /xl volume to 95°C for 5 min followed by snap cooling on ice, before addition of the 
following reagents to the stated final concentrations in a 25/xl volume: lx  first strand
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buffer (Invitrogen), lOmM DTT, 0.46mM dATP, dTTP and dGTP (Invitrogen), 
0.184mM dCTP (Invitrogen), 0.116mM Cy3- or Cy5- labelled dCTP (Amersham) and 
500u Superscript III (Invitrogen). The reaction mix was then incubated in the dark for 5 
min at 25°C followed by incubation in the dark at 50°C for 60 min, after which the 
labelled cDNA samples were mixed and purified through a Minelute column (Qiagen) 
breaking the wash step into two washes of 500/d and 250/d but otherwise according to 
the manufacturer’s instructions. The purified labelled cDNA was eluted from the 
Minelute column with 15.9/d water.
2.5.4.2 DNA-RNA
DNA-RNA hybridisation consists of hybridisation of labelled cDNA from a 
standard sample of genomic M. tuberculosis DNA and labelled cDNA from RNA 
extracted from either the wild-type or a mutant strain on the same slide. Separate slides 
therefore contain information on either the wild-type or the mutant, and the RNA/DNA 
ratios of the separate slides must be compared to generate results. The advantage of this 
approach is the use of a universal standard (genomic DNA kindly supplied by Colorado 
State University) that allows comparisons to be drawn between experiments. The one- 
sample-per-slide method also facilitates analysis in GENESPRING, where all slides can 
be directly normalised to the values for each gene present on the arrays hybridised with 
wild-type sample. Furthermore, because the RNA-derived cDNA under test is only ever 
labelled with Cy5, there is no need to perform ‘dye swap’ technical replicates. The 
method used in this study for DNA-RNA hybridisation is adapted from a protocol 
provided by the B/iGS group (St. George’s Hospital Medical School, London).
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3.5 fig RNA extracted from the wild-type or a mutant strain is labelled with Cy5 
as described in section 2.5.4.1. 1 fig DNA is randomly primed by the addition of 3fig 
random hexameric primers in a 41.5/d total volume and heating to 95°C for 5 min before 
snap-cooling on ice. Labelled cDNA is then created by incubation in the dark for 1 hour 
at 37°C of the primed DNA with lx  DNA polymerase buffer (Promega), 0.23 mM dATP, 
dTTP and dGTP (Invitrogen), 0.092 mM dCTP (Invitrogen), 0.045mM Cy3 labelled 
dCTP (Amersham) and 3-9u DNA polymerase Klenow fragment (Promega) in a 50/d 
total volume. After labelling both DNA-derived cDNA and RNA-derived cDNA are 
mixed and purified through a Minelute column (Qiagen).
2.5.43 DNA-DNA
Two samples of DNA are separately labelled with Cy3 or Cy5 (Amersham) as 
described in section 2.5.4.2 for one sample. The labelled cDNA from the two samples is 
then mixed and purified through a Minelute column (Qiagen) as described above in 
section 2.5.4.1.
2.5.5 Hybridisation
The slide is prepared for hybridisation by incubation in 50ml of prehybridisation 
buffer containing 3.5x SSC (Sigma), 0.1% SDS (w/v) (BioRad) and lOmg/ml fraction V 
BSA (Sigma) for 20 min at 65°C, followed by consecutive washes in 400 ml water and 
400 ml propan-2-ol (Fisher Scientific) before centrifugation at room temperature in 50ml 
capacity Falcon tubes (Becton Dickinson) at 1500rpm in a Sigma centrifuge.
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The labelled cDNA samples were prepared for hybridisation by the addition of 
4.6/d 0.22/im filtered 20x SSC (Sigma) and 3.5/d 0 .2 2 /xm filtered SDS. The samples 
were then heated to 95°C for 2 min before brief centrifugation in an MSE microcentrifuge 
and application onto the prepared array. 22mm x 22mm LifterSlips (Erie Scientific) were 
placed over the array to assist the even distribution of the sample after application.
After application of the sample, the array is sealed in a slide chamber with two 
15/d aliquots of water and incubated in a water bath at 65°C for 18-24 hours. After 
hybridisation the array is washed in 400ml of Wash A solution containing lx  SSC 
(Sigma) and 0.05% SDS (BioRad) at 65°C, followed by two washes in 0.06x SSC, the 
first of which is at 65°C and the second at room temperature. The array is then dried by 
centrifugation in 50ml capacity Falcon tubes (Becton Dickinson) in a Sorvall centrifuge 
with a SS-34 rotor at 1500 rpm for 5 min and removed to a dark, dust-free box until 
scanning.
2.5.6 Microarray scanning and data generation
Microarrays were scanned in an Axon 4000A dual-wavelength scanner at 635nm 
(Cy5 channel) and 532nm (Cy3 channel) providing the red and green aspects, 
respectively, to the visualisation of the array using the GENEPIX PRO 5.0 software. The 
GENEPIX software was used to detect the locations of the spots on each array using the 
gridmap supplied by J. Hinds (B/iGS facility, St. George’s Hospital Medical School, 
London), the location and size of which were then assessed by eye and adjusted where 
necessary. The intensity of each spot was given by the median brightness o f the pixels
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within the spot boundary less the median brightness of the pixels in the area adjacent to 
the spot for each given wavelength, abbreviated to V635 and V532 respectively.
In a DNA-DNA hybridisation, all genes from both tested strains would be 
expected to be represented in the appropriate cDNA populations at the same frequency, 
with the exception of genes that are present as more than one copy on the chromosome or 
have been deleted. If the wild-type-derived cDNA is labelled with Cy5 and the mutant- 
derived cDNA labelled with Cy3, then spots on the microarray specific for the null gene 
of the mutant will hybridise only the Cy5-labelled cDNA from the wild-type and will 
appear red on the scanned microarray image. The V635/V532 ratio of the gene will be 
greater than 1. Conversely, if  a potential mutant strain is diploid for any genes, then the 
corresponding cDNA will be present at twice the frequency of that in the wild-type- 
derived cDNA and the spot will appear green with a V635/V532 ratio of less than one.
In an RNA-RNA hybridisation it is likely that transcripts for most genes are 
present at similar levels in both samples, with only a few genes differentially regulated 
between the two. A cDNA spot hybridised to by samples that contain labelled Cy3 and 
Cy5 transcript in equal quantities, as a result of equal numbers of transcripts in the parent 
RNA samples, will therefore display a yellow colour when both wavelengths are 
visualised together and produce a V635/V532 ratio of one provided both lasers are at 
comparable strengths. If a gene is over- or under-expressed in either parent RNA sample 
then the spot will correspondingly appear red or green as the V635/V532 ratio departs from 
one (Figure 2.2A).
In a DNA-RNA hybridisation, Cy3-labelled cDNA from the genomic DNA 
source should represent all genes equally, whereas the Cy-5 labelled cDNA from an RNA
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Figure 2.2: Strategies for comparison of labelled cDNA derived from RNA isolated from 
two different strains o f M. tuberculosis. A, RNA-RNA hybridisation; B, DNA-RNA 
hybridisation. Diagrams refer to the hypothetical slide image (left) and scatter plot 
generated by GENEPIX (right).
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source should contain different levels of transcript for each gene depending on its 
expression level. This results in uniform intensities for each gene in the 532nm channel, 
and a variety of intensities for each gene in the 635nm channel. The results are expressed 
as an RNA/DNA ratio, with arrays hybridised with cDNA derived from RNA extracted 
from the wild-type compared with arrays hybridised with cDNA derived from RNA 
extracted from the test strain. Genes that show a change in RNA/DNA ratio between the 
two groups can be said to be present at different quantities in the two samples (Figure 
2.2B).
2.5.7 Replicating microarray data
Microarray results were replicated in at least three biological experiments to 
enable valid statistics to be carried out. In addition, the evaluation of technical replicates 
for each biological sample allowed array-array variation to be minimised. Technical 
replicates performed as dye-swaps were essential for RNA-RNA hybridisation 
experiments, since some cDNA spots on the arrays preferentially bind sample cDNA 
labelled with one cyanine dye or the other. A typical RNA-RNA experiment therefore 
consisted of 6 slides, with the wild-type and a mutant compared directly on each slide. 
For each biological experiment 2 slides were used, one of which the cDNA extracted 
from the wild-type RNA was labelled with Cy3, and the other of which the cDNA 
extracted from the wild-type RNA was labelled with Cy5 (Figure 2.3).
A typical DNA-RNA experiment does not need dye-swap technical replicates, and so the 
technical replication of samples is simply done by performing the same hybridisation 
twice. In a simple wild-type versus mutant DNA-RNA experiment, 12
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Figure 2.3: Analysis strategy for RNA-RNA hybridisations. Sets o f slides representing 
three biological experiments are analysed and compared to isolate genes that are 
consistently and significantly above or below a Cy5/Cy3 ratio of one.
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slides were used: two slides for each RNA sample, three RNA samples per strain (Figure 
2.4).
Data files for transcriptional microarrays involving the hybridisation of cDNA 
samples derived from RNA were imported from GENEPIX to GENESPRING specifying 
which columns contained the “gene identifier”, “flags” (whether a spot was present or 
absent) and “F635-B635” and “F532-B532” . The latter two columns refer to the V635 
and V532 respectively.
2.5.8 Analysis of microarray results
2.5.8.1 DNA-DNA microarrays
When examining DNA from potential knockouts it was not necessary to perform 
statistical analysis, and visualisation was performed using the GENEPIX 5.0 software.
2.5.8.2 GENESPRING analysis of RNA-RNA microarrays
The range of V635 and V532 signal intensities in both channels followed an almost normal 
distribution with the exception of a small proportion of differentially regulated genes, 
resulting in the majority of genes being represented at equal ratios in both samples. 
Therefore it was appropriate to include a per-chip normalisation that divided the value for 
each spot by the 50th percentile of the measurements on the array. Control sample values 
below 0.1 were transformed to 0.1; if both the V635 and V532 were below 0.1 then the data 
was excluded from the analysis. For each spot the value for the mutant-derived value 
was divided by the wild-type-derived value, and dye-swapped technical replicate data
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Figure 2.4: Analysis strategy for DNA-RNA hybridisations. Hybridisation o f a control 
labelled cDNA source (generated from genomic DNA) against labelled cDNA derived 
from RNA generates a ‘fingerprint’ of relative RNA transcript levels in the mutant strain. 
Groups of slides representing three biological experiments for both the wild-type and 
mutant are compared, and analysed to isolate genes that have changed their DNA/RNA 
ratio significantly between the wild-type and mutant groups.
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was reversed to take account of the use of different wavelength channels for the 
measurements.
After normalisation, the cross-gene error model is fitted to the experiment 
parameters, based on replicates, and the average of the base/proportional error estimates 
is noted. Values with a control intensity less than this were excluded from the data.
Genes that appeared to preferentially bind cDNA labelled with one cyanine dye 
over the other were also excluded from the data. To generate a list of genes that may be 
differentially regulated in the mutant strain, the remaining genes are filtered to produce a 
list of genes that are up- or down-regulated by two-fold or more. Gene lists were then 
exported to MICROSOFT EXCEL for subsequent editing.
2.5.83 GENESPRING analysis of DNA-RNA microarrays
Since the range of intensities for the DNA control data (V532) would not 
necessarily be expected to follow a normal distribution, and that the majority of genes 
were not represented in both samples at equal ratios, a per-chip normalisation was not 
performed. Control sample values below 0.1 were transformed to 0.1; if both the V635 
and V532 were below 0.1 then the data was excluded from the analysis. For each spot the 
V635 representing the mutant strain or wild-type RNA-derived cDNA was divided by that 
of the wild-type DNA-derived V532. All arrays were normalised to the V635/V532 ratios 
present on the arrays hybridised with the cDNA derived from the RNA extracted from the 
control strain.
Genes that were present at different ratios between the arrays hybridised with 
cDNA derived from RNA extracted from the wild-type or the mutant were found by one­
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way ANOVA comparison, at a level of p<0.05 between the two groups using the tool 
contained within the GENESPRING 7.1 program. These genes, their p-value and fold 
change were copied into MICROSOFT EXCEL for subsequent editing.
2.6 Protein production
2.6.1 Considerations for the expression of recombinant polyhistidine-tagged 
RegX3
2.6.1.1 Tools used for the expression and purification of recombinant RegX3
There are a number of different strategies that may be taken to produce purified 
soluble protein. The most popular is the addition of a peptide tag to one end of the 
protein being expressed that allows it to be isolated from a heterogeneous protein source, 
and which may also aid the solubility characteristics of the protein. For example, a 
glutathione-S-transferase (GST) tag tends to increase the soluble characteristics of the 
peptide it is fused to, but its large size may affect the behaviour of the protein to which it 
is fused.
In the expression of recombinant RegX3 in this study it was decided to add a 
polyhistidine (6-His) tag to the N-terminus of the RegX3 sequence. The small size of the 
polyhistidine tag makes it unlikely to alter the function of RegX3 compared to other tag 
types, and it is usually unnecessary to cleave the tag from the protein before use. The 
presence of the polyhistidine tag allows purification of the protein on an immobilised 
metal anion chromatography (IMAC) column. IMACs contain a matrix holding a 
divalent cation which can interact with the imidazole group of histidine residues and form
139
a stable structure. The interaction can be reversed at acid pH, or by washing the column 
with high concentrations (in excess of 150mM) of imidazole.
The polyhistidine tag is also unlikely to alter the solubility of RegX3. It is 
reasonable to assume that RegX3 is a cytoplasmic protein since it interacts with DNA and 
does not appear to have any transmembrane sections when analysed by the Pfam 
(Bateman et al. 2004) and JPRED (Cuff et a l)  servers. These data suggest that RegX3 is 
likely to be soluble in M. tuberculosis. Himpens et al. (2000) used a denaturing 
purification protocol that does not distinguish between soluble and insoluble protein, 
suggesting that they were unable to isolate soluble protein in their system.
To purify recombinant RegX3 the coding sequence of the gene was cloned into 
the multiple cloning site 3’ of a polyhistidine-encoding sequence in the replicating, non- 
integrative plasmid vector pET15b (Novagen). The completed construct was transformed 
into BL21-RIL codonplus E. coli (Stratagene) and grown in liquid media with 
carbenicillin. Transcription of the recombinant regX3 allele is repressed during the 
growth of the E. coli and derepressed by the addition of ImM IPTG when the culture 
reached late-exponential phase. Strong expression of the recombinant RegX3 sequence 
in this vector derives from the transcription activity of the lac promoter.
Initial experiments to study the characteristics of the protein of interest involved 
the addition of IPTG to 10ml cultures of transformed E. coli. This allowed some of the 
variables influencing solubility of the protein to be assessed without the expense of 
making large-scale protein preparations. Once the most useful parameters for expression 
were found, the process was scaled up to 1 litre volume cultures.
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After 18-24 hours of expression at 18°C the soluble fraction of the cell was 
harvested by centrifugation at 13 000 rpm in a microcentrifuge (Heraeus) and 
resuspension in a nondenaturing buffer such as PBS. The cells were lysed by sonication 
and the recombinant polyhistidine-tagged RegX3 isolated.
2.6.1.2 Visualisation and identification of recombinant proteins
The separated proteins on the gel were visualised by staining with Coomassie 
Blue R-250 (Bio-Rad Laboratories), after which the protein of interest was distinguished 
by its predicted molecular weight and comparison with proteins from vector-only control 
cells.
Polyhistidine-tagged proteins were visualised by Western blotting (Sambrook et 
al. 2000) with an anti-polyhistidine antibody (Novagen), or a commercial InVision stain 
(Invitrogen). The InVision stain was a fast and easy method of staining gels for his- 
tagged proteins, since the protocol time of one hour and requires minimal attention. The 
InVision stain is also compatible with Coomassie staining. Unfortunately it was found in 
this study to bind promiscuously to other proteins in E. coli lysates.
Western blotting involved the transfer of the proteins in the gel to a positively 
charged PVDF membrane (Invitrogen) which was then probed with a murine anti­
polyhistidine primary antibody (Novagen). Addition of horseradish peroxidase- 
conjugated goat anti-mouse antibody (Jackson ImmunoResearch) specific for the primary 
antibody allowed visualisation of the complex by production light from lumophoric 
substrates (Pierce) that were captured on Amersham Hyperfilm as an 
autoelectrochemilumograph.
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The use of Western blots allows the protein of interest to be identified by epitope 
and apparent molecular mass. Use of an antibody specific for the peptide of the cloned 
region of the protein can confirm its identity; however these can be expensive to produce. 
When studying recombinant tagged proteins it is often feasible to probe with a 
commercially available monoclonal antibody specific for the tag. These commercial 
antibody preparations are consistent, specific and inexpensive. However it is important 
to be aware that it is the tag, and not the protein of interest that is being detected. This 
may cause difficulties if  the cloned sequence contained mutations, or if the wrong 
sequence was cloned; this can be checked by sequencing.
Mass spectrometry can be used to unambiguously identify the recombinant 
protein. Electrospray ionisation mass spectrometry provides an extremely accurate 
estimate of the mass of the protein, which may be compared to the predicted mass and is 
accurate enough to allow identification of mutations in the sequence. Matrix-assisted 
laser desorption ionisation time-of-flight (MALDI-TOF) mass spectrometry involves 
digestion of the protein with trypsin and estimation of the sizes of the resulting 
fragments. This ‘fingerprint’ can then be submitted to a database containing predicted 
sequence digests and the protein identified qualitatively.
2.6.2 Methods for expression, identification and purification of recombinant 
polyhistidine-tagged RegX3
2.6.2.1 Acrylamide gels used for electrophoresis
Gels used for the electrophoresis and visualisation of protein used in this work 
were commercially available, pre-cast Bis-Tris gels from Invitrogen of lmM thickness
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with wells that held ~15pl sample. These were used in conjuction with the denaturing 
SDS buffers contained in the kit and following the manufacturer’s instructions. 
Denaturing gels separate proteins based on molecular mass, and were used to analyse 
products of protein expression and purification experiments. Nondenaturing TBE gels 
also purchased from Invitrogen at 6, 8, 10 or 4-20% (gradient) acrylamide concentration 
(with the same dimensions) were used for the study of DNA-protein interactions, with 
either lx  or 0.5x TBE as an electrophoresis buffer. The use of 0.5x TBE (Sambrook et 
al. (2001), Appendix 4) as an electrophoresis buffer strengthens potential DNA-protein 
interactions, and requires the TBE acrylamide gel to be pre-run with this buffer for 30 
min at 15mA and 200 V to replace the lx  TBE buffer that the gel is supplied in.
2.6.2.2 Visualisation of proteins in SDS-polyacrylamide gels
Gels were stained overnight in Coomassie R250 stain (Bio-Rad Laboratories) and 
destained for 1-2 hours in a 5% methanol (Sigma), 5% acetic acid (Sigma) solution 
(Sambrook et al. (2001). When the bands became clear the gels were dried using an 
alcohol-buffer based gel-drying kit (Invitrogen) and photographed. Alternatively, the 
InVision stain (Invitrogen) was used to stain gels containing recombinant polyhistidine- 
tagged proteins according to the manufacturer’s protocol and were visualised and 
photographed on a UV transilluminator (UVP) as for agarose gels (2.3.4).
2.6.2.3 Visualisation of polyhistidine-tagged proteins by Western blot
Western blot analysis of gels was performed by semi-dry transfer of the proteins 
from an acrylamide gel onto an Invitrolon PVDF membrane (Invitrogen) by sandwiching
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the PVDF membrane, prewetted in methanol, water and semi-dry transfer buffer 
(Appendix 4), against the acrylamide gel. Three sheets of Whatman 3M paper cut to the 
size of the gel were wetted in semi-dry transfer buffer and placed on each side of the 
PVDF membrane/acrylamide gel sandwich. The sandwich was then placed in a semi-dry 
transfer apparatus unit (Biometra) with the PVDF membrane facing the cathode and 
transferred at 100V and 15mA per gel for one hour. The PVDF membrane was then 
blocked by overnight incubation in TTBS buffer (Appendix 4) with 10% w/v milk 
powder (Marvel), before being washed three times in TTBS for five minutes each wash. 
The primary antibody was diluted at 1/1000 concentration into 5ml antibody buffer 
(TTBS buffer with 3% w/v milk) and incubated with shaking at room temperature for 1 
hour, before three further washes in TTBS. The secondary antibody was diluted at 
1/2500 into 5ml antibody buffer and used to blot the washed membrane for an hour with 
shaking at room temperate, after which the membrane was given four further washes in 
TTBS, one wash in TBS, and one wash in PBS. The protein-antibody complexes were 
detected by incubation with the substrates contained within the SuperSignal West Pico kit 
(Pierce) according to the manufacter’s instructions and the autochemiluminescent signal 
visualised by exposure to Hyperfilm (Amersham).
2.6.2.4 Autoradiography
Gels were placed on Whatman 3MM filter paper, covered with Saranwrap and 
dried under a vacuum with heating. When dry the filter paper/gel/Saranwrap sandwich 
was transferred to an autoradiography cassette and exposed against X-Omat-AR film
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(Kodak) at -80°C for an appropriate amount of time. Autoradiographs were developed 
using an automatic X-ray processing machine (Fuji).
2.6.2.5 Small scale assay for the solubility of recombinant polyhistidine-tagged 
RegX3
Frozen stocks of expression-plasmid containing E. coli were inoculated into 10ml 
LB broth (see Appendix 4 and Sambrook et al. 2000) under the appropriate antibiotic 
selection pressure (ampicillin, see 2.1.2.2) and grown to an OD600 of 0.6 -  0.8. IPTG 
(Sigma) was then added to a final concentration of ImM and the cultures incubated with 
shaking at ~280 rpm for a further three hours. The cells were pelletted by centrifugation 
at 10 OOOg in a high speed centrifuge (Sorvall) using an SS34 rotor. After decanting the 
supernatant, the cells were resuspended in 1ml PBS and sonicated on ice using a 
sonicator fitted with a narrow (2mm) tip (Dawe). Lysis and genomic DNA shearing was 
confirmed by observing the fluidity of each sample through a 20/xl pipette tip. After 
centrifugation of the lysed bacteria for 5 min at 13 OOOrpm in a microcentrifuge 
(Heraeus) the supernatant, representing the soluble fraction of the cells, was removed. 
10/d of each soluble fraction was added to 4fi\ of SDS loading buffer. The insoluble 
pellet is then resuspended in 500fil SDS loading buffer (Novagen), and both the soluble 
and insoluble fractions were heated to 95°C for 5 min, followed by 30 sec vortexing and 
5 min centrifugation at 13 000 rpm in a microcentrifuge (Heraeus). 5-15/ri of each 
fraction was then loaded into the wells of a 12% Bis-Tris gel (Novagen) before 
electrophoresis at 15mA/200 V for 1 hour, or until the dye front reached the bottom of 
the gel.
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2.6.2.6 IMAC purification of recombinant polyhistidine-tagged RegX3
Immobilised metal anion chromatography used in this work utilised the His-Bind
kit and proprietary buffers (Novagen). 2ml supplied resin was loaded into a 7.5ml plastic 
column fitted with a glass fibre filter disc to retain the resin, and allowed to dry by 
gravity to its settled bed volume of 1ml (capacity 5mg/ml). The resin (matrix) was then 
washed twice with 10 bed volumes (b.v.) of water before charging with 10 b.v. of the 
supplied 50mM NiSC>4 solution and equilibration with 10 b.v. of binding buffer (20mM 
Tris-Cl, 0.5M NaCl, pH7.9, 5mM imidazole). The protein sample prepared in the 
supplied binding buffer was then applied to the column and allowed to drain by gravity 
flow. Aliquots of all flowthroughs were taken for later analysis and stored at 4°C. After 
washing with 10 b.v. supplied binding buffer and a 10 b.v. wash with the low- 
concentration imidazole buffer (20mM Tris-Cl, 0.5M NaCl, pH7.9, 60mM imidazole) to 
elute weakly-bound proteins, the remaining protein bound to the column was eluted in 10 
b.v. of elution buffer (20mM Tris-Cl, 0.5M NaCl, pH7.9, 1M imidazole). The eluate was 
collected as a single fraction and stored at 4°C overnight before analysis.
2.6.2.7 Dialysis of recombinant polyhistidine-tagged RegX3
Dialysis of protein samples allows the equilibration of the concentration of small 
molecules between one liquid sample and another. This is useful for protein chemistry 
since it allows the protein buffer to be changed after protein purification, where the 
elution buffer may contain high concentrations of urea or imidazole that may interfere 
with downstream applications. The following protocol was used for the dialysis of the
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recombinant polyhistidine-tagged RegX3 protein, and its RegX3 negative control sample, 
after elution from an IMAC column.
Three 5 litre aliquots of PBS with 10% glycerol (see Appendix 4) were prepared 
and chilled to 4°C in 5 litre beakers and covered with aluminium foil. Two 10ml volume 
Slide-a-Lyser cassettes (Pierce) with 3.5 kDa pore size cut-off were pre-wetted with PBS- 
glycerol buffer before the samples were injected into them using large bore needles 
(Kendall). The cassettes were then suspended in 5 litres of the PBS-glycerol aliquots 
using the supplied floatation devices, and left for 18-24 hours with stirring before two 
further changes of buffer.
2.6.2.8 Storage of recombinant polyhistidine-tagged RegX3
To store the dialysed protein, 25pl aliquots were made into 0.5ml tubes 
(Eppendorf) that were then snap-frozen in a dry-ice ethanol bath. The protein was 
subsequently stored at -80°C.
2.6.2.9 Phosphorylation of recombinant polyhistidine-tagged RegX3
Phosphorylation was carried out by a method adapted from Zahrt et al. (2003). 30 
pmol recombinant polyhistidine-tagged RegX3 was incubated with 1M MgCh (Sigma), 
lOmM DTT (Sigma) and 200mM acetyl phosphate (Sigma) for 30 min at 37°C. Acetyl 
phosphate is a high-energy phosphate donor that under these conditions is likely to 
phosphorylate all possible sites on the protein. This is also an equilibrium reaction, so 
that both phosphorylated and unphosphorylated species of protein will be present after 
the incubation, albeit with the phosphorylated form representing the greatest portion of
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the protein. An alternative, but more difficult method is to use a cognate or promiscuous 
sensor kinase to phosphorylate the recombinant polyhistidine-tagged RegX3, which 
would be more likely to recreate conditions in vivo. However due to time constraints this 
approach was not attempted in this study.
2.6.2.10 Ultrafiltration
Protein samples were concentrated at 4°C using an Ambion chamber (Millipore) 
with a 3.5kDa pore size cutoff membrane according to the manufacturer’s instructions. 
Approximately 8ml of dialysed eluate from the purification column (2.6.2.7) was placed 
in the chamber and concentrated with pressure through the membrane until the volume 
was approximately 800pl. The concentration of the protein was then measured using a 
BSA reagent kit (Pierce) according to the manufacturer’s instructions.
2.6.2.11 Preparation of recombinant polyhistidine-tagged RegX3 for MALDI-TOF 
mass spectrometry
15/d of the recombinant polyhistidine-tagged RegX3 protein sample was 
electrophoresed on a Tris-borate gel (Novagen) and an approximate 1mm2 volume of the 
appropriate band removed using a clean scalpel blade, keeping the amount of excess gel 
to a minimum. In a clean 0.5ml PCR tube (Starlabs) the gel slice was given a 2-5 min 
wash with water, two washes with 25mM ammonium bicarbonate (Sigma) and three 
washes with a 50:50 mix of acetonitrile (Sigma) and 50mM ammonium bicarbonate. If it 
was still stained, the gel slice was given two more washes in the acetonitrile/ammonium 
bicarbonate mix. After two further washes with 50mM ammonium bicarbonate the
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protein was reduced with 20mM DTT (Sigma) dissolved in 50mM ammonium 
bicarbonate and incubated at 37°C for one hour. After two further washes with 50mM 
ammonium bicarbonate the protein was alkylated by incubation for 30 min in the dark 
with 25mM iodoacetamide (Sigma) dissolved in 5GmM ammonium bicarbonate. After 
two further washes with 50mM ammonium bicarbonate the gel is dehydrated by washing 
with 200/d acetonitrile and air-dried.
Trypsin digestion of the protein sample was carried out on the dehydrated gel 
slices, which were incubated on ice for at least 15 min before addition of ice-cold 2/xg/ml 
solution sequencing grade modified trypsin (Promega) in 5mM AB. Trypsin digestion 
was then allowed to occur overnight at 32°C and 0.5/d of the supernatant was then used 
for MALDI-TOF mass spectrometry. The mass spectrometry results were kindly 
provided by S. Howell (NIMR).
2.6.3 Electrophoretic mobility shift assays
2.6.3.1 Radiolabelling of probes
Labelling of the probes for use in the electrophoretic mobility shift assays was 
accomplished by the addition of a radiolabelled phosphate group from 3/d adenosine 5’ y-
32  •  •P triphosphate triethylammonium salt at 400 Ci/mmol (Amersham) by incubation with 
T4 polynucleotide kinase at 37°C for 30 min in the supplied buffer in a final volume of 
30/d. Components unincorporated into the probes were removed by centrifugation of the 
reaction through Sephadex G25 columns (Amersham).
2.63.2 Binding buffer
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The binding buffer to allow the interaction of recombinant polyhistidine-tagged 
RegX3 was taken from Himpens et al. (2000), and adjusted from 5x concentrate to lOx 
concentrate, to allow more space in the reaction mix for other components. The 
composition can be seen below for the final lx  solution. Some preliminary experiments 
were carried out using the 5x binding buffer described in Himpens et al. (2000), however 
the alteration of the stock buffer to lOx concentrate allowed more flexibility in the 
inclusion of other reagents in the binding reaction. No differences in results were seen 
during preliminary experiments using the 5x or the lOx buffer. The final concentrations 
of components in the reaction are Tris/Cl, 2mM; MgCh, 0.4mM; KC1, lOmM; DTT, 
0.2mM; glycerol, 10% v/v; Nonidet P40,0.01% v/v.
2.63.3 Protein-DNA binding reactions
Volumes were adjusted in the protein-DNA binding reaction to allow for other 
components such as antibody or unlabelled specific DNA. The molar ratio of protein to 
probe in the final reactions are specified in each experiment, but were typically 50:1, 
which was similar to that used in Himpens et al. (2000) and contained 33.4 pmol of 
recombinant polyhistidine-tagged RegX3 and 0.66 pmol radiolabelled probe, and the 
reaction additionally contained 0.2/ig poly dldC bulk carrier DNA (Sigma) in binding 
buffer (described above in section 2.6.3.5) in a 10/d final volume. Further discussion on 
protein-DNA binding reactions can be seen in Asusubel et al.
2.6.3.4 Electrophoresis of protein-DNA binding reactions for gelshift assays
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The radiolabelled probe was added to the reaction as the final component, before 
the reaction was gently mixed and incubated at 37°C for 30min. BlueJuice loading buffer 
(Invitrogen) was added to 3x concentration, the sample gently mixed by tapping and the 
reactions loaded onto a nondenaturing 0.5x TE polyacrylamide gel (Invitrogen) and 
electrophoresis carried out at ~100V/gel for 40-60 min. Where necessary the amount of 
protein added was adjusted to allow for the inclusion of other components such as 
unlabelled competitor probe (annealed oligonucleotides 160 and 161, see Appendix 3). 
1/d was added of molar preparations of the unlabelled probe to give amounts relative to 
the labelled DNA (see individual experiments).
2.63.5 Supershift assays
Supershift assays were carried out according to standard published protocols 
(Asusubel et al., 2005). Briefly, an electrophoretic mobility shift assay was carried out as 
above, with the inclusion of lpl antibody specific for the protein of interest (anti­
polyhistidine antibody, Novagen) or the same amount of nonspecific antibody (anti-GST 
antibody, Novagen) into the binding reaction either before the protein-probe binding 
reaction or after. When antibody was added after the protein-probe binding reaction, all 
reactions in the experiment were then incubated for a further 30 min at 37°C.
2.63.6 Shift-Blot assays
Shift-blot assays were carried out according to the method in Demczuk et al. 
(1993). For further discussion on the shift-blot protocol see 5.1.3.3 and Figure 5.1.
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2.7 Allelic exchange
2.7.1 Construction of a vector for the deletion of the Rv0465c gene of M. 
tuberculosis
PCR was used to amplify regions of DNA flanking the gene Rv0465c (Figure 
2.5). Primers 133 and 134 (Appendix 3) were used to amplify a region 1650 bp 5’ of 
Rv0465c to produce a 1674 bp fragment which was then cloned into pCR-4 using a 
blunt-ended ligation kit (Invitrogen), creating pDH3. A region 1601 bp 3’ of Rv0465c 
was amplified with primers 135 and 135 (Appendix 3) to produce a 1645 bp fragment 
which was cloned into pCR-4, again with blunt-ended ligation, to produce pDH 4.
The plasmid p2NIL-H contains a hygromycin resistance cassette in the Kpnl site, 
flanked by a BamHl site 5’ of it and Notl site 3’ of it. The amplified region 5’ of 
Rv0465c had to be cloned into p2NIL-H first since the amplified region 3’ of Rv0465c 
contains a BamHl site (Figure 6.1).
p2NIL-H and pDH3 were digested with BamHl, and the 1656 bp fragment from 
pDH3 ligated into the linearised p2NIL-H to create pDH6. Seven clones of pDH6 were 
digested using the restriction enzyme Sail to determine the orientation of the insert, and a 
clone with the insert in the correct orientation was chosen for further manipulation. A 
sample of the correct clone of pDH6 was also digested with Kpnl, Pacl and Notl to 
confirm the integrity of these sites.
The 1609 bp Notl fragment from pDH4 ligated into the Notl site of pDH6 to 
create pDH9. pDH9 was digested with Pstl and Notl to determine the orientation of the 
Notl fragment. The BamHl, Kpnl and Pacl sites were also confirmed. To generate the
152
Figure 2.5: Cloning strategy for generating knockout constructs. This diagram follows 
the construction of the Rv0465c knockout vector as an example. 5’, amplified region 5’ 
of the gene to be deleted by allelic exchange; KO, gene to be deleted by allelic exchange; 
3’, amplified region 3’ o f the gene to be deleted by allelic exchange; kan\ kanamycin 
resistance cassette; hygr, hygromycin resistance cassette; sacB/lacZ, negative selection 
markers.
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final knockout construct, a sacB/lacZ marker cassette was cloned into the Pacl site of 
pDH9. Pacl has the recognition sequence TTAATTAA and this site is not present 
anywhere in the GC-rich genome of M. tuberculosis. The sacB gene from Bacillus 
subtilis creates a lethal phenotype when bacteria containing this gene are grown in the 
presence of sucrose (Dedonder 1966). Bacteria that are lacZ? produce /3-galactosidase, 
and when grown in the presence of the lactose homologue 5-bromo-4-chloro-3-indolyl-/5- 
D-galactopyranoside (X-gal) and the gratuitous inducer IPTG the bacteria produce 5- 
bromo-4-chloroindigo which gives the colony a blue colour.
A 4.5 kb Pacl fragment of pGOAL17 containing the genes sacB and lacZ was 
ligated into the single Pacl site of plasmid pDH9 to create pDH19. The restriction 
pattern of a pDH19 clone displaying the correct phenotype (sucrose sensitive, kanamycin 
resistant and blue colour on X-gal plates) with BamHl, Notl, Kpnl, Pacl and Hindlll 
confirmed the presence of all cloned inserts.
The 5’ and 3’ ends of the BamHl and Notl fragments of pDH19 were sequenced 
using the primers 139, 140, 169 and 170 (Figure 6.1 and Appendix 3). BLAST searches 
(Altschul et al. 1990) of the sequence data were performed and confirmed the structure of 
the plasmid.
2.7.2 Construction of a vector for the deletion of the Rvl049 gene of M.
tuberculosis
The knockout vector for Rvl049 was produced by the same method as in 2.7.1 
and Figure 2.4. Regions of DNA flanking the gene Rvl049 were amplified by PCR. 
Primers 137 and 138 (Appendix 3) were used to amplify a region 1500 bp 5’ of Rvl049
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to produce a 1524 bp fragment which was blunt-end cloned into pCR-4 (Invitrogen) to 
create pDH5. This 3’ region is truncated to avoid the IS 1081 insertion element upstream 
of it (Figure 2.6).
A region 1619 bp 3’ of Rvl049 was amplified with primers 119 and 122 
(Appendix 3) to produce a 1635 bp Augment that was cloned into pCR-4, again using a 
blunt-end cloning kit (Invitrogen), to produce pDH2. As with the Rv0465c knockout 
construct, the amplified region 5’ of Rvl049 had to be cloned into the hygromycin- 
marked manipulation vector p2NIL-H first since the amplified region 3’ of Rvl049 
contains a BamHl site close to the 3’ end (Figure 6.2). Cloning the fragments in the 
opposite order would have resulted in a large deletion in the final vector.
The 1512 bp BamHl Augment A*om pDH5 was ligated into the BamHl site of 
p2NIL-H to create pDH7. The orientation of the insert was determined by a Hindlll 
digestion.
The 1623 bp Notl Augment fiom pDH2 was ligated into the Notl site of pDH7 to 
create pDHlO. Three clones of pDHIO were analysed by PCR with the primer pairs 122 
and dl53, and 122 and 137 (Appendix 3), which should result in products of ~3kb and 
~4.5kb respectively if the orientation of the inserts was correct, and no products if the 
insert orientation was incorrect. Three clones appeared to have both inserts orientated in 
the correct direction.
A 4.5kb Pacl Augment from pGOAL17 was ligated into the Pacl site of pDHIO 
to create pDH14. The restriction pattern of a pDH14 clone displaying the correct 
phenotype (sucrose sensitive, kanamycin resistant and blue colour when grown on X-gal 
plates) with the enzymes BamHl, Notl, Kpnl, and Pacl confirmed the presence of all
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Figure 2.6: The Rvl049 gene region of M. tuberculosis. The amplified regions 5’ and 3’ 
are marked, as is the location o f the insertion sequence IS 1081. Rvl047 is a probable 
transposase, Rvl048 is a hypothetical protein, Rvl050 is a probable oxidoreductase and 
Rvl051c is a conserved hypothetical protein. All annotations were taken from the 
Tuberculist web server (http://genolist.pasteur.fr/TubercuList/)
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inserts. The 5’ and 3’ ends of the BamHl and Notl fragments of pDH14 were sequenced 
using the primers 147 and 148 (Appendix 3) from the 3’ end of the 5’ fragment and the 5’ 
end of the 3’ fragment, respectively, which read into the hygromycin resistance gene 
(Figure 6.1), BLAST searches (Altschul et a l 1990) of which were used to confirm the 
identity and orientation of the inserts and the presence of the hygromycin resistance gene.
2.7.3 Electroporation and selection of a Rv0465c and a Rvl049 null mutant
Wild-type M. tuberculosis H37Rv (a gift from Dr. S. Cole, Institut Pasteur) was 
grown and made electrocompetent. 1 /xg of pDH19 in a total volume of 4.8/il, or the same 
amount of pDH14 in a total volume of 4.052/d, was used to transform 400/d of 
competent M tuberculosis for the Rv0465c knockout. pDH19 and pDH14 were not pre­
treated with UV exposure as recommended in some published protocols (Hinds et a l 
1999) since it was considered that this may increase the frequency of base-pair mutations 
and illegitimate recombination.
The competent M. tuberculosis electroporated with either pDH19 or pDH14 were 
then diluted into 3.6ml pre-warmed liquid media and incubated for 24 hours at 37°C in a 
Swallow incubator to allow expression of the plasmid-encoded genes before aliquots 
were plated onto agar containing hygromycin and X-gal (Figure 1.1). After 46 days there 
were 13 blue and 8 white colonies on the 200/d and 400/d platings of the cells 
transformed with pDH19, and 13 blue and 15 white colonies on the 200/d and 400/d 
platings of the cells transformed with pDH14. Control plates of cultures transformed 
with water had no colonies, suggesting that the number of spontaneously hygromycin-
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resistant mutants were fewer than hygromycin-resistant mutants arising from some 
interaction with pDH19 or pDH14.
The blue colonies were streaked onto further agar plates containing hygromycin 
to allow for a second recombination event to occur. The white colonies were streaked 
onto agar plates containing kanamycin and on separate plates containing hygromycin, 
sucrose and X-gal, since the white colonies may represent (a) mutants that have arisen 
spontaneously from two recombination events and contain the desired mutant genotype, 
or (b) spontaneous kanamycin resistant mutants of either wild-type or single­
recombination event parentage.
Colonies were counted after 62 days, and those displaying the correct phenotype 
were frozen. The clones giving rise to blue colonies after the first-round selection were 
also frozen as stocks, and the plates stored at 4°C. The potential mutant clones were 
frozen and analysed further.
2.7.4 Analysis of potential Rv0465c and Rvl049 null mutant strains by PCR
Primers were designed to distinguish between the different possible genotypes of 
the products of either single or double recombination events after electroporation of M  
tuberculosis with pDH19 or pDH14 (Figure 2.7). The size of the primer product pairs 
was predicted for the different scenarios (Table 6.1).
The six potential mutant clones were grown and DNA extracted using the 
Instagene prep kit (Bio-Rad). PCR was used to assess the genotypes of the potential 
mutant clones, and one clone of M. tuberculosis electroporated with pDH19 and one 
clone of M. tuberculosis electroporated with pDH14 selected for further analysis.
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Figure 2.7: Locations of primer pairs used to distinguish between genotypes of strains 
potentially arising during the knockout process. The plasmid sequence is blue; the 
chromosomal sequence is red.
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2.7.5 Analysis of potential Rv0465c and Rvl049 null mutant strains by microarray
The potential Rv0465c and Rvl049 null mutants were grown in roller bottles and 
high-quality DNA preparations made (see section 2.4.1.2). DNA-DNA microarrays were 
performed as described in section 2.5.4.3 above. Hybridisations were carried out on 
separate arrays for each of the potential mutants.
2.7.6 Alignment of senXS promoter regions
Regions of sequence between senX3 and the upstream gene were taken from the 
genome sequences of M. tuberculosis (Cole et al. 1998), M. leprae (Cole et al. 2001) and 
M. avium (TIGR online, http://www.tigr.org/tdb/mdb/mdbinprogress.html), and 
compared using the MEGALINE software in the DNA STAR package.
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3 Assessment of the role of SenX3 and RegX3 using in vitro 
and in vivo assays of infection and cell viability
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3.1 INTRODUCTION
When M. tuberculosis enters the body it is exposed to reactive oxygen and nitrogen 
intermediates within the macrophage. The reactive oxygen and nitrogen intermediates 
can be generated either by the macrophage using phagocyte oxidase and inducible nitric 
oxide synthase, or by the bacterium as a product of aerobic respiration. These ROI and 
RNI cause damage to the bacterium, which must detoxify or repair the damage caused if 
they are to survive.
Several lines of reasoning suggest that the SenX3/RegX3 two component system of 
M. tuberculosis is involved in the response of the bacterium to oxidative stress. Firstly, 
both proteins have high homology to proteins from other organisms that are involved in 
oxidative stress resistance. It is possible that the SenX3/RegX3 system is either acting in 
direct response to the stress stimuli, or that it is acting like the ArcA/B system of E. coli 
where it is involved in shutting down the ROI-generating aerobic respiration system 
when the bacterium encounters anaerobic conditions (Nystrom 1998).
Secondly, SenX3 contains a PAS domain that may bind a haem prosthetic group 
(Rickman et a l 2004). PAS domains are signal input domains that act as internal sensors 
of, e.g., redox, oxygen and light, depending on the ligand they contain. Haem-containing 
PAS domains are often involved in oxygen sensing (reviewed in (Taylor & Zhulin 
1999)). Thirdly, microarray data tentatively supports a role for the SenX3/RegX3 system 
in sensing oxygen (see 4.3)
Further to the above arguments, it is also reasonable to hypothesise that the 
SenX3/RegX3 two component system plays a role in the infection process. Two 
component systems are often key regulators of virulence in other organisms, such as
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Salmonella typhimurium and Haemophilus influenzae, and the conservation of SenX3 
and RegX3, one of the eleven two component systems of M. tuberculosis (Cole et al. 
1998) and one of only four in M. leprae (Cole et al. 2001), which suggests an important 
role in the lifestyle of the mycobacteria. Recent work by Haydel & Clark-Curtiss (2004) 
showed that the regX3 transcript was upregulated at 48 hours after infection of human 
peripheral blood monocyte-derived macrophages.
The following experiments were designed to determine if there were any 
differences in the ability of SenX3 and RegX3 null mutants of M. tuberculosis to resist 
damage by ROI and other macrophage-like stresses compared to the wild-type. By 
adding specific agents to in vitro cultures it is possible to examine particular routes of 
damage -  for example, nitrosative stress or superoxide stress. The strains were also 
grown in mouse and cell culture models of M. tuberculosis infection, which allows 
assessment of the contribution that SenX3 and RegX3 play in the virulence of this 
organism.
Previous work on these strains has shown no difference in the susceptibility of the 
SenX3 and RegX3 null mutants to hydrogen peroxide or cumene hydroperoxide stress 
(Rickman 2002).
Raw data for the stress experiments contained within this chapter, including the 
statistical treatment of them, can be seen in Appendix 5.
3.2 RESULTS
3.2.1 In vitro assessment of the senX3 and regX3 null mutants
3.2.1.1 Aerobic growth curve
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In order to assess the growth phenotype of senX3 and regX3 null mutants of M. 
tuberculosis in vitro, the growth of the mutants and wild-type were followed in a standard 
aerobic in vitro model, growing aerobically in Dubos medium with albumin and glycerol 
at 37°C (see 2.1.1.4). Strains were grown to early exponential phase in Dubos media 
(2.1.1.4.1) and passaged at 1/500 dilution into a further set of identical rolling bottles. 
The procedure was as discussed in 2.1.1.4.3. The OD600 was measured daily (Figure 3.1). 
The data in Figure 3.1 is representative of a number of experiments carried out with 
identical results. Each curve therefore represents a single culture per strain, with each 
culture measured at different times.
The wild-type and the senX3 null mutant grew at the same rate with doubling 
times of 13.63 hours during exponential phase (between 96 and 144 hours post-dilution). 
The regX3 null mutant grew at a rate approximately 83% that of the wild-type and the 
senX3 null mutant, with a doubling time of 16.45 hours. The regX3 null mutant also 
entered stationary phase with an OD600 of approximately 80% that of the wild-type and 
the senX3 null mutant.
3.2.1.2 Microaerobic growth curve
In order to assess the growth phenotype of the senX3 and regX3 under oxygen- 
limited conditions, the mutants and wild-type were grown aerobically in Dubos medium 
with albumin and glycerol at 37°C before inoculation into Dubos media (see 2.1.1.4.1) in 
oxygen-limited, standing bijou tubes and grown at 37°C. The senX3 and regX3 mutants 
and the wild-type were grown as before (2.1.1.4.3) to early exponential phase before 
1/250 dilution into 5 ml pre-warmed liquid media in 7 ml plastic bijou tubes with a
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Figure 3.1: Aerobic growth of wild-type, and senX3 and regX3 null mutants o f M. 
tuberculosis at 37°C in Dubos medium supplemented with albumin and glycerol as 
described in 2.1.1.4.1. Each strain was diluted at 1/500 into 100ml fresh liquid media in 
a 1L rolling bottle (Nalgene) and allowed to roll at ~2rpm at 37°C. Optical densities at 
600nm wavelength were taken daily of the cultures. Data shows a single experiment that 
has been repeated on several occasions.
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ainmedia ratio of 0.4. The caps of the bijou tubes were tightly sealed by hand to 
minimise gaseous exchange.
Sufficient bijous were used to allow three to be used per strain per time point for the 
OD600 readings (Figure 3.2). To take an OD600 reading three bijou cultures per strain 
were removed from the incubator and vortexed to resuspend the sediment. ‘Clumping’ of 
the bacteria was not apparent by eye. After the OD600s had been measured the cultures 
were discarded. The use of undisturbed cultures for measuring growth of the bacteria at 
each time point meant that a consistent as possible oxygen concentration was provided to 
the bacteria throughout the experiment.
The senX3 and regX3 null mutants and the wild-type showed doubling times of 
18.5, 19.9 and 19.1 hours respectively during exponential phase growth (from zero to 143 
hours) and persisted in stationary phase at low mean OD600s of 0.68, 0.65 and 0.70 
respectively. The difference in OD600 at the last time point between the regX3 null 
mutant and the wild-type is significant below the p=0.05 limit as compared by a two- 
tailed homoscedastic Student’s t-test. It may be possible that after 336 hours the strains 
are entering linear growth phase, although viable count data would need to be measured 
to examine this properly.
3.2.I.3 Nutrient starvation
To assess whether the senX3 and regX3 null mutants were less viable than the 
wild-type under nutrient starvation condition, exponential cultures of the mutants and 
wild-type grown in Dubos medium with albumin and glycerol at 37°C (2.1.1.4.1) were 
washed several times and resuspended in equal volumes of phosphate-buffered saline
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Figure 3.2: Microaerobic growth of wild-type and senX3 and regX3 null mutants o f M. 
tuberculosis in Dubos medium supplemented with albumin and glycerol as described in 
2.1.1.4.1. All strains were grown to mid exponential phase as per 2.1.1.4.3 in Dubos 
media with albumin and glycerol at 37°C before dilution at 1/500 into Dubos media with 
albumin and glycerol in multiple standing Bijou cultures and further cultured at 37°C. 
The data points represent the mean of three used cultures per strain per time point. The 
regX3 null mutant was at an ODgoo significantly lower than the wild type at a level of 
p<0.05 as compared by a two-tailed homoscedastic Student’s t-test.
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before four aliquots of 10 ml per strain were made into 25ml universal tubes. An 
initial culture was used for each strain on day one to provide a baseline viable count. The 
nutrient-depleted cultures were then left to stand without disturbance for 43 days at 37°C, 
after which viable counts were made again (Figure 3.3). Statistics were not performed 
on these data since the base line measurement at day one was performed once for each 
strain and was therefore statistically unviable. No difference in viability was apparent 
between the survival of the wild-type or the senX3 or regX3 null mutants at days one and 
43.
3.2.1.4 pH growth curve
In order to assess the ability of the senX3 and regX3 null mutants to grow in a 
low-pH environment, early-exponential phase cultures grown aerobically in Dubos 
medium with albumin and glycerol at 37°C were inoculated at 1/500 dilution into 
triplicate rolling bottles containing media that had been acidified to pH 5.5 with HC1. 
The growth of the strains was followed daily by measuring the optical density (Figure 
3.4). Each data point represents three cultures per time point. Sequential readings were 
taken from each culture.
There was no difference in growth rates between the senX3 and regX3 null 
mutants and the wild-type. After the last time point the pH of the media was assessed 
with pH strips to be between pH 5 and pH 6. Growth rates were not calculated due to the 
non-linear growth of the strains.
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Figure 3.3: Viability o f senX3 and regX3 null mutants o f M. tuberculosis and the wild- 
after nutrient starvation for 43 days, following the washing of cultures grown aerobically 
in Dubos medium with albumin and glycerol at 37°C in PBS (Appendix 4), expressed as 
A) cfu/ml and B) % viability. Triplicate exponential-phase cultures were washed 
thoroughly in phosphate-buffered saline before aliquotting into standing cultures. Viable 
counts were performed at day one and at day 43. Percentage viability loss was calculated 
as the number of viable bacteria per ml of stressed cultures divided by the number of 
bacteria per ml o f unstressed cultures, times 100. This gives the number o f bacteria after 
stress as a percentage o f the unstressed cultures. Statistics were not performed on these 
data since the base line measurement at day one was performed once for each strain and 
was therefore statistically unviable.
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Figure 3.4: Growth of senX3 and regX3 mutants in media acidified to pH5.5 with HC1. 
Exponential-phase cultures grown in Dubos media with albumin and glycerol at 37°C in 
aerobic culture as per 2.1.1.4.1 were diluted at 1/500 into triplicate rolling cultures 
containing 100ml of Dubos media with albumin and glycerol acidified to pH5.5 with HC1 
and incubated at 37°C. Optical densities were followed over a period o f one month. At 
the final time point the pH was between pH5 and pH6 using indicator strips (Merck). 
There was no statistical difference between the three strains as measured by a two-tailed 
homoscedastic Student’s t-test.
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3.2.1.5 Toluidine blue assay
Mutants of ArcA in E. coli are hypersensitive to the dye toluidine blue (Roeder & 
Somerville 1979; Buxton & Drury 1983; Buxton et al. 1983; Buxton & Drury 1984). To 
assess whether the senX3 and regX3 mutants were more sensitive to the dye toluidine 
blue than the wild-type, bacteria from cultures grown aerobically in Dubos media with 
albumin and glycerol at 37°C (2.1.1.4.1) were streaked onto agar plates containing 
increasing concentations of the dye. All strains were unable to grow on agar plates 
containing lOOpg/ml or more. The three strains were also inoculated into triplicate 
standing cultures containing titrations of toluidine blue in liquid media. These conditions 
are similar to those in 3.1.1.2 in which oxygen is thought to be the limiting growth factor. 
Again, no difference in sensitivity to the dye between the wild-type and the senX3 and 
regX3 null mutants was apparent (data not shown).
3.2.2 Stress studies
3.2.2.1 Superoxide stress
In order to assess the relative resistance of the senX3 and regX3 null strains and wild-type 
to superoxide stress, the strains were exposed to paraquat, a superoxide radical generator. 
The strains were grown aerobically to early exponential phase in Dubos media with 
albumin and glycerol at 37°C (see 2.1.1.4.1) then split into six aliquots of 20ml per strain 
in rolling bottles. Three 20ml aliquots of each strain were exposed to paraquat to a final 
concentration of 50mM and the three controls were exposed to volumes of solvent (in this 
case water) equal to that of the paraquat. After exposure the cultures were cultured for 
two further hours at 37°C before viable counts were taken (Figure 3.5). The
178
Figure 3.5: Viability of senX3 and regX3 mutants after two hours exposure to 50mM 
paraquat, a superoxide radical generator, expressed as A) cfu/ml and B) percentage drop 
in viability. Triplicate cultures of each strain were grown aerobically in Dubos media 
with albumin and glycerol at 37°C (2.1.1.4.1) to early exponential phase and were then 
split into two rolling bottles, half of which were treated with paraquat to a final 
concentration of 50mM. After two hours of further incubation at 37°C viable counts 
were taken. The log loss of viability of the regX3 null mutant was significant at p<0.03 
when compared to the wild-type by a two-tailed homoscedastic t-test.
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wild-type and senX3 and regX3 null mutants showed -0.09, 0.13 and 0.05 log losses in 
viability respectively after treatment, comparing the log data of the triplicate unstressed 
cultures to the log data of the triplicate stressed cultures The log loss of viability of the 
regX3 null mutant was significant at p<0.03 when compared to the wild-type by a two- 
tailed homoscedastic t-test.
In a separate experiment, the treated bacteria were cultured for 24 hours at 37°C 
before viable counts (Figure 3.6) and O D ^s (Figure 3.7) were taken. The wild-type and 
senX3 and regX3 null mutants showed 2.29, 1.47 and 0.64 log losses in viability 
respectively after treatment. No strains showed a log loss of viability (a difference in the 
log number of viable bacteria before and after stress) significantly different from any 
other below a level of p<0.05. The data for the optical densities of the cultures supports 
this observation.
3.2.2.2 Nitrosative stress
In order to assess the relative resistance of the senX3 and regX3 null strains to nitrosative 
stress, the strains were grown aerobically in Dubos media with albumin and glycerol
(2.1.1.4.1) at 37°C to early exponential phase, after which the cultures were exposed to 
3mM sodium nitrite (Sigma) after being washed and resuspended in Dubos media with 
albumin and glycerol (see 2.1.1.4.1) acidified to pH 5.5 with hydrochloric acid (Sigma). 
20 ml of each strain was then aliquoted into six rolling bottles and silver nitrite added to 
three of these to a final concentration of 3mM, a concentration known to produce a drop 
in viability in wild-type M. tuberculosis after 24 hours (L Rand, personal 
communication). The cultures were then cultured at 37°C for 24 hours before viable
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Figure 3.6: Viability o f senX3 and regX3 null mutants after 24 hours exposure to 50mM 
paraquat, a superoxide radical generator, expressed as A) cfu/ml and B) percentage 
viability loss. Triplicate cultures of each strain were grown aerobically in Dubos media 
with albumin and glycerol at 37°C (2.1.1.4.1) to early exponential phase and then split 
into separate cultures and half were treated with paraquat to a final concentration of 
50mM. After 24 hours further incubation at 37°C viable counts were taken. No strains 
showed a log loss of viability significantly different from any other below a level of 
p<0.05.
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Figure 3.7: Optical densities o f cultures o f senX3 and regX3 null mutants after exposure 
to 50mM paraquat for 24 hours, expressed as A) OD600 and B) percentage viability of 
stressed cultures compared to unstressed cultures. Strains were grown aerobically in 
Dubos media with albumin and glycerol at 37°C (2.1.1.4.1) to early exponential phase, 
the OD600 taken and triplicate cultures o f each strain were split and half were treated with 
paraquat to a final concentration of 50mM. After 24 hours of further incubation at 37°C 
the OD600 o f the stressed and unstressed cultures were taken again. Statistics were not 
performed on the optical density data since more reliable measurements have been taken 
in the form o f the viable count data.
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counts (Figure 3.8) and optical densities (Figure 3.9) were measured. The wild-type and 
senX3 and regX3 null mutants showed 0.1, 0.9 and 0.6 log losses in viability respectively 
after treatment. No strains showed a log loss of viability significantly different from any 
other below a level of p<0.05. The data for the optical densities of the cultures supports 
this observation.
To assess whether growth under microaerobic conditions altered the viability of 
the mutant strains to nitrosative stress when compared to the wild-type, a separate 
experiment was carried out in which exponential-phase cultures were inoculated at 1/500 
dilution into 100ml liquid media in 262.5 ml (75cm2) non-vented tissue culture flasks. 
The air:media ratio was 0.38 in these flasks and after inoculation the caps were screwed 
tightly to prevent gaseous exchange. When the cultures had grown to mid-exponential 
phase, the supernatant was aspirated and the sediment resuspended in acidified media. 
For each strain, two cultures had silver nitrite added to a final concentration of 3mM, and 
two cultures left as controls. Viable counts were taken after 24 hours (Figure 3.10). The 
wild-type and senX3 and regX3 null mutants showed 0.49, 0.48 and 0.43 log losses in 
viability respectively after treatment. No strains showed a log loss of viability 
significantly different from any other below a level of p<0.05.
3.2.2.3 Organic hydroperoxide stress
In order to assess the relative resistance of the senX3 and regX3 null mutants to 
organic hydroperoxide stress, aerobic rolling cultures were exposed to organic 
hydroperoxides.
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Figure 3.8: Viability o f senX3 and regX3 mutants after 24 hours exposure to 3mM 
acidified silver nitrite, a nitrosative stress generator, expressed as A) cfu/ml and B) 
percentage viabilities. Triplicate cultures of each strain grown aerobically in Dubos 
media with albumin and glycerol at 37°C (2.1.1.4.1) to early exponential phase were 
washed and resuspended in media acidified to pH5.5. The cultures were then split and 
half were treated with silver nitrite to a final concentration of 50mM. After 24 hours 
further incubation at 37°C viable counts were taken. No strains showed a statistically 
different log loss in viability compared to the wild-type using a two-tailed homoscedastic 
Student’s t-test.
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Figure 3.9: Optical densities of cultures o f senX3 and regX3 null mutants after exposure 
to 3mM acidified silver nitrite for 24 hours, expressed as A) OD600 and B) percentage 
viability of stressed cultures compared to unstressed cultures. Strains were grown 
aerobically in Dubos media with albumin and glycerol at 37°C (2.1.1.4.1) to early 
exponential phase, then washed and resuspended in media acidified to pH5.5. The OD600 
was taken before triplicate cultures of each strain were split and half were treated with 
silver nitrite to a final concentration of 3mM. After 24 hours o f further incubation at 
37°C the OD600 o f the stressed and unstressed cultures were taken again. Statistics were 
not performed on the optical density data since more reliable measurements have been 
taken in the form o f the viable count data.
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Figure 3.10: Viability of senX3 and regX3 null mutants of M. tuberculosis after growth 
under microaerobic conditions and exposure to acidified silver nitrite, expressed as (A) 
log cfu/ml and (B) % change in viability after stress. Four cultures of each strain were 
grown for 17 days in oxygen-limited culture at 37°C from a 1/500 starting dilution of 
bacteria grown aerobically in Dubos media with albumin and glycerol at 37°C (2.1.1.4.1) 
to early exponential phase, after which the media was aspirated and replaced with 
acidified media (pH5.5). Two cultures for each strain were then exposed to silver nitrite. 
After 24 hours of further incubation viable counts were taken. No strains showed a 
significant change in log loss o f viability when compared with a two-tailed 
homoscedastic Student’s t-test.
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Since the author was unaware of any similar studies on M. tuberculosis, it was 
decided to titrate tert-butyl hydroperoxide against wild-type M. tuberculosis to establish 
the bactericidal concentration of tert-butyl hydroperoxide. The wild-type strain was 
grown in Dubos media at 37°C (see 2.1.1) to early exponential phase then exposed to 
varying concentrations of tert-butyl hydroperoxide for 24 hours, after which the viable 
counts (Figure 3.11) and OD600S (Figure 3.12) were taken. The viability of wild-type M. 
tuberculosis decreased as the concentration of tert-butyl hydroperoxide increased. A one­
tailed homoscedastic t-test of log losses in viability showed all groups with tert-butyl 
hydroperoxide concentrations higher than 250pM to be significant at p values less than 
0.05.
To emphasise any differences in viability between the wild type and the senX3 
and regX3 mutants, tert-butyl hydroperoxide was added to triplicate cultures of the 
strains to a final concentration of 2mM, which was the maximum concentration titrated 
against the wild-type. The strains were grown as normal (see 2.1.1.4) to early 
exponential phase and exposed to tert-butyl hydroperoxide while rolling at 37°C for 24 
hours, after which viable counts (Figure 3.13) and OD600 readings (Figure 3.14) were 
taken.
The wild-type and senX3 null mutant showed mean 1.47 and 1.45 log losses of 
viability respectively after exposure to 2mM tert-butyl hydroperoxide, and the regX3 null 
mutant showed a mean 0.53 log loss of viability. A two-tailed homoscedastic student’s t- 
test showed the difference in loss of viability between the wild-type and the regX3 null 
mutant to be significant at a p value of 0.008. An identical comparison made between the 
wild-type and the senX3 null mutant had a p value of 0.75.
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Figure 3.11: Titration o f terf-butyl hydroperoxide against wild-type M. tuberculosis. The 
strain was grown aerobically in Dubos media with albumin and glycerol at 37°C
(2.1.1.4.1) to early exponential phase before being split into separate triplicate cultures. 
Each group of three cultures was exposed to either 0 (water control), 100, 250, 500, 1000 
or 2000 fiM concentration o f tert-butyl hydroperoxide and incubated for a further 24 
hours at 37°C, after which viable counts were taken. At all concentrations o f tert-butyl 
hydroperoxide over lOOpM the log loss in viability was significant at a level o f p<0.05 
when compared to the untreated control.
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Figure 3.12: Titration of tert-butyl hydroperoxide against wild-type M. tuberculosis. The 
strain was grown aerobically in Dubos media with albumin and glycerol at 37°C
(2.1.1.4.1) to early exponential phase before being split into separate triplicate cultures. 
Each group of three cultures was exposed to either 0 (water control), 100, 250, 500, 1000 
or 2000 /xM concentration o f tert-butyl hydroperoxide and incubated for a further 24 
hours at 37°C, after which OD600 readings were taken. At all concentrations o f tert-butyl 
hydroperoxide over lOOpM the log loss in viability was significant at a level o f p<0.05 
when compared to the untreated control. Input: the OD600 of the strain before the tert- 
butyl hydroperoxide was added.
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Figure 3.13: Viability o f senX3 and regX3 mutants after 24 hours exposure to 2 mM tert- 
butyl hydroperoxide, an organic hydroperoxide generator, expressed as A) cfu/ml and B) 
% viability. Triplicate cultures of each strain grown aerobically in Dubos media with 
albumin and glycerol at 37°C (2.1.1.4.1) to early exponential phase and were split into 
separate cultures, one of which was treated 2mM tert-butyl hydroperoxide, and the other 
exposed to an equal volume of water. After 24 hours further incubation at 37°C viable 
counts were taken. The dashed lines represent the limits o f the assay at using the 
dilutions described in 2.2.1.1. The log loss in viability of the regX3 null mutant was 
significant at a level o f p<0.008.
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Figure 3.14: Viability o f senX3 and regX3 mutants after 24 hours exposure to 2 mM tert- 
butyl hydroperoxide, an organic hydroperoxide generator, expressed as A) OD600 and B) 
% viability. Triplicate cultures of each strain grown aerobically in Dubos media with 
albumin and glycerol at 37°C (2.1.1.4.1) to early exponential phase were split and treated 
with either 2mM tert-butyl hydroperoxide, or equal volumes of water. After 24 hours 
further incubation at 37°C optical density measurements were taken. Statistics were not 
performed on these data since more reliable figures were provided by the viability data 
shown in Table 3.13.
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3.2.3 In vivo characterisation of the senX3 and regX3 null mutants
3.23.1 Construction of complemented senX3 and regX3 null mutants
A 2.7 lkb region of the M. tuberculosis chromosome (from 578814 to 581523) 
was amplified by PCR using primers 114 and 115 (Appendix 3, and Figure 3.15). The 
PCR product was then blunt-end cloned into pCR-4 blunt (Invitrogen) to create pDHl. 
The cloned region contained senX3, regX3 and 469bp upstream of senX3 that was 
assumed to contain the promoter of senX3 (Figure 3.15). Both genes were included in the 
complementation region for both senX3 and regX3 null mutants since the genes are 
presumed to be co-transcribed (Supply et al. 1997) and the hygromycin resistance marker 
that replaced senX3 in the senX3 null mutant would be expected to have a polar effect of 
the expression of regX3.
pDHl was digested with the EcoRl restriction enzyme to yield an insert 
containing the amplified senX3, regX3 and a 223 bp region upstream of senX3. The 
region upstream of senX3 was shorter here due to the presence of an £coRI site in the 
cloned sequence. The insert was then cloned into the ZscoRI site of the attP+Hnf suicide 
vector pKP186 (see Table 2.2) to produce pDH12. The EcoKl insert of pDH12 was then 
completely sequenced and did not have any mutations when compared to the wild-type 
sequence.
The senX3 and regX3 null mutants were prepared for electroporation (see 
2.1.1.4.8 ). I fig of pDHl 2 and 300ng of pBS-int were electroporated simultaneously into 
each mutant strain (see 2.1.1.4.8), and the transformants plated onto kanamycin agar 
plates.
Since only pDHl2 has a kanamycin resistance marker, and neither pDH12 or
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Figure 3.15: The senX3 and regX3 region of the M. tuberculosis chromosome. AsenX3 
and AregX3 represent the regions deleted in the senX3 and regX3 null mutants, 
respectively. The complement region shows the relative position o f the functional allele 
cloned into the complementing vector pDH12. gpm is a probable phosphoglycerate 
mutase, and Rv0492c encodes a probable oxidoreductase (Tuberculist, 2005).
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pBS-int have mycobacterial origins of replication, only bacteria that have acquired a 
stable copy of pDHl2 integrated into the chromosome should be able to form colonies 
(Stover et al. 1991). Kanamycin-resistant colonies were then grown without selection in 
standing cultures and frozen stocks prepared.
3.23.2 Growth and complementation of senX3 and regX3 null mutants in a murine 
model of infection
To determine whether the senX3 or regX3 genes play a role in the virulence of M  
tuberculosis, the senX3 and regX3 null mutants were assayed in a murine intravenous 
injection model of infection. The two mutant strains, the wild-type and the two mutant 
strains containing pDHl2 were grown aerobically (see 2.1.1). When the cultures reached 
mid-exponential phase they were diluted to an OD600 of 0.024 in sterile phosphate- 
buffered saline pH 7.4 and injected into the tail veins of 6-8 week old female Balb/C 
mice. Groups of three to five mice were killed over a period of 140 days and the number 
of viable M. tuberculosis bacilli determined in the lungs and spleen (Figure 3.16).
Both the senX3 and regX3 null mutants grew to about 5xl04 CFU/gram tissue in 
the lungs at 36 days, after which they did not appear to continue growing. The wild-type, 
in comparison, grew to 4xl05 CFU/gram tissue in the lungs at day 36, gradually 
increasing to about lxlO6 at day 140. The difference between the senX3 and regX3 null 
mutants and the wild type was significant at a level of p<0.0002 and p<0.00001, 
respectively. The regX3 null mutant containing the complementing allele on the 
chromosome via pDH12 grew to the same levels as the wild-type in the lungs, however
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Figure 3.16: Growth o f wild-type M. tuberculosis, senX3 and regX3 null mutants o f M. 
tuberculosis and the senX3 and regX3 null mutants carrying the plasmid pDH12 
integrated into the chromosome. The infection was monitored by removing the lungs and 
spleens of 3-5 infected mice per strain at intervals, and viable counts performed after 
serial dilution in 0.15% saline.
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the growth of the senX3 null mutant did not reach similar levels as the wild-type until 
after 60 days.
The growth of the five strains in the spleens was largely similar to the growth in 
the lungs, although the rate of growth between the different time points for the different 
strains was less predictable. At 140 days the difference in CFU/gram tissue in the spleens 
between the senX3 and regX3 null mutants and the wild-type and complementing strains 
was about one log, and was significant at levels of p<0.003 and p<0.002 for the senX3 
and regX3 null mutants respectively as compared by paired t-test. The CFU/gram tissue 
were approximately one log higher in the spleens, which is most likely due to the greater 
exposure the spleen has to bacilli during the initial stages of an intravenous infection. A 
notable difference in the spleens is that the growth of the senX3 null mutant carrying 
pDHl2 is that restoration of virulence by the functional allele does not seem to occur 
until 140 days post infection.
The complementation of the senX3 and regX3 null mutants shows conclusively 
that it is the mutations in these particular genes that give rise to the attenuated phenotype 
in the mouse model, rather than some genetic polar effect or other fortuitous mutation 
elsewhere on the genome. Other studies of isogenic mutants in this signal transduction 
system have not performed this complementation test (Parish et al. 2003).
3.2.3.3 Complementation of the senX3 and regX3 null mutants in bone-marrow 
derived macrophages
To further examine the role of the senX3 and regX3 genes in a more defined in 
vitro model of infection, the senX3 and regX3 null mutants, the wild-type and the
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complementing strains were used to infect primary macrophages that had not been 
activated by the addition of exogenous interferon-7 .
The five strains were grown as before (see 2.1.1) to mid-exponential phase before 
dilution to an OD600 of 0-04 in Iscove’s Modified Dulbecco’s media (IMDM). The bacilli 
were then used to infect bone marrow-derived macrophages from 8  month old female 
Balb/C mice at a multiplicity of infection of two macrophages per one bacillus. 
Infections were carried out in triplicate at each time point (Figure 3.17).
All strains were present at about 8xl04 bacteria per millilitre of lysed macrophage 
supernatant at day zero. The viable count of the wild-type and the complementing strains 
increased over 12 days to approx 7xl05, whereas the senX3 null mutant showed a slight 
loss of viability over the same period of time to a viable count of around 4xl04. The 
regX3 null mutant showed slight increase in viable count during the first week to around 
0.5x10s, after which the growth remained static.
3.2.3.4 PCR analysis of the complementing senX3 and regX3 strains used in the 
murine infection (3.2.3.2)
DNA was extracted from a plate culture of the senX3 null mutant carrying the 
complementing allele recovered from the mice and two co-transformants (see 3.2.3.2, and 
method at 2.4.1.2). regX3 and part of senX3 was amplified from the complementing 
allele by using a primer from the senX3 sequence (primer 104) and one specific for the 
plasmid (primer PMV306-4)(Figure 3.18 and Appendix 3). All products were of the 
expected size, and when sequenced, products from all three senX3 null mutant strains
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Figure 3.17: Growth of senX3 and regX3 null mutants of M. tuberculosis and their 
respective complementing strains in a macrophage infection assay. Strains were grown 
to early exponential phase before dilution to an OD600 of 0.04 in IMDM. Cells obtained 
from the bone marrow o f BALB/c mice were infected at a multiplicity o f infection o f 2:1, 
and the infection followed by lysis and viable counts o f triplicate cultures at intervals. 
Comp: complemented by the insertion of pDH12. The y axis units represent logio colony 
forming units per ml lysate. H37Rv is the wild-type strain.
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Figure 3.18: Sequenced region of the chromosome of the senX3 null mutant carrying a 
functional allele on the plasmid pDH 12.
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carrying the complementing plasmid were identical to the published sequence of M. 
tuberculosis.
3.2.3.5 Transcriptomic microarray analysis of the complementing senX3 and regX3 
null mutant strains
To examine the transcription levels of senX3 and regX3 in the complementing 
senX3 and regX3 null mutant strain, one culture each of the wild-type, the 
complementing strains and the mutants were grown aerobically (2.1.1.4.3) and RNA was 
extracted (2.4.2). The RNA of each mutant or complementing strain was then compared 
to the RNA of the wild-type (2.5.4.1). The microarray results were analysed using the 
GENESPRING software by the method described in 2.5.8.2. It appears that the 
complementing allele in the senX3 null mutant is unable to produce a regX3 transcript 
(Figure 3.19), whereas the same allele in the regX3 null mutant restores wild-type levels 
of the transcript (Figure 3.20).
3.3 DISCUSSION
3.3.1 In vitro assessment of the senX3 and regX3 null mutants
3.3.1.1 Aerobic growth curve of the senX3 and regX3 null mutants
Both the senX3 and regX3 null mutants grow at approximately the same rate as 
the wild-type under aerobic growth conditions (see 3.2.1.1), a phenotype that would be 
expected of strains of M. tuberculosis mutated in non-essential genes. An average 
generation time of ~ 14 hours during exponential phase in rolling bottles, and this was 
approximately the case here in this study (Figure 3.1).
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Figure 3.19: Genotypes and transcriptional profiles of the senX3 null mutant and the 
senX3 null mutant carrying a functional allele on the plasmid pDHl2. Microarray 
comparisons were made by RNA-RNA hybridisation (see 2.5.4.1) between the senX3 null 
mutant and the wild-type, and the senX3 null mutant with the integrated pDH12 and the 
wild-type. Cells were grown under microaerobic conditions (see 2.2.1.2) and RNA was 
extracted when the bacteria had reached stationary phase. Each scatter plot represents the 
results from two dye-swapped slides, derived from a single biological experiment. EP, 
integrated plasmid; hygR, hygromycin resistance cassette. The scatter plot represents the 
relative normalised ratios of transcript abundance between two strains. The units on the 
axes are the median normalised intensity of the spot for each gene on the microarray, 
after subtraction of the median normalised intensity of the background pixels in the area 
adjacent to the spot.
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Figure 3.20: Genotypes and transcriptional profiles of the regX3 null mutant and the 
regX3 null mutant carrying a functional allele on the plasmid pDHl2. Microarray 
comparisons were made by RNA-RNA hybridisation (see 2.5.4.1) between the regX3 null 
mutant and the wild-type, and the regX3 null mutant with the integrated pDH12 and the 
wild-type. Cells were grown under microaerobic conditions (see 2.2.1.2) and RNA was 
extracted when the bacteria had reached stationary phase. Each scatter plot represents the 
results from two dye-swapped slides, derived from a single biological experiment. IP, 
integrated plasmid; hygR, hygromycin resistance cassette. The scatter plot represents the 
relative normalised ratios of transcript abundance between two strains. The units on the 
axes are the median normalised intensity of the spot for each gene on the microarray, 
after subtraction of the median normalised intensity of the background pixels in the area 
adjacent to the spot.
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This contrasts sharply with the findings in Parish et al. (2003) where two 
different, abrogated forms of growth were seen in an isogenic regX3 null mutant. There 
are doubts about the validity of the strain used in that study (see 1.3.2.1), namely that the 
regX3 null mutant also lacks some of the 228 bp intergenic region between the senX3 and 
regX3 genes, and that to our knowledge the authors have not been able to restore a wild- 
type phenotype to their strain by complementation with a functional allele. Another 
regX3 null mutant produced by these authors created a fusion between senX3 and regX3 
(T Parish, personal communication). The assessment of aerobic growth was performed 
differently in that study, where a number of universal tubes were inoculated at a dilution 
lower than the ones used in this study (1/10 dilution), with one universal used per time 
point. In this respect, the experiment was similar to one performed in this thesis (see 
3.2.1.2).
It is not clear whether the cultures used for the study of aerobic growth in Parish 
et al. (2003) were oxygen limited, but it is common for a substantial variation in growth 
rates in standing, non-shaken cultures to occur, hence it is useful to perform the 
experiment in triplicate to prevent culture-to-culture variation masking the actual growth 
rate of the bacilli. The assessment by Parish et al. (2003) of the aerobic growth rate of 
their regX3 null mutant was performed twice, with different growth patterns each time. 
The variation in growth between the two experiments is likely to be an artefact of their 
growth system, as will be the pattern of growth within an experiment. In addition, the 
strain used in that study has been kindly provided to the author of this thesis, who found 
that it would not grow in vitro from a low dilution, unlike the regX3 and senX3 null 
mutants used in the majority of this study. It can be suggested, therefore, that normal
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growth in vitro, as shown in 3.2.1.1, represents the true phenotype of a senX3 or regX3 
null mutant of M. tuberculosis.
3.3.1.2 Microaerobic growth
It has been hypothesised that the SenX3/RegX3 system might be acting like ArcB/A 
of E. coli, in which situation null mutants for these genes would be expected to lose 
viability during oxygen-limited stationary phase (see 1.2.1.1 and Dukan & Nystrom 
(1998)). This was not the case here in 3.2.1.2, suggesting that in this assay senX3 and 
regX3 does not appear to play a role vital to the growth or survival of this organism. In 
the current study it was impossible to measure exact oxygen concentrations in the media 
due to biosafety restrictions in our laboratory. However, collaborative work is addressing 
this issue (see 7.5).
It is possible to draw a number of suppositions from the data in 3.2.1.2:
i) the bacilli are entering stationary phase due to metabolism geared to 
microaerobic growth, since nutrient limitation does not occur in this media 
until a much higher OD600 (see 3.2.1.1)
ii) the model for microaerobic growth used here is untested for efficacy in the 
ArcA/B mutants of E. coli and may not represent the proper system for 
development of this phenotype
iii) it is not possible to comment on the viability of the bacilli in stationary phase 
when assaying growth by OD600 measurements; only differences in the time 
between the limitation of oxygen beginning and the cessation of bacterial 
replication will be apparent.
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iv) the SenX3/RegX3 two component system may not be acting like ArcA/B of 
E. coli
In 4.2.2.1 the same mutants are examined in a more controlled microaerobic 
environment and the senX3 and regX3 null mutants show no loss of viability in what is 
assumed to be oxygen-induced stationary phase, negating point (iii) above. Therefore we 
must assume that either the model is not a good one, or that the SenX3/RegX3 system is 
not acting like the ArcA/B system of E. coli. It is possible that the time-frame of the 
experiment in 3.2.1.2 was too short, and that a phenotype may have become apparent at 
later time points.
It may also be the case here that the strains are entering a stage of arithmetic 
growth after 336 hours, although viability data would be required to show this.
33.1.3 Nutrient starvation
Another method of testing the phenotype of potential ArcA/B- like mutants is by 
causing the bacilli to enter stationary phase by starving them of carbon sources. Like the 
experiments above, if the senX3 and regX3 null mutants are acting like ArcA/B, then 
prolonged incubation of the strains without a carbon source should result in a gradual loss 
of viability when compared to the wild-type (see 1.2.1.1 and Dukan & Nystrom (1998, 
1999)). This was not apparent with the senX3 and regX3 null mutant strains. Since the 
experiment is a simple one, and the cells were washed thoroughly, one can only conclude 
that either the time-frame of the experiment was insufficient to see a phenotypic 
difference between the mutants and the wild-type, or that SenX3 and RegX3 are not 
acting in a similar manner to ArcA/ArcB of E. coli.
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3.3.1.4 Growth of mutants at pH 5.5
Another environment experienced by M. tuberculosis in vivo is the lowering of 
pH in the phagocytic vacuole. Rather than exposing exponential-phase cultures to acidic 
conditions, it was felt that observing the growth of the mutant and wild-type strains 
would be a more sensitive assay for the strains’ ability to resist acid stress. Previous 
work on an OmpA mutant used a similar technique (Raynaud et al. 2002).
There was no difference in growth between the senX3 and regX3 null mutant 
strains and the wild-type, indicating that senX3 and regX3 do not play a role in the 
adaptation of M. tuberculosis to acid stress. Curiously, all cultures displayed a biphasic 
growth curve that could represent a period of adjustment of the bacilli. Other bacteria 
can regulate the pH of acid growth media to a level more suitable for survival, however 
pH indicator strips used at the last time-point showed that the acidity of the media had not 
changed appreciably. It is likely that the lowered pH is making some of the metabolic 
pathways of the bacterium less viable, requiring the adaptation period to alter the 
bacterium’s metabolism to one more favourable. Future work may wish to repeat this 
experiment in glycerol-free media.
The results of this study differed from those of Raynaud et al. (2002) in the 
occurrence of the biphasic growth and the low OD600 at which the bacteria enter 
stationary phase. In Raynaud et al. (2002) the bacteria underwent a long lag phase, then 
grew as normal to a high OD600. This may be due to the use of an H37Rv substrain, 
“1424” in that study, or different methods in preparing the strains. However for the
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purposes of this study it is sufficient only to note that there is no difference in the growth 
of the senXS and regX3 mutants and the wild-type M. tuberculosis.
3.3.1.5 Toluidine blue assay
ArcA mutants of E. coli are exquisitely sensitive to the dye toluidine blue, 
although the mechanism for this sensitivity is not known. Although there is little reason 
to believe that toluidine blue would cause an equally dramatic phenotype in a strain of M  
tuberculosis lacking ArcA-like function, it would represent a very fast and simple method 
of screening for complementation of the senX3 and regX3 mutants if this approach 
proved successful.
Growth of the senX3 and regX3 null mutants and the wild-type all stopped at a 
concentration of lOOpg/ml toluidine blue when it was present in both solid and liquid 
media. This indicates that SenX3 and RegX3 are either not acting like the ArcA/B 
system, or that the ArcA/B orthologous system in M. tuberculosis is not sensitive to 
disruption by toluidine blue.
3.3.2 Stress studies
33.2.2 Superoxide stress
At two hours, but not 24 hours exposure to paraquat, the regX3 null mutant 
showed a significant drop in viability when compared to the wild-type. Viable counts 
were taken and are a reliable indicator of bacterial killing. At 24 hours there were large 
losses of viability in all three strains, confirming that the bacilli are damaged in this 
system.
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Counterintuitively, the senX3 and regX3 null mutants appear to be more, rather 
than less, resistant to killing by superoxide at 24 hours, with the regX3 null mutant more 
so than the senX3 null mutant. It is possible that senX3 and regX3 act as a negative 
regulator of genes involved in the detoxification of superoxide and ROI, and that these 
responsive genes are now constitutively expressed resulting in a resistant phenotype. 
There is no reason to believe that this is the case, especially when one considers work 
later in this chapter (3.2.3.2) demonstrating reduced virulence of the senX3 and regX3 
null mutant strains during infection. Furthermore, there should be no reason for the 
regX3 and senX3 null mutants to differ in their responses to superoxide stress, unless the 
few base pairs missing from the 3’ end of Rv0492c in the regX3 null mutant are involved 
in producing this phenotype. Complementation of the mutants in vivo (see later) would 
suggest that this is not the case. Since the mutants do not show increased sensitivity in 
vitro to superoxide stress, it is difficult to envisage that they have a role in the survival of 
the bacterium to such stress generated in vivo.
3.3.23 Nitrosative stress
There was no significant difference in the ability of the senX3 or regX3 null 
mutants to resist killing by nitrosative stress in either aerobic conditions or microaerobic 
conditions. This suggests that SenX3 and RegX3 are not involved in the response to 
nitrosative stress, and also detracts from the hypothesis that the SenX3/RegX3 system 
could be acting like ArcA/B from E. coli, whereby the mutants would generate excess 
oxidative stress under microaerobic conditions and therefore be more susceptible to
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killing by nitrosative stress since the ROI could react with the RNI to form the highly 
damaging peroxynitrite.
3.3.2.4 Organic hydroperoxide stress
Organic hydroperoxides represent some of the later stage products in the 
breakdown of ROI in the cell. The regX3 null mutant alone appeared to be more resistant 
to killing by bactericidal levels of organic hydroperoxide than either the wild-type or the 
senX3 null mutant. This discrepancy between the senX3 and regX3 null mutants can 
perhaps be tentatively explained by the slightly slower growth rate of the regX3 null 
mutant, perhaps allowing it more time to repair damage. In conclusion, it is unlikely that 
SenX3 or RegX3 play a role in resistance to organic hydroperoxide stress.
33.3 In vivo characterisation of the senX3 and regX3 null mutants
333.1 Growth of the senX3 and regX3 null mutants in a mouse model of infection
Previous work in our laboratory had shown that the regX3 and senX3 null mutants 
were attenuated in mice (Rickman 2002) when compared to the wild-type. The dynamics 
of the attenuation followed a pattern described as ‘growth in vivo’ attenuation in Hingley- 
Wilson et al. (2003). To confirm the attenuation of the senX3 null mutant, and to prove 
that the attenuation of both strains was due solely to the absence of senX3 or regX3, 
functional alleles were inserted into the attP site on the chromosome of each of the 
mutants in an attempt to restore wild-type virulence. The same region was used to 
complement both strains.
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The results in mice showed that the growth of the senX3 and regX3 null mutant 
strains was attenuated by ~ 10-fold compared with the wild type, but the cells still persist. 
The mutant strains carrying the complementing allele were restored, at least partially, to 
wild-type growth. Of note is the growth of the complementing strain of the senX3 null 
mutant, which does not reach wild-type levels in the lungs until 65 days and in the 
spleens until 140 days. The late complementation of die senX3 null mutant is examined 
further below.
Overall the data show that SenX3 and RegX3 are essential for growth of M. 
tuberculosis in mice.
Genotypically, the senX3 null strain carrying the complementing allele has two 
copies of regX3, one chromosomal (regX3°) and one on the integrated pDH12 (regX3p). 
We already suspected that regX3c might have been inactivated due to a polar effect of the 
hygromycin resistance marker present upstream of it. This led us to think that the senX3 
null mutant carrying the complementing allele was deficient in expression of regX3p, 
which may have acquired a deletion or mutation that prevented its expression. To test 
this, regX3 and part of senX3 was amplified from a plate culture of the senX3 null mutant 
carrying the complementing allele recovered from the mice and two co-transformants 
(see 3.2.3.4). All products were of the expected size, and when sequenced, products from 
all three senX3 null mutant strains carrying the complementing plasmid were identical to 
the published sequence of M. tuberculosis. Therefore, deletions or mutation was not 
evident in the complementing regX3p gene in the senX3 complementation strain.
Microarray analysis of the complementing strains used in the murine infection 
(3.2.3.5) enabled the transcriptotypes of the strains to be examined (3.2.3.5). This
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confirmed that the complementing allele in the senX3 null mutant is unable to produce 
levels of regX3 transcript comparable to that of the wild-type (Figure 3.19), whereas the 
same allele in the regX3 null mutant restores wild-type levels of the transcript (Figure 
3.20).
There seem to be two possible explanations for this partial complementation of 
the senX3 null mutant. Firstly, there may have been some error in the experiment that 
caused either the senX3 null mutant to grow aberrantly or some of the mice to behave in 
an immunologically different way, although this is unlikely. Secondly, RegX3 may bind 
to the promoter of senX3 and regulate its expression (Himpens et al. 2000) and the 
presence of atypical copy numbers of regX3 and the senX3 promoter may by causing an 
imbalance in the regulation of transcription of the two genes, with a subsequent 
downstream effect on virulence.
It would be difficult to analyse this discrepancy further because the transcriptional 
analysis of the complement situations by microarray was only performed once, and some 
of the values for the senX3 and regX3 gene spot intensities on the microarrays were low 
and possibly unreliable. Furthermore, Figure 3.16 shows that the growth of the senX3 
null mutant is inconsistant in vivo, and the true cause of this may not be detectable in 
vitro due to differences in the model of growth.
Our concern was that the lack of a reliable complementation model for the senX3 
null mutant would make more detailed analysis of the role of SenX3 in the virulence of 
M. tuberculosis difficult. It was decided to examine the growth of the strains in a 
macrophage model of infection, due to the shorter experiment time and fewer mice used. 
The benefits and drawbacks of a macrophage model of infection are discussed in 1.4.6.
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3.33.2 Growth of the senX3 and regX3 null mutants in bone-marrow derived 
macrophages
The growth of the wild-type, the senX3 and regX3 null mutants and their 
respective complementing strains confirmed the attenuation of the mutants and the 
restoration to wild-type growth of the complementation strains in this model. These data 
suggest that RegX3, and probably SenX3, are essential for growth of M. tuberculosis in 
primary murine macrophages. This allows a number of conclusions to be drawn 
regarding the nature of the stimulus for the SenX3/RegX3 and the mechanism by which 
the senX3 and regX3 null mutants are attenuated in macrophages:
i) the stimulus/attenuation mechanisms are not part of the acquired immune 
response
ii) the SenX3/RegX3 system is not responding to granuloma-like conditions in 
this model, since granulomas do not form in cell layers.
Although the mechanism for attenuation in macrophages discounts granuloma­
like conditions such as long-term nutrient starvation and oxygen deprivation, this data 
does not preclude it. It does, however, suggest that the senX3 and regX3 null mutants are 
sensitive to control by the host in the early stages of infection when they encounter the 
innate immune response of the phagocytes. These would typically be the stresses 
discussed in this chapter, although it is possible that macrophages have antibacterial 
mechanisms that we are unaware of and it is one of these that accounts for the attenuation 
of the mutants. Another possibility is that the SenX3/RegX3 system is responding to a 
combination of stresses, where the application of one stress alone is not enough to
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produce a phenotype, and that this combination has not been reproduced in the in vitro 
conditions described in these experiments.
3.3.4 Summary
The data discussed in this chapter highlight the importance of the SenX3/RegX3 
system in the growth of M. tuberculosis, and have begun to elucidate the stresses or 
mechanisms to which strains of M. tuberculosis lacking this system are sensitive. Such 
information would allow hypotheses to be formed of the role of senX3 and regX3 within 
the bacillus. Unfortunately we have so far been unable to single out one particular agent 
that is convincingly responsible for the attenuation of the senX3 and regZ3 null mutants, 
for reasons described above. It may be possible to further examine these promising 
results by testing a wider range of superoxide-producing agents in the same system. 
However, the apparent subtleties of the sensitivities in vitro may be consistent with a 
hypothesis that multiple signals are required for the full activity of the SenX3-RegX3 two 
component signal transduction system.
There is no doubt, from the mouse infection experiments described, that the 
SenX3/RegX3 two component signal transduction system is absolutely required for the 
normal, wild-type growth of M. tuberculosis in this infection model. The 
complementation experiments prove that mutation of regX3, and possibly also senX3 
gives rise to the observed phenotype. By analogy with orthologous genes in other 
bacteria, viz. E. coli, it was hypothesised that the SenX3/RegX3 system was involved in 
the response of the bacterium to oxidative and/or nitrosative stress. However, no 
convincing in vitro stress conditions have been found to which the senX3 or regX3 null
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mutants were more sensitive than the wild-type, and thus the reason for the reduced 
growth of the mutants in vivo remains unknown.
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4 Transcriptional microarray studies of mutants in the 
SenX3/RegX3 two-component signal transduction system.
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4.1 INTRODUCTION
4.1.1 Use of microarrays to study bacterial genetic regulation
Microarray is a recently established technology that allows comparative analysis 
of the genomes or transcriptomes of all genes in an organism simultaneously. This 
immensely powerful tool relies on unique probes to each gene being synthesised, either 
by PCR or as synthetic oligonucleotides, for which the genome sequence of the organism 
needs to be known. The M. tuberculosis genome sequence was completed in 1998 (Cole 
et al. 1998) and a cDNA microarray platform was developed at St. George’s Hospital 
Medical School, London (Hinds et a l 2001). This resource has since been available to 
researchers and is often a key step in the elucidation of gene function by comparing 
different strains of M. tuberculosis (Stewart et al. 2002).
4.1.2 Comparison of mutants and wild-type under defined growth conditions
Two approaches have proved to be particularly useful in studying mutants of M. 
tuberculosis. Firstly, a null mutant of the gene under study can be compared to the wild- 
type and any differences in the apparent quantities of transcripts between the two strains 
marked as a fold change in regulation. This approach is only effective if the gene would 
ordinarily interact with other components of the cell under the conditions in which the 
two strains are compared. For example, if  a regulatory protein is active only during 
exposure to UV radiation, then one would only expect to see a difference between the 
transcriptomes of a null mutant in that gene and the wild-type if  they had been exposed to 
UV radiation. It is possible to hypothesise that superoxide may fill this role if indeed die 
SenX3-RegX3 two component signal transduction system is sensing superoxide stress.
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Alternatively the lack of a constitutively active regulator would show a transcriptome 
difference to the wild-type under all conditions tested. Therefore to study regulatory 
genes that are only active in specific circumstances, one must know the signal to activate 
the system. This approach was used to identify the operon of DosR, since it was already 
known that the DosRS system responded to hypoxia (Park et al. 2003).
4.1.3 Overexpression of regulatory genes
A second method to identify signalling system regulons is to overexpress the 
regulator at levels that overcome the usual unresponsiveness of the system in the absence 
of the specific signal, and compare this overexpressing strain to its parent, either the wild- 
type or a null mutant. The results gained by this method depend much on the mode of 
action of the regulator, whether it is a repressor or an activator. For instance, if a 
regulator prevents transcription of its regulon, then increased amounts of the repressor are 
not likely to decrease the expression of those genes any further. In two-component 
systems a further complication is the phosphorylation state of the regulator -  is 
phosphorylation of the regulator the rate-limiting step in signal transduction, rather than 
rate of expression? Another issue may be the potential toxic effects o f overexpressing the 
regulator. However, these experiments are not necessarily performed on well- 
characterised regulators, so in practice one can only really attempt to express the 
regulator at different levels, using different expression systems, to minimise any potential 
problems with toxicity.
4.1.4 Caveats with gene list comparisons
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Both of these approaches were attempted with the SenX3-RegX3 two component 
signal transduction system in this study. Although the two methods may produce 
different results, it is important to consider that the stimulus in the different experiments 
differs greatly and this may affect the regulatory response of the system. Furthermore, it 
is difficult to emulate growth conditions in other laboratories, so differences to published 
data may often be due to the use of different growth media and conditions.
4.2 RESULTS
4.2.1 Transcriptional microarray analysis after superoxide stress
The wild-type and regX3 and senX3 null mutants were grown in four rolling 
bottles per strain to early exponential phase when paraquat was added to half of the 
cultures. Incubation was continued for a further two hours before RNA was extracted 
from both the stressed and non-stressed cultures (see 2.2.1.5). Paraquat was used at a 
25mM concentration to reduce the bactericidal effect seen with paraquat used at 50mM 
concentration (see 3.2.2.1).
Microarray hybridisation directly compared RNA from the wild-type M. 
tuberculosis and RNA extracted from a null mutant, enabling small differences in the 
relative abundance of transcript between the two strains to be measured (see 2.5.4.1). 
Analysis of the microarray results failed to show any reproducible differences between 
the wild-type and senX3 and regX3 null mutants after superoxide stress
4.2.2 Transcriptional microarray analysis after growth in oxygen-limited 
conditions
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4.2.2.1 The microaerobic model
To investigate whether there were any difference apparent between the 
transcriptomes of the senX3 and regX3 null mutants and the wild-type when grown under 
oxygen-limited conditions, the wild-type, senX3 and regX3 null mutants were grown in 
standing culture as described in 2.2.1.2, although at a lower (1/500) dilution than the one 
stated in that section. This preliminary data showed that there was a difference between 
the transcriptomes of the mutants and the wild-type, suggesting that the SenX3-RegX3 
two component signal transduction system was active under these conditions (data not 
shown). These data were not, however, reproducible.
To examine the above responses in a more controlled fashion, it was decided to 
use a higher dilution (1/10) of the wild-type, senX3 and regX3 null mutants and the 
Tame 15 mutant inoculated from early exponential-phase rolling cultures to make a large 
stock culture that was subsequently aliquoted into flasks and grown in an identical 
manner to that described in 2.2.1.2.
Sufficient cultures were inoculated to allow one culture per strain to be used daily 
so that the OD600 and viable counts o f the strains could be followed and RNA extracted as 
soon as the OD600 similar to that seen in the extractions for 4.2.2.1 was reached, 
representing early stationary phase (figure 4.1). The strains showed uniform growth and 
the OD600 at which RNA was extracted were more consistent than the OD600 
measurements taken from the strains in 4.2.2.1.
The relative abundance of transcript levels between different cultures were 
compared indirectly on microarray slides using DNA-RNA hybridisation (see 2.5.4.2). 
Pairwise analysis of the wild-type and each of the mutants yielded lists of genes whose
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Figure 4.1: Optical densities and viable counts of mutants in the SenX3-RegX3 system 
when grown from a 1/10 dilution of early exponential-phase strains in the standing 
culture microaerobic model as described in 2.2.1.2. Solid line, optical densities, left axis; 
dashed line, colony forming units per millilitre of culture, right axis. The growth of 
Tame 15 was done on a separate occasion, and viable counts were not measured. The 
arrow represents the time at which RNA extractions were carried out on these cultures or 
cultures that had been treated in an identical manner.
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transcript levels differed significantly (p < 0.05) between the groups (see 2.5.8.3). The 
full gene lists can be seen in Appendix 1. The transcript levels of 59 genes were 
significantly different in the senX3 null mutant compared to the wild-type, and the 
transcript levels of 65 and 112 genes were significantly different in the regX3 null mutant 
and the Tame 15 mutant respectively. Of the genes identified as being differentially 
expressed in the three mutant strains, one gene was common to the senX3 and regX3 null 
mutants only, 20 were common between the senX3 null mutant and the Tamel5 mutant 
only, four were common between the regX3 null mutant and the Tame 15 mutant only, 
and six genes were common to all three strains (Figure 4.2 and Table 4.1).
4.2.3 Overexpression of regX3 in a regX3 null background
Strains of M. tuberculosis were constructed in a regX3 null background that 
contained an extrachromosomal copy of regX3 driven by either an Hsp60 (Stover et al. 
1991) or acetamidase (Triccas et al. 1998) promoter. Identical strains containing the 
empty vector without the regX3 coding sequence were also constructed as negative 
controls. Strains were grown aerobically in rolling bottles under antibiotic selection to 
early exponential phase before RNA extraction, after which DNA-RNA hybridisation 
microarrays were carried out (see 2.5.4.2).
Cursory analysis of the arrays using the GENEPIX 5.0 program showed that the 
strain AregX3/Pace-regA3+ did not produce any measurable levels of regX3 transcript, 
consistent with other reports of problems with this promoter in M. tuberculosis (S. 
Kendall, personal communication). However AregX3/PhSp6o-^ gAr5+ produced high levels 
of regX3 transcript, with regX3 as the most highly expressed gene when the data was
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Figure 4.2: Venn diagram showing the incidence of homology between gene lists 
generated by assessment o f differentially regulated genes in mutants in the SenX3-RegX3 
two component signal transduction system compared with the wild-type when grown 
under microaerobic conditions at 37°C, as described in 2.2.1.2.
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seriX3 regX3
Tamel5
2 4 0
Table 4.1: Genes that appear to be differentially regulated in more than one SenX3- 
RegX3 two component signal transduction system mutant after growth in microaerobic 
conditions. The colours correspond to those seen on the Venn diagram in Figure 4.2.
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senX3 and regX3 null mutants 
Rv 1632c Rv1632c
senXZ and regX3 null mutants andTamel5 
Rv2706c Rv2706c
Rv 1736c narX
Rv2658c Rv2658c
Rvl952 Rvl952
Rv3301c phoYl
Rv0637 Rv0637
senX3 null mutant andTame!5
Rv0883c Rv0883c
Rv0343 Rv0343
Rvl988 Rvl988
Rv3853 menG
Rv 1398c Rvl398c
Rv0491 regX3
Rv3854c Rv3854c
Rv0932c pstS
Rv2197c Rv2197c
Rv3089 fadD13
Rv2820c Rv2820c
Rv0297 PE PGRS
Rv2461c clpP
Rv0483 Rv0483
Rvl955 Rvl955
Rv3680 Rv3680
Rv0174 Rv0174
Rv 1172c PE
Rv2116 IppK
Rv2007c fdxA
regX3 null mutant and Tame 15
Rv0497 Rv0497
Rv0715 rplX
Rv2935 ppsE
Rvl601 hisB
represented on the GENEPIX scatter plot (data not shown). AregX3 /Phsp60-re,gAT did not 
appear to produce any regX3 transcript when analysed using GENEPIX.
GENESPRING analysis showed 199 genes whose expression levels were 
significantly different in the AregX3/Phsp60-regA'3+ strain compared to the AregX3/PHsp6o- 
regX3~ strain. Of these, 21 sets of adjacent genes were apparent, suggesting that they 
may be co-transcribed. These can be seen marked in bold in Appendix 2. 13 genes up or 
downregulated in the AregX3/PhSp60-'*^g^+ strain were also present in a published list of 
genes up- and down-regulated in Tamel5 (Parish et al. 2003). These can be seen marked 
with an asterisk in appendix 2.
4.23.1 MEME motif analysis of potential promoter regions of genes identified to 
be differentially expressed between a AregX3/PhSp6o-regX3+ strain and a 
AregX3/Phsp60-re£X3~ strain of M. tuberculosis
The DNA regions upstream of all 199 genes identified to be differentially 
expressed between a AregX3/Phsp60-regA3 + strain and a AregX3/PhSp60-f’e4gAX strain of M. 
tuberculosis (see Appendix 2) were analysed by visual inspection using the ARTEMIS 
program (Rutherford et al. 2000). Genes lacking a stop codon of a gene transcribed in 
the same direction within 100 bp upstream of the potential start site were considered to 
contain potential RegX3 binding sites within their upstream region. The sequence of the 
upstream region for these genes was recovered from ARTEMIS, between either the 
feature immediately upstream of the differentially regulated gene if that distance was less 
than 200 bp, or a region 200 bp upstream of the start site of the differentially regulated 
gene. 113 of the 199 genes matched the criteria, and the appropriate sequence regions as
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described above were then submitted to the MEME server (Bailey & Elkan 1994) for 
motif analysis.
No similar sequences of nucleotides, making ‘motifs’, were found that occurred in 
more than ten of the 113 sequences.
43  DISCUSSION
4.3.1 Superoxide stress
A lack of differentially regulated genes between the wild-type and the senX3 and 
regX3 null mutants after superoxide stress suggests that the SenX3-RegX3 two 
component signal transduction system is not responding to exogenous superoxide stress. 
This conclusion is backed up by the viability data in 3.2.2, and although the superoxide 
microarrays were only performed in duplicate it was felt on the strength of this not to 
continue with the third replicate.
4.3.2 Growth in a standing culture model of microaerobic adaptation
A number of genes appeared to be up- or down-regulated in the senX3 null mutant 
after growth under microaerobic conditions, suggesting that the SenX3-RegX3 system is 
responding in some way to the environment in the microaerobic culture. The preliminary 
result was important in that it suggested a possible stimulus for SenX3, although the 
variation in growth rates in this high-dilution microaerobic culture may be to blame for 
an inability to repeat these experiments enough to gain statistically significant results.
43.3 Further microaerobic analysis
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In the absence of statistically reliable results from the preliminary model, 
refinement of the microaerobic model and acquisition of the Tame 15 mutant (Parish et al 
2003) allowed us to further examine and compare the transcriptional responses of the 
different mutants in a more reliable system. Following the growth curve of the strains 
enabled the extraction of RNA at the point where the cells have just entered stationary 
phase, presumably through the limitation of oxygen since nutrients are generally not 
limiting in an M. tuberculosis culture until a much higher OD600 is reached. Of note is 
the apparent increase in cell density after 48 hours while the numbers of viable bacteria 
remain constant. This could be explained by the thickening of the bacterial cell wall, 
which Wayne & Hayes (1996) referred to as non-replicating persistence. Cell wall 
thickening under oxygen-limited conditions is associated with the upregulation and co­
localisation of HspX with the cell wall (Cunningham & Spreadbury 1998), and may be 
controlled by DosR (Park et a l 2003).
Comparison of differentially regulated genes between each of the mutants and the 
wild-type showed that while there was a small degree of overlap in the gene lists between 
the senX3 and regX3 null mutants, the greatest similarity between the strains under these 
condition was between the senX3 null mutant and Tame 15. This suggests that the 
Tame 15 mutant may be acting more like the senX3 null mutant than the regX3 null 
mutant in this model.
Interestingly, fdxA, encoding a ferridoxin, can be seen to be differentially 
regulated in both the senX3 null mutant and Tamel5. narX is one of the few genes that 
appears to be differentially regulated in all three mutants, and is also reported to be 
induced by hypoxia (Sherman et a l 2001) as part of the DosR response. Also of interest
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is the upregulation in the regX3 null mutant of the mycobactin synthesis genes (mbtB, C, 
D and G) that code for siderophore biosynthesis enzymes, and mce3, which is involved in 
macrophage cell entry.
Overall the data produced by this method shows a number of potentially 
interesting genes that may be regulated by the SenX3-RegX3 two component signal 
transduction system or some other component that interacts with it. The appearance of 
apparently co-transcribed genes up- or down-regulated by similar fold changes suggests 
that the microarray method and analysis are working well, and these data provide a solid 
foundation for the transcriptional study of the mutants in other, more defined conditions.
4.3.4 Overexpression of RegX3 in a regX3 null mutant
The high levels of regX3 transcript in the AregX3/Phsp6o-regX3+ strain compared 
to the AregX3/Phsp60-regAT strain appeared to overcome the need for the correct stimulus 
of the SenX3-RegX3 two component signal transduction system in order to initiate 
transcription of genes either controlled by RegX3 or another factor that is regulated by 
RegX3. This is in contrast to microarray studies comparing the regX3 null mutant to the 
wild-type in aerobic rolling culture (Rickman 2002) and after superoxide stress (this 
study) where no significant difference between the strains was found, presumably 
because the SenX3-RegX3 two component signal transduction system was not active as a 
result of lack of the proper signal for SenX3.
The presence of 20 sets of apparently co-transcribed genes again suggests that the 
gene list generated by overexpression of RegX3 is not entirely random. Five other genes
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also appear after overexpression of RegX3 that are differentially regulated in the regX3 
null mutant after microaerobic growth (see Appendices 1 and 2).
4.3.4.1 Comparison of genes upregulated after overexpression of regX3 to other 
gene lists
Many of the genes that are differentially regulated in the regX3 overexpressing 
strain appear in published microarray data. 13 of the genes differentially regulated in the 
regX3 overexpressing strain can be seen in the published list of potentially RegX3- 
regulated genes in the Tame 15 mutant grown in rolling cultures in Middlebrook broth, 
representing 13.3% of the published list. This is not altogether surprising since the 
comparison in that paper is between a regX3 null mutant and the wild-type with normal 
levels of regX3. Of greater interest is appearance of many of the differentially-regulated 
genes in the RegX3 overexpressing strain in Betts et al. (2002), where transcriptional 
microarrays of the wild-type M. tuberculosis were carried out after 96 hours of nutrient 
starvation. 14 genes that are differentially regulated in the RegX3 overexpressing strain 
appear in their list of 114 genes, representing 12.3% of the genes discussed in that paper. 
Although not a great proportion, it is the key and representative genes mentioned in the 
discussion of Betts et al. (2002) that also appear in Appendix 2 here. Such genes include 
regulatory genes (pknD, ideR), genes involved in energy metabolism (ATP synthase 
genes atpB, F, H; nuoC; pdhC), polyketide synthesis (ppsD, pks!8), translation apparatus 
(rplV), antibiotics (Rv2036, lat), and lipid biosynthesis (desA3). aid is also in this 
published list, and was seen in other microarray results in this study and used for RegX3- 
DNA binding experiments in 5.2.2.5.
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Taken together, this supports a hypothesis that overexpression of RegX3 can 
mimic some of the conditions that the SenX3-RegX3 two component signal transduction 
system may be responding to some in vitro test condition, and may represent a more 
representative view of the RegX3 regulon than that obtained by the ad hoc testing 
achieved by stressing rolling cultures of the bacterium.
4.3.4.2 Genes differentially regulated between a AregX3/PhSp60-regX3+ strain and a 
AregX3/PhSp6o-regXT strain of M. tuberculosis
4.3.4.2.1 Regulatory genes
The most upregulated gene in the strain overexpressing RegX3 is regX3 itself, 
whose normalised fold upregulation is ~340 000 with a p value of 0.00000002. SenX3 is 
upregulated two-fold, suggesting that RegX3 interacts with the senX3 promoter and 
increases transcription. This result supports the interaction between RegX3 and the 
promoter for senX3 suggested in Himpens et al. (2000) and elsewhere in this study. The 
overexpression of regX3 has not caused an equal upregulation in se/iX3 transcript; 
however since the interaction between the SenX3 and RegX3 proteins occurs at the 
phosphorylation level (Himpens et al. 2000) it is likely that transcriptional control of the 
SenX3-RegX3 two component signal transduction system is not the major factor 
controlling this system’s activity.
Other upregulated regulatory genes in the regX3 overexpressing strain that have 
been shown to be important in M. tuberculosis are pknD, encoding protein kinase D, a 
eukaryotic-like serine-threonine protein kinase (Peirs et al. 1997), and ideR, encoding an 
iron-dependant repressor protein.
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PknD is thought to regulate phosphate transport since it is likely to be co­
transcribed with Rv0932c that encodes a protein involved in a phosphate-uptake system 
(Av-Gay & Everett 2000). PknD phosphorylates the FHA-A domain of Rvl747 
(Grundner et al. 2005), which contains an ABC transporter domain. A null mutant of 
Rvl747 is attenuated in three models of infection, and it can therefore be assumed that 
the protein encoded by Rvl747 plays a key role in the M. tuberculosis infection process 
(Curry et a l 2005).
ideR encodes an iron-dependant repressor protein of the DtxR (diphtheria toxin 
repressor) family that is required for siderophore repression in iron-abundant 
environments (Rodriguez et a l 2002) and may be important for survival in macrophages 
(Gold et al 2001). Gold et a l (2001) based this latter observation on the upregulation of, 
amongst others, the mbtB gene in macrophage-like THP-1 cell infection (De Voss et a l 
2000) and in iron-limited culture. mbtB was seen to be downregulated in the regX3 null 
mutant after microaerobic growth (see Appendix 1) and it is conceivable that the SenX3- 
RegX3 two component signal transduction system is acting as a level of control above 
that of ideR.
ptpA is downregulated 10-fold in the regX3 overexpressing strain. ptpA encodes a 
low-molecular weight secreted tyrosine phosphatase that is upregulated in M. bovis BCG 
when it enters stationary phase or infects primary human monocytes (Cowley et a l 
2002), and is potentially acting as a virulence factor affecting host proteins. Potential 
regulation of this gene by the SenX3-RegX3 two component signal transduction system 
further suggests a role in controlling the molecular pathogenesis of M. tuberculosis.
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4.3.4.2.2 Genes involved in energy metabolism
A number of genes involved in energy metabolism are differentially regulated in 
the regX3 overexpressing strain. atpB, F and H  encode parts of the ATP synthase which 
generates ATP from ADP in the presence of a proton gradient and are upregulated in the 
regX3 overexpressing strain. nuoC encodes NADH dehydrogenase I, which forms part of 
the NADH dehydrogenase operon that is the major aerobic electron transport chain in M. 
tuberculosis. This gene was upregulated 10-fold in the regX3 overexpressing strain. In 
contrast to Betts et al. (2002), both the ATP synthase genes and part of the NADH 
dehydrogenase operon were seen to be upregulated in the regX3 overexpressing strain, 
suggesting that RegX3, or another component that interacts with RegX3, acts as a 
transcriptional activator of these genes.
pdhC, encoding dihydrolipoamide acetyltransferase was also upregulated. PdhC 
catalyses the production of acetyl-CoA and carbon dioxide from pyruvate and is critical 
in regulating carbon flux into the TCA cycle.
cydB, seen to be upregulated, encodes a cytochrome D ubiquinol oxidase that also 
plays a role in the cellular respiration. Taken together, it could be that RegX3 can act as 
a transcriptional activator, allowing the maximal use of the aerobic respiratory 
mechanisms while sufficient oxygen is present.
4.3.4.23 Genes involved in polyketide synthesis
ppsD, also known as pksE, encodes part of the phthiocerol dimycocerosate 
(PDIM) locus (Azad et al. 1997) whose synthesis and transport are involved in M. 
tuberculosis pathogenicity and cell wall permeability (Camacho et al. 2001). pksl8
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encodes a calchone synthase-like condensing enzyme that is also involved in polyketide 
synthesis (Saxena et ah 2003). The ppsD gene was downregulated around two-fold in the 
regX3 overexpressing strain, whereas pksl8 was upregulated 35-fold. The potential 
regulation of these genes by RegX3 reinforces a hypothesis for a role for RegX3 during 
the infection process, since the products of both of these genes are involved in synthesis 
of cell wall lipids that can interact with the host. The differences in up- and down- 
regulation of these genes may represent the complex nature of the response to this 
interaction.
4.3.4.2.4 Genes differentially regulated in a strain of M. tuberculosis overexpressing 
regX3 and after growth of a regX3 null mutant in microaerobic conditions
Two genes in particular are shared between the gene lists for the regX3 
overexpressing strain and the list generated by comparing the regX3 null mutant against 
the wild-type under growth in low oxygen conditions: sahH and nadA. sahH encodes a 
thioester hydrolase which may be involved in methionine and selenoamino acid 
metabolisms (Tuberculist,(2005) and was identified by proteomic methods to reside in 
the cytoplasm (Rosenkrands et al. 2000). nadA is a probable quinolinate synthetase that 
catalyzes the formation of quinolinate from aspartate. The appearance of these genes in 
both lists is compelling evidence for an interaction with RegX3 and a role for the SenX3- 
RegX3 two component signal transduction system in regulation of the intermediary 
metabolism.
4.3.4.2.5 Genes involved in the oxidative stress response
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Upregulated about 1.5-fold compared to the average were the co-transcribed ahpC 
and D genes, encoding alkyl hydroperoxidases C and D respectively. AhpC and D are 
key components in the oxidative stress defence of M. tuberculosis, particularly in the 
absence of KatG which is inactivated in the majority of isoniazid-resistant clinical strains. 
AhpD is required for the reduction of AhpC and also has its own alkylhydroperoxidase 
activity (Bryk et a l 2002; Koshkin et al. 2003); AhpC is particularly important in the 
detoxification of the highly damaging peroxynitrite radical (see 1.4.3 and Master et al. 
(2002)) and also has thioredoxin-dependant peroxidase activity (Wieles et al. 1995). The 
level of upregulation of these genes is not great in the regX3 overexpressing strain 
compared to induction of ahpC expression in M. tuberculosis (Sherman et al. 1996) and 
other organisms (Vattanaviboon et al. 2003) upon exposure to organic hydroperoxides; 
however the small level of upregulation may be biologically significant as in the growth 
model used in this study there was no specific inducer of AhpC/D expression. Perhaps 
the SenX3-RegX3 two component signal transduction system has a role in priming or 
otherwise contributing to the expression of AhpC and D in vivo.
4.3.4.2.6 MEME motif analysis of potential promoter regions of genes identified to 
be differentially expressed between a AregX3/PhSP60-regX3+ strain and a 
AregX3/Phsp60-regAT strain of M. tuberculosis
The lack of apparent motifs in the upstream sequences of differentially regulated 
genes between the AregX3/Phsp6o-regA3+ and AregX3/PhSP6o-^g^ strains does not 
compromise the validity of that gene list, since regulatory motifs are notoriously difficult 
to find (Rand et al. 2003). Where this approach has been successful, for example in
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Gamulin et al. (2004), prior experimental knowledge of the regulation of the analysed 
genes (Gopaul et al. 2003) allowed the search for motifs to be restricted to much shorter 
lengths of DNA than those analysed here.
43.5 Summary
Overall, given the apparent upregulation of a number of genes thought to be 
involved in the oxidative stress response and adaptation to oxygen and nutrient limiting 
stationary phase in a regX3 overexpressing strain of M. tuberculosis and after growth of a 
regX3 null mutant in microaerobic conditions, it is possible to envisage a role for the 
SenX3-RegX3 two component signal transduction system in the adaptation of the 
bacterium to conditions within the lung, perhaps during the initial replication of the 
organism. This would be likely to be as a result of sensing oxygen levels, but at an 
intermediate level compared to DosR. Furthermore, given the diverse nature of the 
possible regulons of RegX3, it is also possible to hypothesise that the input signal for 
SenX3 requires a combination of environmental factors, either direct or indirect, for the 
system to become active. This may be a possible explanation for the lack of an obvious 
in vitro phenotype of the null mutants in the SenX3-RegX3 two component signal 
transduction system to a single agent seen in Chapter 3.
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5 Expression, purification and analysis of the DNA-binding 
interactions of recombinant RegX3
254
5.1 INTRODUCTION
Both structure prediction and previous experimental evidence suggest that RegX3 
is a DNA-binding protein. Pfam analysis (Bateman et al. 2004) of the RegX3 sequence 
from Tuberculist (2005) indicates that RegX3 contains a receiver domain at the N- 
terminus and a DNA-binding domain at the C-terminus similar to one described for 
OmpR of E. coli (Martinez-Hackert & Stock 1997).
5.1.1 Previous work on the DNA-binding properties of RegX3
RegX3 has been shown to act as the response regulator for the sensor protein 
SenX3 by Himpens et al. (2000), where a renatured form of recombinant, polyhistidine- 
tagged RegX3 expressed in E. coli was shown to interact with the region upstream of 
RegX3. There are two major caveats to this work. Firstly, recombinant RegX3 was 
purified under denaturing conditions and renatured through two successive rounds of 
dialysis. The polyhistidine-tagged RegX3 may not have refolded correctly by this 
method, meaning that the structure of the DNA binding site may not represent the 
natively folded RegX3 as it occurs in M. tuberculosis, altering its recognition of the 
binding sequence. Secondly, the identity of the purified RegX3 was confirmed by size 
and reaction with anti-polyhistidine antibody. The apparent molecular weight of the 
recombinant RegX3 was 4.2 kDa higher than expected in that paper, and it is possible, 
although extremely unlikely, that this polyhistidine tag was not attached to the correct 
peptide. The paper makes no mention of sequencing the expressing construct; it is 
possible that frameshift or substitution mutations could have occurred during the 
amplification of the regX3 sequence.
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This paper (Himpens et al. 2000) attributed the RegX3 binding sequence to a 
region of 42 bp upstream of the senX3 gene by out-competing the DNA-protein 
interaction of a labelled, amplified region between the stop codon of gpml and the start 
codon of senX3 with smaller, unlabelled DNA fragments derived from this region 
(Himpens et al 2000). They did not systematically map the region, and relied on ad hoc 
evidence derived by eye from the sequence of this region from M. tuberculosis to identify 
this 42 bp fragment.
5.1.2 Potential difficulties with the expression of mycobacterial proteins in E. coli
When attempting to express and purify mycobacterial proteins, there are a number 
of factors that have to be considered. Ideally, M. tuberculosis proteins would be 
overexpressed in M. tuberculosis’, meaning that the purified proteins would be most likely 
to be in their native conformation. Unfortunately biosafety considerations make this 
difficult, as does the long generation times of M. tuberculosis and M. bovis. There are 
expression systems available in mycobacteria, but none are as versatile as those 
developed for the expression of proteins in E. coli.
Problems with protein solubility may arise due to the speed at which the induced 
E. coli strains translate the recombinant RegX3 peptide. The protein may not have time 
to fold properly at this level of expression, so forms aggregate ‘inclusion bodies’ that are 
insoluble. These may be recovered by denaturing the inclusion bodies although it is less 
likely that the protein, when renatured by dialysis, will be folded correctly in an active 
state. It is also possible to decrease the rate of translation by reducing the temperature of
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the expressing culture, or by inducing expression of the peptide with lower levels of 
IPTG.
In conclusion, E. coli is a safe, fast and efficient method for the production of 
proteins and a number of commercial kits are available for this purpose. The 
disadvantage is that heterologous proteins from sources other than E. coli may be 
misfolded. Furthermore, M. tuberculosis has a high GC-content genome and translation 
of genes in this organism may require the use of some codon-specific tRNA more often 
than would be needed for the translation of E. coli sequences in E. coli. To prevent a lack 
of the tRNA in the appropriate quantities limiting the translation rates of M. tuberculosis 
sequences during protein expression, E. coli strains that carry a plasmid encoding the 
supplementary tRNA genes are used as standard in our laboratory.
5.1.3 The use of electrophoretic mobility shift assays to analyse protein-DNA
interactions
The electrophoretic mobility shift assay (EMSA, also referred to as a bandshift or 
gelshift assay) provides a method of analysing directly the interactions between protein 
and DNA. Gelshift assays rely on the ability of protein to bind radiolabelled DNA and 
retard its progress through a nondenaturing gel during electrophoresis (see 2.6.3). The 
results are visualised by autoradiography, where an interaction will be seen as a band 
present in the sample where protein and probe have been allowed to mix before 
electrophoresis, which is not present in a sample to which no protein has been added. 
Alternatively, protein extract from a source not containing the protein of interest may be 
used as a negative control.
257
Further experiments can be used to confirm the nature of the interaction: i.e. 
specificity of the probe sequence for binding, or the identity of the protein that is 
retarding the electrophoretic mobility of the probe.
5.1.3.1 Cold-competition assay
To confirm the importance of the specific sequence of the probe in the DNA- 
protein interaction, it is preferable to show that the ‘shift* -  i.e. the visualisation of die 
retardation of the labelled probe by the protein -  can be out competed by identical, 
specific unlabelled probe, but not a comparable, unlabelled probe that should not bind the 
protein.
5.13.2 Supershift assay
To confirm the identity of the protein forming the complex with the DNA, antibodies to 
the protein can be used to increase the molecular mass of the DNA-protein complex and 
further retard its passage through the gel, causing an apparent ‘supershift’ (see 2.3.6.7 
and Asusubel et al. (2005) for method). In practice the effects of the addition of antibody 
depends on the way it interacts with the protein of interest. If the epitope on the protein 
is away from the DNA-binding site, then it is likely that a supershift will occur whether 
the antibody is added before or after the DNA-protein complex is allowed to form. If the 
binding of the epitope to the antibody obscures the DNA-binding site, then addition of 
the antibody before the DNA-protein complex is allowed to form will abolish the original 
shift. Alternatively if the DNA-binding site is obscured after the DNA-protein complex
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is allowed to form, then the supershift should still occur provided the epitope has not 
been destroyed.
5.1.33 Shift-blot
Another method of confirming the interaction of the protein of interest with the 
probe is to visually co-localise the protein with the shifted band. This may be done by 
performing a shift-blot assay where the complexes contained within the gel after a 
standard gel-shift assay are electroblotted onto a membrane, which is then processed as 
for a Western blot (see 2.6.3.6 and Demczuk et al. (2003) for method). The gel still 
contains enough radiolabelled probe to allow it to be dried and autoradiographed. The 
autoradiograph and the autoelectrochemilumograph from the Western blot are then 
aligned to co-localise the protein with the shift (Figure 5.1).
These control experiments are particularly necessary when using impure protein 
preparations; less so when the protein is purified and its identity confirmed. They do, 
however, contribute to our understanding of the interaction. It is possible to use the shift- 
blot and supershift assays to perform investigations of the interactions of multiple 
proteins that may be involved in DNA binding; however for this to be effective a good 
working method must be established and the identity of other proteins in the DNA- 
protein complex usually need to be identified by other methods.
5.1.4 Protein sources for gelshift assays
There are two possible sources of protein for gelshift assays. The preferable 
method involves the use of enriched or pure protein preparations, which means that it is
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Figure 5.1: Diagram illustrating the steps involved in a shift-blot experiment.
DNA-protein binding reaction
I
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semi-dry transfer of gel
process PVDF membrane as for a 
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I
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more likely that DNA-protein interactions seen will be the correct ones attributable to 
that particular protein. It must also be considered as to whether the protein of interest is 
not folded in the correct manner and that the interaction does not represent that which 
would happen in vivo.
An alternative protein source for gelshift assays is to use whole cell protein 
extracts from the native bacterium, and rely on comparisons between the wild-type 
protein extract and that taken from a mutant shown to be lacking only the protein of 
interest. Although this does have the advantage that the proteins are more likely to be in 
their native, correctly folded state, this approach requires a knockout strain for the protein 
of interest, and it is possible that a number of interaction will take place between the 
DNA probe and non-sequence-specific DNA-binding proteins. This approach was not 
used in this study due to the large quantity of M. tuberculosis that needs to be cultured to 
obtain sufficient protein for an experiment (~10 litres for comparable experiments with 
M. bovis, R. Curtis, personal communication) which represents a significant drain on the 
resources of the laboratory and raises biosafety concerns.
Prior understanding of the potential interaction between the protein of interest and 
its mode of action may also be relevant when considering its interaction with DNA. For 
example, a regulatory protein that requires phosphorylation to activate transcription of 
genes may not bind to the probe unless it is phosphorylated. Fortunately, in the absence 
of the purified cognate phosphate donor protein that would phosphorylate the protein in 
vivo, phosphorylation of proteins can be carried out in a relatively simple, crude manner 
by incubation of the protein with acetyl phosphate, a high-energy phosphate donor. This
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will cause phosphorylation at most likely phosphoacceptor sites on the protein (E. Davis, 
personal communication).
5.1.5 DNA sources for gelshift assays
A sequence of DNA that the protein of interest is thought to bind must first be 
identified. This is then either amplified by PCR (for fragments >50bp), or ordered as 
complementary oligonucleotides. Longer products are more likely to contain secondary 
structure that will obscure the bandshift, but are more likely to contain protein binding 
sites if the exact position is not known. Complementary oligonucleotides must be 
annealed in equimolar concentrations to produce short lengths of double stranded DNA.
5.1.6 Labelling of DNA for gelshift assays
The most versatile method of visualising the shift of a probe is by radiolabelling 
the probe with 32P before the DNA and protein are mixed, followed by autoradiography 
of the dried gel once the electrophoresis has finished. A non-radioactive method of 
labelling the DNA is to label using dioxygenin, which is visualised by 
electrochemiluminescence, although that method has not been used in this study.
Blunt-ended probes generated by the annealing of oligonucleotides or PCR 
amplification with a Pfu-based polymerase may be radiolabelled by the addition of a P 
phosphate group from 32P-y-ATP by a polynucleotide kinase. All probes labelled by this 
method should show uniform radioactivity regardless of probe size.
Probes generated with overhangs (by cleavage by restriction enzymes, addition of 
polylinkers or by the annealing of oligonucleotides mismatched at the 5’ or 3’ and) may
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also be labelled in this fashion. Alternatively, the ends may be ‘polished’ by the Klenow 
fragment of DNA polymerase I using 32P-t-ATP as a substrate. The intensity of the 
radioactive signal in this case will depend on the number of adenosine bases on the 
overhanging regions.
To generate highly radioactive probes it is possible to amplify the target sequence 
of interest using the 32P-y-ATP as a replacement for the usual cLATP in the 
deoxynucleotide mix of the PCR reaction. The radioactivity of a probe labelled in this 
fashion will therefore depend on the number of adenosine bases in the total sequence and 
is therefore likely to increase with the length of the probe. However, it is preferable to 
work with the minimum amount of radioactivity necessary for an experiment, and the 
end-labelling method described above is usually sufficient for adequate exposure times in 
autoradiographs.
5.2 RESULTS
5.2.1 Purification of recombinant polyhistidine-tagged RegX3
5.2.1.1 Construction of an E. coli strain expressing recombinant polyhistidine- 
tagged RegX3
The open reading frame of regX3 was amplified by PCR and cloned into a 
commercial vector (pET15b, see Table 2.2) in-frame and downstream of the polyhistidine 
tag sequence by D. Hunt. A protease-negative strain of E. coli was used to study the 
expression characteristics of small-scale cultures that had been induced to transcribe the 
recombinant RegX3 gene (see 2.6.2). Whole cell extracts of all analysed cultures were 
able to express a polyhistidine-tagged protein of approximately the expected molecular
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weight (25.67kDa) for the cloned allele (Figure 5.2) that was assumed to be recombinant 
polyhistidine-tagged RegX3.
5.2.1.2 Assessment of the solubility of recombinant polyhistidine-tagged RegX3 
expressed at different temperatures
The solubility of the expressed recombinant RegX3 was assessed after induction of 
expression of an expressing strain of E. coli at 18°C, 25°C, 30°C and 37°C and isolation 
of the soluble and insoluble portions of the cell pellets at each temperature (see 2.6.2.5), 
which were obtained after sonication by the centrifugation of the lysed cells at 1300Grpm 
in a Heraeus microcentrifuge and separation of the fluid phase (soluble protein) from the 
pellet (insoluble protein). The proteins in the pellet were recovered by resuspension in an 
SDS-containing buffer (Novagen) and heating at 95°C for 5 min, with vortexing for 5 sec 
every minute. Analysis of the soluble and insoluble samples by a commercial, histidine- 
selective stain showed that the expressing clones produce proportionally more soluble 
recombinant protein at 18°C than at 37°C (Figure 5.3), although the band was quite faint. 
Although it appears that a greater proportion of recombinant protein is in the insoluble 
fraction of the cell lysate, it was felt that sufficient soluble protein had been produced to 
allow the experiment to proceed. Recombinant polyhistidine RegX3 was identified by 
comparison with the empty vector control since the stain proved to be poorly selective for 
polyhistidine sequences; however it was felt that the results were clear enough to remove 
the need for a Western blot of the same gel.
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Figure 5.2: Autoelectrochemilumograph of recombinant polyhistidine-tagged RegX3 
expressing clones of E. coli after Western blot analysis with an anti-polyhistidine primary 
antibody. M l, coloured molecular weight markers, M2, polyhistidine-tagged molecular 
weight markers, C, empty vector control strain, 1-7, separate expressing clones. The 
molecular weight marker sizes expressed on the left hand side correspond with lane M l, 
and estimate the molecular weight of the polyhistidine tagged RegX3 (band marked with 
an arrow on the image) to be around 24 or 25 kDa. The expected size o f the recombinant 
protein is 25.67 kDa. Approx 60 ng of whole cell extract in a volume of lOpl was added 
to the sample wells of a precast 10% Bis-Tris gel (Novagen), and was electrophoresed 
and blotted as described in 2.6.2.2 and 2.6.2.3. Markers were added as detailed in the 
manufacturers’ instructions.
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Figure 5.3: Photograph of a gel stained with a commercial polyhistidine-specific stain 
and visualised under UV light as part of a solublility assay, showing increased solubility 
of the recombinant polyhistidine-tagged RegX3 when expressed at lower temperatures. 
Ml and M2, coloured and polyhistidine-tagged molecular weight markers, respectively. 
EVC, empty vector control (expressed at 37°C), S, soluble cell fractions, I, insoluble cell 
fractions. Red spots mark the band thought to be recombinant polyhistidine-tagged 
RegX3. The molecular weight marker sizes expressed on the left hand side correspond 
with lane Ml and are measured in kDa. Approx 60 ng of whole cell extract in a volume 
of lOpl was added to the sample wells of a precast 10% Bis-Tris gel (Novagen), and was 
electrophoresed as described in 2.6.2.2. Markers were added as detailed in the 
manufacturers’ instructions. The separated proteins were stained and visualised using the 
InVision stain (Invitrogen) according to the manufacturer’s instructions (see 2.6.2.2).
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5.2.1.3 Purification of recombinant polyhistidine-tagged RegX3
A large culture of E. coli expressing the recombinant RegX3 allele was grown and 
induced at 18°C (see 2.6.2.5). After lysis of the cells under nondenaturing conditions the 
soluble fraction was passed through an IMAC column and the flow-through was analysed 
by Coomassie stain and Western blot (Figure 5.4) after each stage in the process (see 
2.6.2.6). An identical strain without the cloned regX3 sequence was treated in an 
identical manner and used as a control in this and other experiments (see later). The 
results show that soluble recombinant polyhistidine-tagged RegX3 can be isolated in 
almost pure form from the E. coli cell lysate.
5.2.1.4 Manipulation of soluble recombinant polyhistidine-tagged RegX3
The purified recombinant polyhistidine-tagged RegX3 recovered from the IMAC 
column was dialysed into an appropriate buffer (PBS, Appendix 4) to remove the 
imidazole present in the elution buffer. An estimation of the concentration of the protein 
using BSA reagent (Pierce) gave a concentration of ~6pg/ml (0.2 pmol//xl). The protein 
sample was then concentrated to 0.17mg/ml (5.5pmol/pl) by ultrafiltration (see 2.6.2.8), 
the RegX3 negative control IMAC eluate volume adjusted by the same amount, and the 
two samples and their flow-through analysed on a Coomassie stained gel (Figure 5.5), 
which shows that the protein had indeed been concentrated successfully, producing a 
stronger band, had not visually degraded and had not been lost through the pores in the 
ultrafiltration membrane,
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Figure 5.4: SDS-PAGE analysis of soluble extracts of E. coli BL21 DE3-RP/pET15b- 
regX3 cultured at 18°C, stained with Coomassie R250 (A) and an anti-polyhistidine 
Western blot (B) of IMAC column fractions. Approx 60 ng of whole cell extract in a 
volume of lOpl was added to the sample wells of a precast 10% Bis-Tris gel (Novagen), 
and was electrophoresed and blotted as described in 2.6.2.2 and 2.6.2.3. Markers were 
added as detailed in the manufacturers’ instructions. Ml and M2, coloured 
‘kaleidoscope’ markers (Bio-Rad Laboratories) and polyhistidine-tagged molecular 
weight markers (Invitrogen), respectively. The numbers to the left o f the images 
represent the molecular weights of the Ml markers; the numbers on the right of the 
images represent the molecular weights o f the M2 markers. 1, empty vector control 
{regX3~) flow-through (5mM imidazole), 2, regX3+ flow-through (5mM imidazole), 3, 
binding buffer flow-through of regX3+ protein sample (5mM imidazole), 4, imidazole 
buffer flow-through of regX3+ protein sample (60mM imidazole), 5, imidazole elution of 
matrix-bound protein of regX3+ protein sample (1M imidazole), 6, imidazole elution of 
matrix-bound protein of regX3~ protein sample (1M imidazole). Molecular weights 
indicated on the left refer to the coloured markers, M l. 15pi aliquots of each sample 
were loaded into each sample well of two pre-cast 10% Bis-Tris polyacrylamide gel and 
were electrophoresed and blotted identically according to 2.6.2.2 and 2.6.2.3.
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Figure 5.5: Coomassie stained SDS-polyacrylamide gel of concentrated protein samples 
after ultrafiltration. M l, coloured molecular weight markers, with molecular weight in 
kDa, 1, flowthrough of regX3‘ protein sample, 2, concentrated regX3' protein sample, 3, 
flowthough of regX3+ protein sample, 4, concentrated regX3+ protein sample. The arrow 
marks the recombinant polyhistidine-tagged RegX3. lOpl of each sample was loaded 
into the wells of a 12% Tris-Cl gel (supplied by E. McGovan), with approximately 1.8pg 
of purified protein in the regX3+ sample. Some of the higher bands in lane 4 correspond 
with those in lane 2, and are likely to represent proteins in the E. coli lysate that 
themselves bind the nickel purification resin. Those bands in lane 4 that are not present 
in lane 2 are likely to be E. coli proteins that have associated with the expressed 
heterologous M. tuberculosis protein. The band marked with an arrow on the right hand 
side o f the image is assumed to be recombinant polyhistidine-tagged RegX3. It appears 
to have a higher molecular weight than seen previously, although this is most likely due 
to the use o f Tris-Cl gel (rather than the Bis-Tris gels used elsewhere in this chapter), and 
a higher concentration of that protein in the sample, resulting in slower migration of the 
protein during electrophoresis.
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5.2.1.5 Identification of recombinant RegX3
The protein assumed to be recombinant polyhistidine-tagged RegX3 was excised 
from a gel and prepared for MALDI-TOF mass spectrometry (see 2.6.2.11), the results of 
which showed 68% coverage of a protein with a nominal mass of24.891kDa (Table 5.1), 
as opposed to the predicted mass of 25.67kDa. MALDI-TOF MS is predominantly a 
method of identifying proteins; a more accurate method of measuring the actual mass of 
the protein would be to perform electrospray ionisation mass spectrometry, which was 
not performed here. The results showed a Mascot mowse score of 153 for RegX3 from 
M. tuberculosis, where the mowse score is -10*log(P), and P is the probability that the 
observed match is a random event. Mowse scores over 76 are significant below p=<0.05. 
A mowse score of 153 is approximately similar to an e=10'15 value for a BLAST search 
(S. Howell, personal communication). The polyhistidine tag was not included in the 
sequence for RegX3 in the database used to query the results of the mass spectrometry 
and hence was not identified in the results. However it was felt unnecessary to re-submit 
the query to the database since direct evidence tells us that the polyhistidine tag is present 
in the recombinant protein.
5.2.2 Gelshift assays
The recombinant polyhistidine-tagged RegX3 was used to study DNA-protein 
interactions with regions of DNA thought to contain RegX3 binding sites.
5.2.2.1 Titration of recombinant RegX3 against a previously identified binding site
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Table 5.1: MALDI mass spectrometry results for the purified RegX3 protein showing 
matched peptides in black and unmatched H, K and R residues in red.
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1 MTSVLIVEDE ESLADPLAFL LRKKGFKATV VTDGPAALAE FDRAGADIVL LDLMLPGMSG TDVCKQLRAR
71 SSVPVXMVTA RDSBIDKWG LELGADDYVT KPTSARELIA RIRAVLRRGG DDDSEMSDGV LKSGPVRMDV
141 ERHWSVNGD TITLPLKKPD LLKTUOtNSG RVLTRGQLID RVNGADYVGD TKTLDVHVKR LRSKIEADPA
211 NFVHLVTVRG LG7KLSG
Observed Mr(expt) Mr(calc) ip p m Start End Miss Peptide
701.419 700.411 700.387 34.5 176 181 0 GQLIDR
727.485 726.477 726.486 -13.4 112 117 1 IRAVLR
811.416 810.408 810.460 -64.3 193 199 0 TLDVHVK
836.383 835.375 835.444 -81.9 220 227 1 GLGYKLEG
967.513 966.505 966.561 -57.8 193 200 1 TLDVHVKR
1159.611 1158.603 1158.643 -34.3 71 81 0 SSVPVIMVTAR
1175.594 1174.587 1174.638 -43.6 71 81 0 S S VP VIM VTAR 1 Oxidation (M)
1210.525 1209.517 1209.567 -40.9 182 192 0 VWGADYVGDTK
1630.826 1629.818 1629.884 -40.2 205 219 0 IEADPANPVHLVTVR
1845.956 1844.948 1845.011 -34.0 203 219 1 SKIEADPANPVHLVTVR
1892.855 1891.847 1891.943 -50.8 176 192 1 GQLIDR VWGADYVGDTK
1924.856 1923.848 1923.933 -43.8 176 192 1 GQLIDR VWGADYVGDTK 1 Oxidation (W)
2052.982 2051.974 2052.053 -38.4 88 106 0 WGLELGADDYVTKPYSAR
2093.836 2092.828 2092.897 -32.7 118 137 1 RGGDDDSEMSDGVLESGPVR 1 Oxidation (M)
2094.886 2093.878 2093.990 -53.5 24 43 0 EGFEATWTDGPAALAEFDR
2740.221 2739.214 2739.360 -53.5 82 106 1 DSEIDKW GLELG ADDYVTKPY SAR
2902.306 2901.299 2901.531 -80.1 143 167 1 HVVSVNGDTITLPLKEFDLLEYLMR
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Himpens et al. (2000) identified a 42bp sequence that lies upstream of senX3 as a 
potential binding site for RegX3 (given as oligonucleotide 106 in Appendix 3; 
sequence 5’-atgtgaacggtaaccgaacagctgtggcgtagtgtgtgactt-3’). We initially sought to 
replicate the results of that paper to confirm the interaction between soluble recombinant 
RegX3 and this potential binding site.
A titration of different concentrations of the recombinant RegX3 bracketed 
around that described in Himpens et al. (2000), and equivalent volumes of the empty 
vector control preparation, were allowed to bind to labelled oligonucleotides of the same 
sequence as described in Himpens et al. (2000) (primer 160 annealed to its 
complementary primer 161, see Appendix 3). The reaction conditions were as described 
in 2.6.3.3. Autoradiography of the gel after electrophoresis showed two apparent shifts in 
the electrophoretic mobility o f the probe when incubated with recombinant RegX3, both 
of which grew less intense with reducing concentrations of RegX3 (Figure 5.6). The 
upper shift seemed to be visible, although less intense, in the empty vector control strain. 
This could represent contamination of the empty vector control strain. The lower shift, 
however, did not seem to be present in the empty vector control strain and may represent 
a second binding site on the protein. The shift was not present in a reaction with no 
protein added.
5.2.2.2 Specificity of the interaction of recombinant RegX3 with a previously 
identified binding site
To identify the specific nature of the DNA sequence in the interaction between 
recombinant RegX3 and the probe, a cold-competition assay was carried out. The
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Figure 5.6: Bandshift analysis of RegX3. Autoradiograph of a titration of recombinant 
polyhistidine-tagged RegX3 and the empty vector control protein source against the 42 
bp fragment upstream of the senX3 start codon identified in Himpens et al. (2000). 
Reactions were performed as described in 2.6.3.3, after which lOpl of each reaction was 
loaded onto a precast 10% TE gel (Invitrogen). At 77pmol of protein, the molar ratio of 
protein to DNA is 7.7:1; at 15pmol protein the molar ratio of protein to DNA is 1.5:1. 
The two apparent bandshifts are marked with arrows on the left hand side of the image.
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bandshift caused by the electrophoretic mobility change of the probe when complexed 
with protein was challenged by including unlabelled specific (annealed oligonucleotides 
160 and 161, Appendix 3) or nonspecific (annealed oligonucleotides 162 and 163, 
Appendix 3) probe in the reaction (see 2.6.3.3). The unlabelled nonspecific probe was 
double stranded 43bp oligonucleotide (oligonucleotide 162 annealed to its complimentary 
oligonucleotide 163, see Appendix 3) whose sequence is derived from a region internal to 
senX3 and is mismatched from the M. tuberculosis sequence in the central nine bases. 
This sequence does not appear on the M. tuberculosis genome and would not be expected 
to be involved in binding to an M. tuberculosis response regulator. The sequences of the 
forward reading oligonucleotides of the specific (oligonucleotide 160) and nonspecific 
(oligonucleotide 162) regions are atgtgaacggtaaccgaacagctgtggcgtagtgtgtgactt (42bp) and 
gatccgggctatcagtgcgtgggaaagcccggttgctgagcga (43bp) respectively.
The intensity of both of the shifts in electrophoretic mobility of the probe was 
reduced as the concentration of unlabelled specific probe in the reaction increased over
2.5 times that of the labelled probe (Figure 5.7). The lower shift appeared to be 
outcompeted by specific unlabelled double stranded oligonucleotide at higher 
concentrations than the upper shift; this suggests that one of the putative binding sites on 
the protein has a higher affinity for the specific target sequence than the other.
5.2.23 Confirmation of the identity of the protein involved in DNA-binding
5.2.2.3.1 Supershift assay
To identify the protein in the DNA-protein complex causing the electrophoretic mobility 
shift, a supershift assay was carried out. The binding reactions were set up as before but
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Figure 5.7: Specificity of RegX3 for a putative binding site. Autoradiograph of a cold- 
competition assay between recombinant polyhistidine-tagged RegX3 and labelled 42 bp 
fragment derived from oligonucleotides 160 and 161 (identified in Himpens et al. (2000), 
the formation of a complex between which is being outcompeted by either specific 
(annealed oligonucleotides 160 and 161, Appendix 3) oligonucleotide or a nonspecific 
(annealed oligonucleotides 162 and 163, Appendix 3) oligonucleotide at 0, 2.5, 10 and 25 
times the concentration of the labelled probe. Reactions were performed as described in 
2.6.3.3, with the inclusion of unlabelled DNA as described above. 10pl aliquots of each 
reaction were loaded onto precast 10% TE gels (Invitrogen) and electrophoresed as 
described previously. The two bandshifts are marked with arrows at the left hand side of 
the image.
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with the inclusion of anti-polyhistidine tag monoclonal antibody (Novagen), or 
nonspecific anti-glutathione-S-transferase tag (GST)(Novagen) monoclonal antibody at 
different concentrations (see 2.6.3.5). It was not felt necessary to estimate the exact 
concentrations of the antibodies, since the different affinities each antibody is likely to 
have for an epitope will render stoichiometric comparisons unnecessary. Both antibodies 
are likely to be in excess, and were added before the protein-DNA interaction was 
allowed to take place.
No difference in the electrophoretic mobility o f the protein-DNA complex was 
seen between the specific or non-specific antibodies, with a shift present in all lanes 
containing protein (Figure 5.8). The experiment did not appear to work correctly; it is 
possible that the polyhistidine tag of the recombinant RegX3 is buried somewhere in the 
structure of the protein and the antibody is unable to gain access. Anti-RegX3 antibodies 
were obtained on two occasions, but did not seem to detect RegX3 either in the purified 
recombinant form seen here, or in whole cell extracts of M. tuberculosis (data not 
shown). If a functional anti-RegX3 antibody were obtained, this experiment could be 
repeated and may have more fortuitious results.
In an attempt to get the protocol to work, the experiment was repeated with a no­
antibody control reaction included, as well as reactions where specific (anti­
polyhistidine) and nonspecific (anti-GST) antibodies were added after the DNA- protein 
interactions were allowed to occur. A shift was observed in the no-antibody control 
reaction, along with comparable shifts in reactions with specific (anti-polyhistidine) and 
nonspecific (anti-GST) antibody added before or after the DNA- protein binding reaction 
(Figure 5.9). There appeared to be an additional, higher molecular weight shift in the
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Figure 5.8: Attempt to identify recombinant polyhistidine-tagged RegX3 in the DNA- 
protein binding complex using a supershift assay (2.6.3.5). Autoradiograph of a 
supershift assay, where specific (anti-His) or nonspecific (NS) anti-glutathione 
(Novagen) antibody is used to increase the apparent molecular mass o f the DNA-protein 
complex, further retarding the electrophoretic mobility of the DNA-protein complex 
through the gel. Reactions were performed as described in 2.6.3.3, with the inclusion of 
antibody as described above. 10pl aliquots of each reaction were loaded onto precast 
10% TE gels (Invitrogen) and electrophoresed as described previously. The two 
bandshifts are marked with arrows at the left hand side of the image.
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Figure 5.9: Further attempt to identify recombinant polyhistidine-tagged RegX3 as part 
of the protein-DNA complex. Autoradiograph of a supershift assay, where specific (anti- 
His) or nonspecific (anti-GST) antibody is used to increase the apparent molecular mass 
of the DNA-protein complex, further retarding the electrophoretic mobility of the labelled 
42 bp fragment identified in Himpens et al. (2000) through the gel. Lane 1, probe only, 
lane 2, probe and protein, lane 3, probe, protein and nonspecific antibody, lane 4, probe, 
protein and specific antibody added after the DNA-protein binding reaction. Lane 5, 
probe, protein and specific antibody added before the DNA-protein binding reaction. 
Reactions were performed as described in 2.6.3.3, with the inclusion of antibody as 
described above. lOpl aliquots of each reaction were loaded onto precast 10% TE gels 
(Invitrogen) and electrophoresed as described previously. The two bandshifts are marked 
with arrows at the left hand side of the image. See Asusubel et al (2005) for further 
discussion on potential electrophoretic mobility changes of DNA-protein complexes in 
supershift assays.
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reaction containing the nonspecific antibody, and a possible increase in the mobility of 
the shift when specific antibody was added before the DNA-protein binding reaction.
5.2.23.2 Shift-blot
As an alternative method of identifying the protein involved in the DNA-protein 
interaction, a shift-blot was performed (see 2.6.3.6). The electrophoretic mobility of the 
DNA-protein complex was visualised by autoradiography after specific (annealed 
oligonucleotides 160 and 161, Appendix 3) or nonspecific (annealed oligonucleotides 
162 and 163, Appendix 3) probe (see 5.2.2.2) was allowed to bind to the recombinant 
polyhistidine-tagged RegX3. An autoelectrochemilumograph of the Western blot with 
anti-polyhistidine antibody of the proteins contained in the same gel was aligned with the 
autoradiogram in an attempt to co-localise the recombinant RegX3 and the 
electrophoretically retarded probe (Figure 5.10).
The recombinant polyhistidine-tagged RegX3 appeared on the 
autoelectrochemilumograph as two long smears in the reactions containing protein. 
There were no bands in the interaction between the protein and the specific probe that co­
localised with the shift apparent on the autoradiogram, although there did appear to be a 
band in the reaction between the non-specific probe and the protein in the 
autoelectrochemilumograph. This latter band did not co-localise with any band on the 
autoradiogram, suggesting that it may have been a background artefact of the 
autoelectrochemilumograph.
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Figure 5.10: Shift-blot of the recombinant polyhistidine-tagged RegX3 interaction with 
the 42 bp fragment identified in Himpens et al. (2000). A is an autoradiograph of the 
interaction of recombinant polyhistidine-tagged RegX3 with either specific (S, annealed 
oligonucleotides 160 and 161, Appendix 3) or nonspecific (NS, annealed 
oligonucleotides 162 and 163, Appendix 3) radiolabelled probe. B is an 
autoelectrochemilumograph of an anti-polyhistidine Western blot of the gel shown as an 
autoradiograph in A. Reactions were performed as described in 2.6.3.3, with reaction 
components identical to those in 5.2.2.1 and the second and fifth lanes of Figure 5.6. 
This corresponds with a protein:DNA ratio of approximately 7.7:1 where protein is 
present in the reaction. lOpl aliquots of each reaction were loaded onto precast 10% TE 
gels (Invitrogen) and electrophoresed as described previously, after which the protein- 
DNA complexes in the gel were semi-transferred onto a PVDF membrane (Invitrogen). 
The PVDF membrane and the gel were then processed separately in order to visualise the 
location of the recombinant polyhistidine-tagged RegX3 and the DNA probe (see 
2.6.3.6). The arrow at the left of the image marks a clear band in the fourth lane of image 
A.
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5.2.2.4 Mapping of the interactions between recombinant RegX3 and the region 
upstream of senX3.
Since previous published data (Himpens et al. 2000) did not systematically map 
the potential promoter region of the senX3-regX3 operon for interactions with 
recombinant polyhistidine-tagged RegX3, it was decided to map the interactions between 
the recombinant polyhistidine-tagged RegX3 and overlapping oligonucleotides covering 
the region between gpml and senX3.
5.2.2.4.1 Alignment of the potential promoter sites of three mycobacterial species
To develop a rational understanding of potential RegX3 binding sites upstream of 
the senX3 start site, the sequences of this region from M. leprae (Cole et al. 2001), M. 
avium (TIGR online; http://www.tigr.org/tdb/mdb/mdbinprogress.html) and M. 
tuberculosis strain H37Rv (Cole et al. 1998) were aligned using the MEGALIGN 
software to demonstrate regions of homology. Extensive homology throughout the 
region adjacent to the start of the senX3 gene suggests a number of sites at which RegX3 
might bind (Figure 5.11). The 42 bp region implicated in RegX3 binding in (Himpens et 
al. 2000) is shown here as oligonucleotide E, coloured blue on Figure 5.11.
5.2.2.4.2 Design of oligonucleotides to map the potential RegX3 binding sites 
upstream of senX3
Given the extensive nature of the sequence homology between M. leprae, M. 
avium and M. tuberculosis strain H37Rv, especially between base pairs 579173 and 
579348, it was decided to physically map the interactions between recombinant RegX3
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Figure 5.11: Alignment o f the region upstream of senX3 in M. leprae, M. avium and M. 
tuberculosis generated from the program MEGALIGN, annotated by the author. 
Matching bases are marked by a black background. The coloured lines represent the 
oligonucleotides designed for mapping the interactions of recombinant polyhistidine- 
tagged RegX3 with this region, and the corresponding labels for each of the 
oligonucleotides is shown at the 5' end of each sequence. The 42 bp fragment identified 
in Himpens et al. (2000) to interact with RegX3 is shown in blue as oligonucleotide E. 
Oligonucleotides H and I extend 4 and 25 bp into the coding region of senX3, 
respectively. All oligonucleotides with the exception of oligonucleotide E are 43bp long.
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and one of its potential binding sites. It is worth noting that the 42bp region identified in 
Himpens et al. (2000) does not properly cover this region and may be missing sequence 
essential for proper interactions.
To this end, 42 or 43 bp overlapping primer pairs were designed to cover the 
whole region between the 3’ end of the gpml gene and the 5’ end of senX3, starting at the 
42bp region identified in Himpens et al. (2000). The sequence and positions of the 
oligonucleotides can be seen in Figure 5.11 and Appendix 3. This size of oligonucleotide 
should be sufficiently large enough to contain an entire binding site, and the overlapping 
nature of the oligonucleotides means that no binding sites should be missed if they are 
disrupted by the ending of an oligonucleotide.
The nine primer pairs were annealed in 1:1 ratios and radiolabelled (see 2.6.2.4). 
Each primer pair was then used in a reaction with protein added and a reaction without 
protein added.
The autoradiographs show that an electromobility shift occurs in the majority of 
double stranded oligonucleotides pairs, with the faintest band occurring with 
oligonucleotide C and the strongest with oligonucleotide H (Figure 5.12). Second shifts 
seem to be occurring at a lower molecular weight of the complex (and therefore faster 
migration) with oligonucleotides C, D, F, H and I (marked with red spots).
5.2.2.4.3 Confirmation of the sequence-specific nature of the interaction of the 
recombinant RegX3 with oligonucleotide H
The cold-competition assay described in 5.2.2.2 was repeated here with 
oligonucleotide H. Increasing concentrations of unlabelled oligonucleotide H were used
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Figure 5.12: Electrophoretic mobility shifts of double-stranded oligonucleotides covering 
the region between gpml and senX3, and recombinant polyhistidine-tagged RegX3. NS, 
nonspecific oligonucleotide (annealed oligonucleotides 162 and 163, Appendix 3). lOpl 
of each binding reaction (described in 2.6.3.3) with or without protein was added to each 
well of an 8% precast TBE gel (Invitrogen) prerun with 0.5x TBE buffer, followed by 
electrophoresis at lOOv for 40 min. After electrophoresis the gel was dried and 
autoradiographed. The letters A-I and their colours correspond with those in Figure 5.11. 
One potential shift is marked by an arrow on the left hand side of the image, which seems 
to occur with oligo regions A-I. Potential second shifts occurring in some of the lanes are 
marked on the image with red spots.
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to out-compete the interaction between labelled oligonucleotide H and the protein as can 
be seen from a reduction in intensity of the shift. Only high concentrations of nonspecific 
oligonucleotide (annealed oligonucleotides 162 and 163, Appendix 3), 50x more than 
oligonucleotide H, were able to slightly reduce the intensity of the upper shift; and had a 
similar effect on the lower shift (Figure 5.13).
5.2.2.5 Studies of other promoters putatively regulated by RegX3 using 
phosphorylated and unphosphorylated protein
A gene apparently upregulated in an isogenic regX3 null mutant, Rv0096 (Parish 
et al. 2003) and two genes found to be upregulated in initial microarrays carried out in 
early, preliminary experiments after growth of the mutants in microaerobic conditions 
(data not shown), Rvl460 and Rv2780, were assayed by gelshift assay for the ability of 
their upstream regions to bind recombinant polyhistidine-tagged RegX3 (amplified using 
primers 237 and 238, 241 and 242, and 243 and 244 respectively, see Appendix 3). The 
recombinant polyhistidine-tagged RegX3 was also phosphorylated (see 2.6.2.9) and 
treated in the same manner to compare the potential binding of the protein-DNA complex 
in these two different states.
The results show that the electrophoretic mobility of radiolabelled DNA 
representing 200bp upstream of each of the genes could be retarded at a low level by 
binding to RegX3, since bands, although faint, were present in samples containing 
recombinant polyhistidine-tagged RegX3 that were not present in samples without 
protein (Figure 5.14). Phosphorylation of the recombinant polyhistidine-tagged RegX3 
appeared to induce a reduction in the level of binding to DNA, although this may have
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Figure 5.13: Autoradiograph of a cold-competition assay between recombinant 
polyhistidine-tagged RegX3 and labelled double-stranded oligonucleotide H, similar to 
that described in 5.2.2.2. The formation of a complex between the labelled probe and the 
protein is being outcompeted by either unlabelled oligonucleotide H or a nonspecific 
oligonucleotide (annealed oligonucleotides 162 and 163, Appendix 3) at 5, 10 and 50 
times the concentration of the labelled probe. lOpl of each binding reaction (described in 
2.6.3.3) with specific or nonspecific double stranded oligonucleotide was added to each 
well of an 8% precast TBE gel (Invitrogen) prerun with 0.5x TBE buffer, followed by 
electrophoresis at lOOv for 40 min. After electrophoresis the gel was dried and 
autoradiographed. The potential shifts are marked by an arrow.
299
specific oligo nonspecific oligo
competitor . _ 5 10 50 5 10 50
protein - + + + + + +  +
% «  
••
3 0 0
Figure 5.14: Autoradiograph of an electrophoretic mobility shift assay, using both 
phosphorylated and unphosphorylated protein, o f the putative promoter regions of three 
genes identified by in the preliminary microaerobic growth experiments (data not shown) 
by microarray to be upregulated in regX3 null mutants of M. tuberculosis. lOpl o f each 
binding reaction (described in 2.6.3.3) with or without protein, and reactions with 
phosphorylated protein, was added to each well of an 8% precast TBE gel (Invitrogen) 
prerun with 0.5x TBE buffer, followed by electrophoresis at lOOv for 40 min. After 
electrophoresis the gel was dried and autoradiographed. The arrows mark potential 
interactions between the recombinant polyhistidine-tagged RegX3 and the labelled 
probes that do not occur in protein negative controls.
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been due to a reduction in the quantity of protein added to those DNA-protein binding 
reactions as a result of the phosphorylation reaction. However, in all three promoter 
regions examined the phosphorylation of the recombinant polyhistidine-tagged RegX3 
seemed to reduce the number of shifts apparent from two to one.
5.2.2.5.1 Supershift assay
Further retardation of the DNA-protein shift by a specific antibody allows 
confirmation of the identity of the protein involved in causing the shift with the 
recombinant RegX3 binding region upstream of Rvl460. However, no apparent 
supershift was seen whether the specific anti-polyhistidine was added either before or 
after the protein and DNA were allowed to bind (Figure 5.15). This echoes results from 
similar experiments in this chapter (5.2.2.3.1), where the experiment did not seem to 
work properly, possibly as a result of the polyhistidine tag being inaccessible to the 
antibodies.
5.3 DISCUSSION
5.3.1 Production and purification of recombinant RegX3
It has been shown that it is possible to express recombinant polyhistidine-tagged 
RegX3 in a soluble form from E. coli, in contrast with a previous report (Himpens et al. 
2000). Although it was only possible to purify 0.137mg of protein from a 1 litre culture, 
it was more than sufficient to conduct experiments similar to those described previously 
(Himpens et al. 2000), and observe an electrophoretic mobility shift of a specific DNA 
probe. Since the protein was purified under non-denaturing conditions, it is more likely
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Figure 5.15: Autoradiograph of a supershift assay, where specific antipolyhistidine or 
nonspecific anti-GST antibody is used to increase the apparent molecular mass of the 
DNA-protein complex, further retarding the electrophoretic mobility of the labelled 
Rvl460 promoter DNA through the gel. Lane 1, probe only, lane 2, probe and protein, 
lane 3, probe, protein and nonspecific antibody, lane 4, probe, protein and specific 
antibody added after the DNA-protein binding reaction. Lane 5, probe, protein and 
specific antibody added before the DNA-protein binding reaction. lOpl of each binding 
reaction (described in 2.6.3.3) with specific or nonspecific antibody (see text) was added 
to each well of an 8% precast TBE gel (Invitrogen) prerun with 0.5x TBE buffer, 
followed by electrophoresis at lOOv for 40 min. After electrophoresis the gel was dried 
and autoradiographed. The experiment was conducted in the same way as in 5.2.2.3.I. 
The potential shift is marked by an arrow, and seems to show no alteration of 
electrophoretic mobility when specific antibody is added.
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to be folded correctly than protein that has been purified under denaturing conditions and 
renatured by dialysis. It may be possible to increase the yield of the recombinant RegX3 
for use in future experiments by varying the imidazole concentration of the buffer used to 
wash the column in 2.6.2.6 and 0, or by extracting the protein from a larger volume of 
starter culture, however this was felt to be unnecessary for the current study.
5.3.2 Clarification of previous reports of RegX3 binding to a 42bp region
upstream of senX3
Figure 5.6 shows a dose-dependant interaction between recombinant RegX3 and 
the 42 bp region reported as a RegX3 binding site in Himpens et al. (2000). The greatest 
intensity shift was with a molar ratio of protein to DNA of 7.7:1, whereas Himpens et al. 
(2000) indicate that they use half of this amount. The appearance of the shift in the 
experiment seen here was sharper than those shown by Himpens et al. (2000), however 
the only data they show on this subject is with a 189bp fragment, which in my hands 
retarded its own passage through the gel in the absence of protein (data not shown). This 
was probably due to possible loops and secondary structure in the sequence which 
interfered with interpretation of the results. This spurious banding pattern was not 
evident in Himpens et al. (2000).
The evidence for the binding of recombinant RegX3 to the 42 bp fragment 
upstream of senX3 in Himpens et al. (2000) is based on ability of the unlabelled 42 bp 
fragment to displace the binding of the labelled 189 bp fragment, although they do not 
show this data. Since they also do not show retardation of the labelled 42bp region it is 
impossible to directly compare images with those published.
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Himpens et al. (2000) also show that the interaction between recombinant RegX3 
and the upstream region of senX3 can be outcompeted by specific, but not nonspecific, 
unlabelled DNA probes. The unlabelled nonspecific DNA probe used in that study was 
poly-dldC DNA, a highly branched bulk carrier DNA which does not represent a very 
good negative control since its properties are so unlike those of the binding, specific 
DNA probe. It is generally used (as it is here) to reduce the levels o f non-specific 
interaction between protein and probe in the reactions. The evidence shown here in 
Figure 5.7 represents more direct evidence for a sequence-specific interaction of the 42bp 
region upstream of senX3 with recombinant RegX3.
Unfortunately it has not been possible to show interaction of an anti-polyhistidine 
antibody with the shift complex. The ‘smear’ of protein shown in the results of the shift- 
blot in Figure 5.10 suggest that the interaction between the protein and DNA is a brief 
one, where dissociation and reassociation occurs quickly as the complex moves through 
the gel during electrophoresis. In this case protein would be left in the matrix o f the gel 
as the complex migrates, and its subsequent blotting and binding with the anti-His 
antibody would leave the ‘smear’ marks apparent in Figure 5.10. However, a positive 
control was not included in this experiment and may illuminate any technical difficulties 
if included in further experiments. The results of Figure 5.10 confirm that the anti­
polyhistidine antibody will still bind to the recombinant RegX3 after electrophoresis, 
suggesting that the lack of interaction between the antibodies and recombinant RegX3 in 
Figures 5.8, 5.9 and 5.15 is due to the transitory nature of the interaction between the 
recombinant RegX3 and the DNA.
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Overall the results in section 5.2.2.1 - 5.2.2.3 prove and clarify the sequence- 
specific interaction between RegX3 and a 42bp region upstream of senX3 suggested by 
Himpens et al. (2000).
5.33 Mapping the interactions of recombinant RegX3 with the region upstream of 
senX3
The nature of the evidence for binding of RegX3 to the 42bp region by Himpens 
et al. (2000) relies on the ability of the 42bp region investigated above to out-compete the 
interaction of recombinant RegX3 with a larger labelled fragment. This does not 
preclude the possibility that the 42 bp fragment contains only part o f the binding site for 
RegX3, and is blocking the interaction between RegX3 and the full binding site contained 
on the 189 bp larger fragment (see Figure 5.11). Indeed, an alignment of the putative 
senX3 promoter regions from three closely related mycobacterial species shows that 
potential regulatory motifs as regions of homology that occur throughout the region. The 
site of the 42 bp fragment studied in Himpens et al. (2000) and in this study does not 
contain any obvious isolated regulatory motif and we can assume that the proof of 
interaction by blocking binding of the larger fragment does not necessarily mean that the 
sole binding motif lies within this 42 bp region.
To examine the interactions of recombinant RegX3 with the potential senX3 
promoter region in a more systematic fashion, overlapping double stranded 
oligonucleotides that cover the region from the stop codon of gpml to the start codon of 
senX3 were designed and assayed for their ability to bind recombinant RegX3 (Figure 
5.12). Surprisingly, the addition of RegX3 seemed to cause a shift in the majority of
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oligonucleotides, with the strongest interaction occurring with oligonucleotide H, which 
is positioned immediately 5’ of the senX3 start codon.
A perfunctory search for homologous sequences in these regions did not show any 
motifs that the oligonucleotide regions had in common (data not shown). It might be 
reasonable to assume that the recombinant RegX3 is interacting with these regions in a 
non-specific manner. To test this hypothesis, a cold-competition assay of the interaction 
of recombinant RegX3 with oligonucleotide H was performed, and showed that the 
interaction could be out-competed by unlabelled specific oligonucleotide H, but not by 
unlabelled nonspecific oligonucleotide (annealed oligonucleotides 162 and 163, 
Appendix 3)(Figure 5.13). There was a slight reduction in the intensity of the shift when 
the binding of oligonucleotide H and recombinant RegX3 was challenged with a 50-fold 
excess of nonspecific unlabelled probe. Taken together, these results suggest that RegX3 
can bind to different sequences specific for the upstream region of senX3 with an affinity 
at most 50-fold greater than for nonspecific sequences.
5.3.4 Analysis of recombinant RegX3 binding of putative regulatory regions for
genes upregulated by microarray
One gene, Rv0098, from previous work on an isogenic regX3 null mutant (Parish 
et al. 2003) and two genes from this work, Rvl460 and Rv2780, were identified to be 
upregulated by microarray analysis in regX3 null mutants in various conditions. Rv0096 
belongs to the PPE family of genes, whereas Rvl460 is annotated as a probable 
regulatory protein. Rv2780 codes for alanine dehydrogenase, an enzyme that catalyzes 
the reversible deamination of L-alanine to pyruvate.
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All three genes are likely to contain a promoter site at their 5’ end since none of 
them appear to be co-transcribed with genes immediately upstream of them, and have 
clear intervals before their transcriptional start site (Figures 5.16, 5.17 and 5.18).
It was considered likely that the regulatory elements for these genes would occur 
within the 200 bp immediately upstream from each start codon. The gelshift results with 
both phosphorylated and unphosphorylated recombinant polyhistidine-tagged RegX3 
show a possible weak interaction of the unphosphorylated protein with the promoters of 
all three genes. However, these interactions appeared not to occur when the protein was 
phosphorylated. If there is an interaction of RegX3 with the promoter regions for these 
genes then it could be hypothesised that in vivo, the phosphorylation of RegX3 could 
cause it to unbind from the DNA and allow transcription. This hypothesis would be 
consistent with the apparent upregulation of these genes in mutant strains of M. 
tuberculosis in the preliminary microaerobic microarray work (data not shown, see also 
Parish et al. (2003)) where the absence of RegX3 is associated with increased 
transcription of these genes. Activation of genes by the kinase-dependant lifting of gene 
repression through unbinding of a regulatory protein is a common mechanism of genetic 
control and occurs in the ArcB-ArcA system of E. coli (Georgellis et al. 2001).
The implications of these results are that RegX3 may regulate the expression of 
diverse proteins, and that this interaction may be phosphorylation-dependant. Potential 
binding of recombinant RegX3 to the region upstream of Rv2780 (alanine 
dehydrogenase) suggests that RegX3 may have a role in controlling part of the 
intermediary metabolism of M. tuberculosis. The potential regulation by RegX3 of a 
likely regulatory protein (Rv2780) suggests that the SenX3-RegX3 two component signal
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Figure 5.16: Diagram showing the region surrounding the start site o f the coding
sequence of Rv0096 on the chromosome of M. tuberculosis.
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Figure 5.17: Diagram showing the region surrounding the start site of Rv2780 on the
chromosome of M. tuberculosis.
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Figure 5.18: Diagram showing the region surrounding the start site of Rvl460 on the
chromosome of M. tuberculosis.
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transduction system may be part of a signal transduction network of regulators. 
Similarly, if the expression of Rv0096 (a PPE gene) is being regulated by RegX3, then 
this indicates a role for the SenX3-RegX3 two component signal transduction system in 
the avoidance of the host immune response by antigenic variation (Voskuil et al. 2004).
5.3.5 Evidence for two DNA binding sites on RegX3?
In this study, but not in Himpens et al. (2000), two potential shifts were observed. 
These were seen in the initial experiments with the 42bp sequence identified in that 
paper, with some of the oligonucleotides used for mapping the region upstream of senX3, 
and crucially with the longer upstream regions of promoters of other genes used in the 
phosphorylation assays. This is indicative of RegX3 containing two binding sites for 
DNA, with the upper band representing RegX3 complexed with two molecules of double 
stranded probe, and the lower band representing RegX3 complexed with a single 
molecule of double stranded probe. The two sites may be specific for different 
sequences, which might explain the promiscuous binding of the protein to a number of 
sites upstream of senX3, and may have different affinities for DNA, which would explain 
why the upper shift appears to fade first in the cold-competition assays.
5.3.6 Summary
Overall, the results presented suggest that RegX3 may bind to its own promoter 
and regulate its own expression. Furthermore, systematic analysis of the promoter region 
of senX3 has shown that RegX3 may bind at multiple sites in a sequence-specific manner. 
It has been shown that the nature of RegX3 binding is phosphorylation-dependant, and
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studies of promoter regions of three other genes suggest that RegX3 may be a global 
regulator, controlling a variety of processes within M. tuberculosis.
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6 Analysis of the contribution of Rv0465c and Rvl049 to the 
pathogenesis of M. tuberculosis through the isolation of null
mutations
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6.1 INTRODUCTION
6.1.1 Identification of Rv0465c and Rvl049 as genes potentially involved in the
oxidative stress response of Af. tuberculosis
Both Rv0465c and Rvl049 appeared to be highly upregulated in microarray 
studies after stress o f the wild-type M. tuberculosis by an organic hydroperoxide 
generator, cumene hydroperoxide (Rickman 2002). Since it is feasible to consider that 
these genes may be involved in the response of M. tuberculosis to oxidative stress, the 
potential properties of these genes were investigated by homology and literature 
searching.
6.1.2 Identification of Rv0465c as a potential hydroperoxide stress-responsive gene
The predicted open reading frame of the Rv0465c peptide indicates that the 
protein is 474 amino acids long and annotated as a probable transcriptional regulatory 
protein in Tuberculist (2005). It has been suggested as a non-essential gene as defined by 
Himar-1 transposon mutagenesis (Sassetti et al. 2003), where a library of transposon- 
based mutants were screened for their ability to grow in vitro.
The Pfam domain prediction (Figure 6.1) shows that Rv0465c appears to contain 
a helix-tum-helix domain (HTH 3) between residues 10 and 64; this domain is part of a 
large family of DNA binding proteins. Pfam also predicts a domain of unknown function 
(DUF955) between residues 187 and 310, suggesting similarity to metalloproteases. 
Metalloprotease domains often use a divalent cation in the active site to activate a water 
molecule and hydrolyse peptide bonds. Rv0465c lies directly upstream of Rv0464c, with 
which it is likely to be co-transcribed
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Figure 6.1 Rv0465c and Rvl049. The protein sequences (A) for each gene were taken 
from Tuberculist (http://genolist.pasteur.fr/TubercuList/). The diagrams for each protein 
(B) were obtained by submitting the sequences of each protein to the Pfam server 
(http://www.sanger.ac.uk/Software/Pfam/)
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Rv0465c 
A
1  -  V SK TYV G SR V  RQLRNERGFS Q A A L A Q flL E I S P S Y L N Q IE H  DVR PLTV A VL L R IT E V FG V D
6 1  -  A T FFA SQ D D T  RLVAELREVT L D R D L D IA ID  PHEVAEMVSA H P G L A C A W N  LH R R Y R ITTA  
1 2 1  -  Q LA A ATEER F S D G SG R G S IT  MPHEEVRDYF YQRQNYLHAL DTAAEDLTAQ MRMHHGDLAR
1 8 1  -  E LTR R LT EV H  G V R IN K R ID L  GDTVLHRYDP A T N T L E IS S H  LSPGQQVFKM AAELA Y LEFG
2 4 1  -  D LIDAM VTDG K F T SA E S R T L  ARLG LANYFA AATVLPYRQF HDVAENFRYD V E R L SA FY SV
3 0 1  -  S Y E T IA H R L S  TLQRPSMRGV PFTFV R V D R A  GNMSKRQSAT G F H F SSSG G T  CPLWNVYETF
3 6 1  -  A N P G K IL V Q I AQMPDGRNYL WVARTVELRA ARYGQPGKTF A IG L G C E L R H  AHRLVYSEGL
4 2 1  -  D LSG D PN TA A  TPIG A G C R VC  ERDNCPQRAF PALGRALDLD E H R S T V S P Y L  VKQL ( 4 7 4 a a )
Rvl049 
A
1  -  MGKGAAFDEC ACYTTRRAAR QLGQAYDRAL R PSG LTN TQ F S T L A V I S L S E  G SA G ID LT M S
6 1  -  E L A A R IG V E R  TTLTRNLEVM RRDGLVRVMA GADARCKRIE LTAKGRAALQ KAVPLWRGVQ 
1 2 1  -  AEVTASVGDW  PR V R R D IA N L GQAAEACR ( 1 4 8 a a )
B
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6.1.3 Identification of Rvl049 as a potential hydroperoxide stress-responsive gene
The predicted sequence of the Rvl049 protein of M. tuberculosis was identified to 
have strong homology to the organic hydroperoxide resistance regulator (OhrR) proteins 
of Xanthomonas campestris and Bacillus subtilis by BLAST comparison (E. Davis, 
personal communication). Rvl049 is also defined as a non-essential gene after Himar-1 
transposon-based mutagenesis of wild-type M. tuberculosis by Sassetti et a l  (2003). 
Rvl049 is located directly upstream of Rv1050, and these genes may be co-transcribed.
6.1.4 in silico analysis of the Rvl049 predicted protein sequence
The predicted ORF for Rvl049 from Tuberculist (2005) codes for a 148 amino- 
acid protein. PSI-BLAST analysis (Altschul et a l 1997) of the sequence followed by a 
conserved domain search (Marchler-Bauer & Bryant 2004) shows that Rvl049 contains a 
helix-tum-helix MarR domain from amino acids 17 to 134. Rvl049 therefore belongs to 
the MarR family of transcriptional regulators, which among other things are implicated in 
multiple antibiotic resistance (Grkovic et a l 2002). The marR operon of E. coli can also 
be induced by the redox cycling agents plumbagin and menadione (Seoane & Levy 1995; 
Alekshun & Levy 1999), and its transcriptional mechanisms have been comprehensively 
examined (Martin & Rosner 2004).
6.1.5 Previous studies on OhrR in Xanthomonas campestris and Bacillus subtilis
OhrR from X. campestris is an organic peroxide-inducible negative regulator of 
genes responsible for orchestrating the resistance of that organism to organic 
hydroperoxides that arise from oxidative stress. It is induced by tert-butyl hydroperoxide
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and cumene hydroperoxide, both of which generate organic hydroperoxide radicals, and 
only weakly by peroxide itself. Other byproducts of oxidants and metabolites of organic 
peroxide metabolism did not induce the expression of an OhrR-responsive promoter in X. 
campestris (Panmanee et al. 2002), and OhrR may be responding to tert-butyl 
hydroperoxide stress only, in B. subtilis (Helmann et al. 2003). More recently, Klomsiri 
et al. (2005) also showed phenotypic evidence for a role of OhrR in the resistance of X. 
campestris to lipid hydroperoxides.
It seems from the published literature that the oxidation of a single cysteine 
residue in the OhrR protein is essential for the function of OhrR in both B. subtilis and X. 
campestris (Fuangthong & Helmann 2002; Panmanee et al. 2002). There is an equivalent 
cysteine residue present in Rvl049.
In X. campestris, terf-butyl hydroperoxide has been used for induction of 
promoters and operons (Sukchawalit et al. 2001; Mongkolsuk et al. 2002; Panmanee et 
al. 2002) in vivo, whereas cumene hydroperoxide and tert-\mty\ hydroperoxide were used 
for examination of the activity of purified OhrR and lacZ promoter-fusion strains of X. 
campestris containing mutated ohrR complementing alleles (Fuangthong & Helmann 
2002).
In B. subtilis, tert-butyl hydroperoxide and cumene hydroperoxide was used to 
demonstrate either induction of Ohr-region genes, or was used in a disk diffusion assay to 
demonstrate inhibition of growth in various B. subtilis mutant strains (Fuangthong et al. 
2001). It is worth consideration that in these studies, cumene hydroperoxide-stressed 
cultures are compared with untreated controls. As has previously been mentioned (1.4.3), 
cumene hydroperoxide is supplied dissolved in cumene, which itself is likely to be toxic
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to bacteria. Furthermore cumene hydroperoxide is not readily soluble in water, which 
may cause uneven distribution of the agent throughout the bacterial culture during any 
experiments.
6.1.6 A possible role for Rv0465c and Rvl049 in the oxidative stress response of M, 
tuberculosis'!
It was hypothesised that if Rv0465c and Rvl049 were playing roles in the 
detoxification of organic hydroperoxides, then the Rv0465c and Rvl049 null mutant 
strains of M. tuberculosis would be more sensitive to killing by these agents than the 
wild-type M. tuberculosis. In addition, if  the proteins encoded by Rv0465c and Rvl049 
were playing roles in the infection process, then one might expect to see mutants strains 
deficient in these genes to behave differently from the wild-type M. tuberculosis during 
infection. The work described in this chapter attempts to further the understanding of the 
roles of these genes in the oxidative stress response of M. tuberculosis by characterising 
the phenotypes of null mutants of these genes.
6.2 RESULTS
6.2.1 Construction of an Rv0465c null mutant.
An Rv0465c null mutant strain was generated by allelic exchange, using the 
p2NIL suicide delivery vector to substitute the coding region for Rv0465c for a 
hygromycin resistance allele (Figure 6.2). Construction of the allelic exchange vector, 
electroporation of the wild-type M. tuberculosis and selection and confirmation of the 
mutant strains is discussed in 2.7. It was decided hygromycin-
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Figure 6.2: The completed Rv0465c knockout construct, showing the size o f the Pstl 
and Sail restriction fragments of the gene used to confirm the orientation of the 5’ and 3’ 
fragments, the locations of the various restriction sites mentioned in the text, the sizes of 
the plasmid features, and the locations of the primers used to confirm the orientation of 
the 5’ and 3* inserts by sequencing. Red colour, amplified region 5’ of the gene to be 
knocked out; blue colour, amplified region 3’ o f the gene to be knocked out; green 
colour, hygromycin resistance marker; yellow colour, other selectable markers.
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mark the mutation to allow easier selection of the correct mutant genotype.
At the first round of selection (see 2.7.3), 13 colonies displaying a blue colour and 
resistance to hygromycin, and 8 colonies appearing white and resistant to hygromycin 
were observed. Of the colonies appearing white, only one formed a large colony in the 
presence of hygromycin. This colony was streaked onto further selective plates that 
confirmed the presence of a potential Rv0465c null mutant phenotype.
6.2.2 Construction of an Rvl049 null mutant
An Rvl049 null mutant strain was generated by allelic exchange, using the p2NIL 
suicide delivery vector to substitute the coding region for Rvl049 for a hygromycin 
resistance allele to create pDH14 (Figure 6.3). Construction of the allelic exchange 
vector, electroporation of the wild-type M. tuberculosis and selection and confirmation of 
the mutant strains is discussed in 2.7.2. It was decided to create a hygromycin-marked 
mutation, rather than an unmarked deletion, to allow easier selection of the correct 
mutant genotype.
At the first round of selection (see 2.7.3), 13 colonies displaying a blue colour and 
resistance to hygromycin, and 15 colonies appearing white and resistant to hygromycin 
were observed. Of the colonies appearing white, 5 formed large colonies in the presence 
of hygromycin. These colonies were streaked onto further selective plates that confirmed 
the presence of a potential Rvl049 null mutant phenotype.
6.2.3 Analysis of potential Rv0465c and Rvl049 null mutants of M. tuberculosis.
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Figure 6.3: Diagram of the completed Rvl049 knockout construct, showing the size
and location of the Hindlll restriction fragment and the PCR amplification products used 
to confirm the orientation of the 5’ and 3’ fragments, the locations of the various 
restriction sites mentioned in the text, the sizes of the plasmid features, and the locations 
of the primers used to confirm the orientation of the 5’ and 3’ inserts by sequencing. Red 
colour, amplified region 5’ o f the gene to be knocked out; blue colour, amplified region 
3’ o f the gene to be knocked out; green colour, hygromycin resistance marker; yellow 
colour, other selectable markers.
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The potential Rv0465c and Rvl049 null mutants described above were analysed 
by PCR to confirm allelic exchange in these strains (see 2.7.4 and Table 6.1). One strain 
representing a possible Rv0465c null mutant and one strain representing a possible 
Rvl049 null mutant that displayed the correct pattern of PCR products were analysed 
further by microarray analysis to further assess the absence of the targeted genes in these 
strains and look for other genetic alterations on the chromosome that may have occurred 
by illegitimate recombination.
When compared to the wild-type, microarray analysis of the genomic DNA for 
both Rv0465c (Figure 6.4) and Rvl049 (Figure 6.5) potential null mutants showed 
hybridisation profiles consistent with that expected for the correct allelic exchange 
mutants of M. tuberculosis. Ratios of Cy5-labelled wild-type genomic DNA (red) to 
Cy3-labelled potential mutant genomic DNA (green) were around one for all genes, with 
the exception of Rv0465c (Figure 6.6) or Rvl049 (Figure 6.7) in the respective mutant- 
derived genomic DNA that had wild-type:mutant-derived genomic DNA ratios of 58 and 
14 respectively. The spots corresponding to the labelled genomic DNA for Rv0465c and 
Rvl049 appeared red due to the unequal levels of these genes between the mutants and 
the wild-type, whereas all other spots appeared yellow on the scanned microarray.
To further assess the genotypes of the Rv0465c and Rvl049 null mutant strains, 
the region of deletion was amplified from the genomic DNA of each of the strains using 
the primers 139 and 140 for the Rv0465c null mutant and 147 and 148 for the Rvl049 
null mutant (Appendix 3). These regions were then sequenced to confirm allelic 
exchange between the targeted gene and a hygromycin resistance marker. BLAST 
searches were used to confirm the deleted regions of the two strains.
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Table 6.1 Expected product sizes of primer pairs designed to distinguish between the 
genotypes of strains potentially arising during the knockout process to construct Rv0465c 
and Rvl049 insertionally inactivated mutants. The letters denoting the different primer 
pairs refer to Figure 2.7.
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primer pair product pDHI4::Af. tuberculosis RvQ465c::4f iuhfrctdosLr
primer product size (kb) primer product size (kb)
A intergenic hygr F 181 0.659 181 0.659
R 182 182
B intragenic F 183 0.287 185 0.627
Rvl049/Rv0465c R 184 186
C chromosome F 177 1.949 (5: crossover) 179 2.067 (5’ crossover
upstream ofhygr R 157 >14.5 (3' crossover) 157 >16 (3'crossover)
D chromosome F 156 >14.8 (5’ crossover) 156 >15.5 (5’ crossover)
duwiBbeam ofhygr R 178 1.842 (T crossover) 180 1.803 (3' crossover)
E region between the F 147 1.243 (hygr) 139 1.361 ([hygr)
cloned flanking sequence: R 148 571 (ftvl049) 140 1.485 (RvW65c)
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Figure 6.4: Adapted GENEPIX 5.0 screenshot of the microarray analysis o f the potential 
Rv0465c null mutant. Cy3-labelled cDNA (shown as green) derived from the potential 
Rv0465c null mutant was hybridised against Cy5-labelled cDNA (shown as red) derived 
from wild-type M. tuberculosis. Genes that are present in both the wild-type and the 
potential Rv0465c null mutant appear as yellow, and red spots indicate genes that are 
present only in the wild-type and not in the mutant. The control spots are generally used 
for normalisation in RNA-based microarray experiments and locating the comers o f each 
grid, and are not relevant to this experiment. The apparent green spot toward the top left 
of the image is likely to be a technical artefact, as it is not seen in the numerical analysis 
in Figure 6.6. For further discussion of genomic DNA microarrays see 2.5.8.1.
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Figure 6.5: Adapted GENEPDC 5.0 screenshot of the microarray analysis o f the potential 
Rvl049 null mutant. Cy3-labelled cDNA (shown as green) derived from the potential 
Rvl049 null mutant was hybridised against Cy5-labelled cDNA (shown as red) derived 
from wild-type M. tuberculosis. Genes that are present in both the wild-type and the 
potential Rvl049 null mutant appear as yellow, and red spots indicate genes that are 
present only in the wild-type and not in the mutant. The control spots are generally used 
for normalisation in RNA-based microarray experiments and locating the comers o f each 
grid, and are not relevant to this experiment. The apparent green spot toward the top left 
of the image is likely to be a technical artefact, as it is not seen in the numerical analysis 
in Figure 6.7. For further discussion of genomic DNA microarrays see 2.5.8.1.
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Figure 6.6: Adapted GENEPIX 5.0 scatter plot of a microarray comparing the DNA of 
wild-type M. tuberculosis to that of a potential Rv0465c null mutant. Part o f this 
microarray is shown in Figure 6.2 above. The features of the microarray are plotted 
sequentially along the x-axis and compared to the median of the Cy5 values divided by 
the median o f the Cy3 values for each spot. A median of ratios above 1 represents a gene 
that is missing in the Cy3-labelled cDNA from the potential Rv0465c null mutant.
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Figure 6.7: Adapted GENEPIX 5.0 scatter plot of a microarray comparing the DNA of 
wild-type M. tuberculosis to that of a potential Rvl049 null mutant. Part of this 
microarray is shown in Figure 6.4 above. The features of the microarray are plotted 
sequentially along the x-axis and compared to the median of the Cy5 values divided by 
the median of the Cy3 values for each spot. A median of ratios above 1 represents a gene 
that is missing in the Cy3-labelled cDNA from the potential Rvl049 null mutant.
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6.2.4 Construction of Rv0465c and Rvl049 null mutant strains carrying
complementing alleles.
It was decided to complement the Rv0465c and Rvl049 null mutant strains with 
intact alleles on the integrating vector pKP186 before the mutants were assessed for a 
phenotype in vivo.
6.2.5 Construction of a complementation plasmid for the Rv0465c null mutant
To complement the Rv0465c null mutant a 2457 bp region of the M. tuberculosis 
chromosome, a region from base pairs 554146 to 556603 containing the coding 
sequences for Rv0465c and Rv0464c plus 297 bp 5’ of the start site of Rv0465c that was 
assumed to contain the promoter (Figure 6.8), was amplified using the primers 189 and 
190 (Appendix 3), and blunt-end cloned into pCR-4 (see 2.7.1). The Rv0464c coding 
sequence was included in the complementation allele since the substitution of Rv0465c 
with a hygromycin resistance cassette in the Rv0465c null mutant may create a polar 
mutation if Rv0465c and Rv0464c are co-transcribed.
This region, as part of the 2463 bp BamWl fragment of pDH28, was ligated into 
the pKP186 plasmid to create pDH30. pDH30 was fully sequenced, which revealed that 
no mutations were present.
6.2.6 Construction of a complementation plasmid for the Rvl049 null mutant
To complement the Rvl049 null mutant, a 2075 bp region of the M. tuberculosis 
chromosome from 1172019 to 1174094 that contained the coding sequences for Rvl049
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Figure 6.8: Complementation of the Rv0465c null mutant of M. tuberculosis. The 
complementation region covers both Rv0465c and Rv0464c and the region between 
Rv0465c and Rv0466 that is likely to contain the promoter for Rv0465c.
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and Rvl050 plus a 367 bp region 5’ of the start site of Rvl049 that was assumed to 
contain the promoter (Figure 6.9), was amplified using the primers 191 and 192 
(Appendix 3), and blunt-end cloned into pCR-4 TOPO (see 2.7.2) using the Zero Blunt 
kit (Invitrogen). Rvl050 was included in the complementation construct since the 
substitution of Rvl049 for a hygromycin resistance cassette in the Rvl049 null mutant 
may create a polar mutation if Rvl049 and Rvl050 are co-transcribed.
This region, as part of the 2093 bp EcoRl fragment of pDH29, was ligated into 
pKP186 to create pDH31. EcoRl was used to digest the restriction sites of the polylinker 
of pDH29 since the insert contained a BamHl site, digestion by which would have 
cleaved the complementation region. Sequencing revealed that no mutations were 
present.
Both pDH30 and pDH31 were electroporated into their respective mutant strains 
as described in 2.1.1.4.8.
6.2.7 Phenotypic assessment of Rv0465c and Rvl049 null mutants
It was necessary to establish the normal growth phenotype of the Rv0465c and 
Rvl049 null mutants in vitro before examining the response of these strains to ter/-butyl 
hydroperoxide and their growth of these strains in macrophage and murine models of 
infection.
6.2.8 In vitro growth
To assess the growth rate of M. tuberculosis strains lacking the genes Rv0465c 
and Rvl049 in vitro, wild-type M. tuberculosis, the Rv0465c null mutant and the Rvl049
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Figure 6.9: Complementation of the Rvl049 null mutant o f M. tuberculosis. The 
complementation region covers both Rvl049 and Rvl050 and the region between 
Rvl049 and Rvl048c that is likely to contain the promoter for Rvl049
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null mutant were grown to early exponential phase, diluted 1/500 into further roller 
bottles, three per strain, and the growth followed daily (Figure 6.10)(see 2.1.1.4.3). 
During exponential phase (93-164 hours) the wild-type, Rv0465c null mutant and the 
Rvl049 null mutant showed mean generation times of 16.66, 16.41 and 16.36 hours 
respectively. All three strains entered stationary phase around 237 hours with respective 
mean OD600S of 4.64, 4.60 and 4.72 for the wild-type and Rv0465c and Rvl049 null 
mutants.
To assess the ability of wild-type M. tuberculosis to resist organic hydroperoxide 
stress, a titration of te/t-butyl hydroperoxide was made against the wild-type M. 
tuberculosis using OD<>oo and viable counts measured (see 2.2.1.1 and 3.2.2.3). This data 
was used to determine bactericidal concentrations of tert-butyl hydroperoxide; 250juM 
was found to be a suitable concentration (3.2.2.3).
To examine the ability of Rv0465c and Rvl049 mutants to survive exposure to 
organic hydroperoxides, they were grown alongside the wild-type to early exponential 
phase and then each strain split into six aliquots (see 2.2.1.1). Three aliquots per strain 
were exposed to 250/xM tert-butyl hydroperoxide, and the control strains exposed to 
volumes of water identical to that of the tert-butyl hydroperoxide. After 24 hours viable 
counts (Figure 6.11) and OD600S (Figure 6.12) were measured. The wild-type exhibited a 
0.85 mean log drop in viability. The Rv0465c and Rvl049 null mutants showed log 
losses in viability of 1.00 and 1.31 respectively. The loss in viability of the Rvl049 null 
mutant was significantly greater than that of the Rv0465c null mutant and the wild-type 
at a level of p<0.005. The OD600 data (Figure 6.12) shows a similar trend.
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Figure 6.10: Aerobic growth of Rv0465c and Rvl049 null mutants of M. tuberculosis. 
The wild-type and the Rv0465c and Rvl049 null mutants were grown aerobically in 
Dubos media with albumin and glycerol at 37°C (2.1.1.4.1) to early exponential phase, 
before being diluted 1/500 in triplicate into fresh Dubos media with albumin and glycerol
(2.1.1.4.1) and cultured aerobically at 37°C. Growth o f the cultures was followed daily 
by measuring the O D ^. Each data point represents the mean of three cultures with 
standard error bars plotted. Numbers above the data points refer to the calculated 
generation time of the wild-type; numbers below the data refer to the mean OD«ooS at each 
data point for the wild-type.
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Figure 6.11: Viable counts showing the comparative survival o f wild-type M. 
tuberculosis and the Rv0465c and Rvl049 null mutants after stress with 250piM tert- 
butyl hydroperoxide for 24 hours, expressed as A) cfu/ml and B) % viability. Strains 
were grown aerobically in Dubos media with albumin and glycerol at 37°C (2.1.1.4.1) to 
early exponential phase, after which the cultures were split into separate vessels, tert- 
butyl hydroperoxide was added to a final concentration of 250pM to half of the cultures, 
and an equal volume of water was added to the control cultures. Viable counts o f the 
cultures were taken after 24 hours further incubation at 37°C. The experiment was 
performed in triplicate as described in 2.2.1.1, and standard errors are shown. The log 
loss of viability o f the Rv0465c null mutant was significant at a level of p<0.005.
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Figure 6.12: Comparative survival o f wild-type M. tuberculosis and the Rv0465c and 
Rvl049 null mutants after stress with 250/iM tert-butyl hydroperoxide for 24 hours, 
expressed as A) OD600 measurements, and B) percentage difference in ODm  
measurements. Strains were grown aerobically in Dubos media with albumin and 
glycerol at 37°C (2.1.1.4.1) to early exponential phase, after which each culture was split 
into two vessels, one of which was treated with tert-butyl hydroperoxide to a final 
concentration of 250pM. The unstressed control cultures were treated with a water 
control of the same volume as the tert-butyl hydroperoxide used in the stressed cultures. 
After 24 hours further incubation at 37°C the optical densities were measured. The 
experiment was performed in triplicate as described in 2.2.1.1, and standard errors are 
shown.
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To examine the responses of the Rv0465c and Rvl049 null mutants to higher 
concentrations of organic hydroperoxides, the two mutants and the wild-type were treated 
in an identical manner (see above) but exposed to tert-butyl hydroperoxide at a final 
concentration of 2mM. Viable counts (Figure 6.13) and OD600S (Figure 6.14) were taken 
after 24 hours. The wild-type strain showed a mean log loss of viability o f 1.5, the 
Rv0465c null mutant a mean log loss of viability of 1.87 and the Rvl049 null mutant a 
mean log loss of 1.97. At this concentration of tert-butyl hydroperoxide there were no 
significant differences between any of the strains.
6.2.9 Assessment of the role of the Rv0465c and Rvl049 genes of M. tuberculosis in 
macrophage infection
To gain a measure of whether the Rv0465c or Rvl049 genes of M. tuberculosis play a 
role in the growth of this organism in vivo, the Rv0465c and Rv0149 null mutants, and 
the Rv0465c and Rvl049 null mutants carrying the integrated complementation plasmids, 
were assayed for growth in a macrophage model of infection (Figure 6.15). The two null 
mutants, their respective complement strains and the wild-type M. tuberculosis were 
infected into macrophages as described in 2.2.2.1. Roughly 10% of the bacteria were 
taken up during the five hour infection, presenting a mean starting population of 3.2 x 10 
bacteria per ml lysed culture supernatant (=~80 000 macrophages). All three strains grew 
constantly over the 10 days with a mean generation time of 31.1 hours to a final mean 
population of 2.3 x 106 bacteria per ml lysed culture supernatant.
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Figure 6.13: Comparative survival o f wild-type M. tuberculosis and the Rv0465c and 
Rvl049 null mutants after stress with 2mM tert-butyl hydroperoxide for 24 hours, 
expressed as A) cfu/ml, and B) percentage viability. Strains were grown aerobically in 
Dubos media with albumin and glycerol at 37°C (2.1.1.4.1) to early exponential phase, 
after which each culture was split into two further vessels, one of which was treated with 
tert-butyl hydroperoxide to a final concentration o f 2mM. The unstressed control 
cultures were treated with a water control of the same volume as the tert-butyl 
hydroperoxide used in the stressed cultures. After 24 hours further incubation at 37°C the 
viable counts o f each strain were measured. The experiment was performed in triplicate 
as described in 2.2.1.1, and standard errors are shown.
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Figure 6.14: Comparative survival of wild-type M. tuberculosis and the Rv0465c and 
Rvl049 null mutants after stress with 2mM tert-butyl hydroperoxide for 24 hours, 
expressed as A) OD600, and B) percentage difference in OD600 measurements. Strains 
were grown aerobically in Dubos media with albumin and glycerol at 37°C (2.1.1.4.1) to 
early exponential phase, after which each culture was split into two further vessels, one of 
which was treated with tert-butyl hydroperoxide to a final concentration o f 2mM. The 
unstressed control cultures were treated with a water control of the same volume as the 
tert-butyl hydroperoxide used in the stressed cultures. After 24 hours further incubation 
at 37°C the viable counts of each strain were measured. The experiment was performed 
in triplicate as described in 2.2.1.1, and standard errors are shown.
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Figure 6.15: Growth o f the wild-type M. tuberculosis, the Rv0465c and Rvl049 null 
mutants and their respective strains carrying functional alleles on the integrating pKP 186 
vector in primary bone marrow derived macrophages from 8 month old BALB/c mice. 
The wild-type, Rv0465c and Rv0149 null mutants and their respective complementing 
strains were grown aerobically at 37°C in Dubos media with albumin and glycerol
(2.1.1.4.1) to early exponential phase, then washed and resuspended in macrophage 
infection media as described in 2.2.2.1 before being used to infect macrophages isolated 
and grown from 8 month old female Balb/C mice at a multiplicity of infection o f one 
macrophage per two macrophages. The infection was monitored at 37°C by lysis o f the 
infected macrophage cultures at intervals with saponin (2.2.2.1) and measuring the viable 
counts of the lysed cell supernatant. Data are the results o f duplicate infections, showing 
the mean of two infected cell cultures and the standard error per time point.
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6.2.10 Assessment of the role of the Rv0465c and Rvl049 genes of M. tuberculosis In 
a murine model of infection
To determine whether the Rv0465c or Rvl049 genes play a role in the growth of M  
tuberculosis in vivo, the Rv0465c and Rvl049 null mutants, and the Rv0465c and 
Rvl049 null mutants carrying the integrated complementation plasmids, were grown in 
rolling bottles as in other experiments (see 2.1.1.4.3) until they reached exponential 
phase. The bacteria were then diluted to an OD600 of 0.020 in sterile phosphate-buffered 
saline and injected into the tail veins o f 6-8 week old female Balb/C mice. Groups of 
four mice were used at days one, 37 and 63 and the number of viable bacilli determined 
in the lungs and spleen (Fig 6.16).
The wild-type, mutant and potential complementing strains were taken up equally 
well, presenting around lxlO4 cfu/gram tissue in the lungs and around 1x10s cfu/gram 
tissue in the spleens at day one. All strains increased in number by around one and a half 
logs in the lungs at day 37, and by around half a log in the spleens. At day 63, all strains 
had decreased in number by around half a log in the lungs and one and a half logs in the 
spleen. At day 63 in the spleens the Rv0465c null mutant, but not the Rv0465c null 
mutant carrying the integrated functional allele, was present in numbers significantly 
greater than the wild-type at a level of p=0.044 as compared by a homoscedastic t-test.
6.3 DISCUSSION
6.3.1 Construction of Rv0465c and Rvl049 null mutants of M. tuberculosis.
The data presented here shows conclusive proof of the construction of two strains 
of M. tuberculosis lacking the genes Rv0465c and Rvl049. Phenotypic testing,
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Figure 6.16: Growth of wild-type M. tuberculosis, Rv0465c and Rvl049 null mutants of 
M. tuberculosis and the Rv0465c and Rvl049 null mutants carrying integrated copies of 
their respective functional alleles in a murine intravenous injection model o f infection. 
The wild-type, Rv0465c and Rvl049 null mutants were grown aerobically to early 
exponential phase in Dubos media with albumin and glycerol (see 2.1.1.4.1) at 37°C 
before washing in sterile PBS. Approx. 2 x 106 bacteria in a volume of 0.2ml were then 
injected intravenously into the tail vein of 6-8 week old Balb/C mice and the infection 
followed by removing the lungs and spleens o f four mice per strain at intervals, and 
measuring the viable counts of tissue homogenate after serial dilution in saline. See
2.2.2.2 for further details on the method.
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complementation and further analysis will allow the role that these two genes play in 
infection or in resistance to oxidative stress to be assessed.
Both Rv0465c and Rvl049 appear to be the upstream members of co-transcribed 
two-gene operons (Figure 6.17 and 6.18). It is reasonable to assume that the substitution 
of Rv0465c and Rvl049 for hygromycin resistance markers in the two strains are creating 
polar mutations of the downstream genes Rv0464c and Rvl050, respectively. Rv0464c 
is annotated as a conserved hypothetical protein, and RvlOSO is annotated as a probable 
oxidoreductase on the Tuberculist web server (2005).
63.2 in vitro growth of Rv0465c and Rvl049 null mutants of M. tuberculosis
The growth o f the Rv0465c and Rvl049 null mutants of M. tuberculosis was 
indistinguishable from that o f the wild-type, consistent with previous data suggesting that 
Rv0465c and Rvl049 are non-essential genes (Sassetti et al. 2003). The growth 
phenotype here suggests that Rv0465c and Rvl049 are not involved in normal cellular 
growth and division of M. tuberculosis in aerobic rolling cultures.
6.3.3 Resistance of Rv0465c and Rvl049 null mutants to tert-butyl hydroperoxide 
stress
Following the titration of terf-butyl hydroperoxide against the wild-type M  
tuberculosis {3.2.2.3) , it was decided to stress the Rv0465c and Rvl049 null mutant 
strains with terf-butyl hydroperoxide at a 250/iM final concentration to cause a 
significant, measurable drop in viability of the wild-type to which the viabilities of the 
null mutants could be compared. A small but significant drop in the viability of the
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Figure 6.17: Tuberculist (2005) representation of the genome around Rv0465c.
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Figure 6.18: Tuberculist (2005) representation o f the genome around Rvl049.
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Rvl049 null mutant when compared to the wild-type suggested a role for this 
gene in the resistance of M. tuberculosis to terf-butyl hydroperoxide.
To extend upon this finding, it was decided to stress the cultures with a much 
higher concentration of terf-butyl hydroperoxide in order to maximise any differences 
between the Rvl049 null mutant and the wild-type. A 2mM final concentration of tert- 
butyl hydroperoxide was used, representing the highest concentration tested against the 
wild-type (3.2.2.3). At this concentration there was no statistical difference between the 
wild-type and the Rv0465c and Rvl049 null mutants. There is, however, a discrepancy 
between figures Figure 6.13 and Figure 6.14, in that the drop in ODeoo does not match the 
drop in viability. Given the of conflict with these results, it is preferable to consider the 
viability data as indicative of the survival of the bacterial culture, since the measurement 
of the optical density does not take into account bacteriostatic action of the stressing 
agent and may be misled by the thickening of the bacterial cell wall, as discussed in 1.4.4.
Taken together, these results suggest either that:
a) Rvl049 plays a role in the resistance of low, but not high, levels of organic 
hydroperoxide stress in M. tuberculosis and that some other mechanism is 
responsible for high-level resistance of M. tuberculosis to tert-butyl 
hydroperoxide, or
b) Rvl049 plays a central role in the response of M. tuberculosis to tert-butyl 
hydroperoxide, but a 2mM concentration of tert-butyl hydroperoxide is too high a 
concentration for the wild-type to resist killing, or
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c) The behaviour of the Rvl049 null mutant after exposure to 250piM tert-butyl 
hydroperoxide was an experimental anomaly, and the gene plays no role in the 
resistance o f M. tuberculosis to tert-butyl hydroperoxide.
Since the response of the Rvl049 null mutant to 250/iM tert-butyl hydroperoxide was 
performed in triplicate with consistent results, it may be possible to discount scenario (c). 
Scenario (b) is likely to be untrue, since the drop in viability of the Rvl049 null mutant 
was only 0.31 when compared to the wild-type and, although statistically significant, is 
not of the scale one would expect to see if  the sole regulator of tert-butyl hydroperoxide 
responses in M. tuberculosis was rendered non-functional. Scenario (a) is a reasonable 
hypothesis, since MarR-type regulators tend to be part of a general response in other 
bacteria and one would expect a more specialised system to be acting in conjunction with 
this in an organism in which resistance to organic hydroperoxides was important for 
survival.
6.3.4 Construction of potential complementation strains of Rv0465c and Rvl049 
null mutants of M. tuberculosis.
The alleles that were cloned to complement the Rv0465c and Rvl049 null mutant 
strains included what appeared to be the full operon (of two genes) for each of the 
mutants, plus regions that are assumed to contain the native promoter o f the operons.
In the event of either the Rv0465c or Rvl049 null mutant displaying a phenotype, 
the ability to complement the mutant and restore the wild-type virulence would allow 
confirmation of the role of that gene in the physiology of M. tuberculosis, which may be 
particularly important if the allelic exchange of Rv0465c and Rvl049 has lead to polar
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mutations in downstream, cotranscribed genes. Complementation of a mutant phenotype 
would also allow structure-function analysis of the gene product. However, under the 
conditions tested the mutants did not behave differently from the wild-type, although this 
does not preclude the use of the complemented strains in the future should a mutant 
phenotype present itself.
Due to the reasons discussed in 6.1, it is possible to hypothesise that either or both 
of Rv0465c or Rvl049 may play a role in the virulence of M. tuberculosis. This 
hypothesis is supported by the response of the Rv0465c and Rvl049 null mutants to tert- 
butyl hydroperoxide stress, however it is possible that the two genes are responding to 
more diverse stimuli than were replicated in vitro and that in vivo analysis of the two 
mutants would show stronger phenotypes.
6.3.5 Assessment of the role of the Rv0465c and Rvl049 genes of M. tuberculosis in
a macrophage infection model.
There appeared to be no difference between the growth of the Rv0465c and 
Rvl049 null mutants and the wild-type in macrophages. Correspondingly, there was also 
no difference seen between the potential complementing strains, and the Rv0465c and 
Rvl049 null mutants. Since no morphology changes were seen in cells infected with any 
of the strains under test, it can only be concluded that the Rv0465c and Rvl049 genes of 
M. tuberculosis do not play a role in the infection of murine macrophages in this model. 
It is, however, not possible at this stage to conclude that either of these genes do not play 
a role in infection.
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6.3.6 Assessment of the phenotypes of Rv0465c and Rvl049 null mutants of M.
tuberculosis in a murine model of infection.
To examine the in vivo responses of Rv0465c and Rvl049 null mutants in a more 
complex model of infection it was decided to assay them in the same mouse model of 
infection as used in 3.2.3.3. Neither of the mutants grew in a manner particularly 
different to that o f the wild-type, although the number of viable bacteria in the spleens of 
the mice at day 63 was significantly higher than the wild type for the Rv0465c null 
mutant. This may represent a subtle in vivo phenotype since the mutant strain carrying 
the integrated functional copy of the allele did not exhibit this behaviour, however there 
were no differences in the growth of the Rv0465c null mutant to the wild-type in the 
lungs.
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Discussion
7.1 Phenotypic examination of senX3 and regX3 null mutants of M. tuberculosis
By similarity of senX3 and regX3 to orthologous genes in other organisms, i.e. S. 
pombe and E. coli, it was possible to hypothesise a role for the SenX3-RegX3 two 
component signal transduction system in the response of M. tuberculosis to oxidative 
stress. Furthermore, structural modelling of SenX3 by J. Saldanha (Mathematical 
Biology, NIMR) showed a PAS-like domain to be the likely signal input domain of 
SenX3. PAS domains are often sensors of redox levels, and the structural similarity of 
the SenX3 PAS-like domain to PAS domains in other organisms suggests that it may bind 
a haem prosthetic group, further supporting a role for the SenX3-RegX3 two component 
signal transduction system in oxygen sensing.
In contrast with another report (Parish et al. 2003) it has been shown here that null 
mutants in the SenX3-RegX3 two component signal transduction system display normal 
growth in aerobic culture. This is consistent with data arising from mutagenesis work on 
M. tuberculosis that suggests neither senX3 nor regX3 are required for mycobacterial 
growth in vitro (Sassetti et al. 2003). Furthermore, two-component signal transduction 
systems are often only active under specific environmental conditions, and would not be 
active during growth in vitro. In this situation it is possible to imagine that their absence 
would not affect the growth rate in the absence of the environmental signals that require 
their activity.
The importance of the SenX3-RegX3 two component signal transduction system in 
the M. tuberculosis infection process was shown here by demonstrating significantly 
reduced growth o f the senX3 and regX3 null mutants in a mouse model of infection. 
Complementation of the null mutants with functional copies of senX3 and regX3 proved
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conclusively that the attenuated phenotype of the mutants was solely due to the absence 
of these genes.
To further study the role of SenX3 and RegX3 during infection, the growth of the 
senX3 and regX3 null mutants was followed in macrophages derived from murine bone 
marrow. The mutants were attenuated in this in vitro model of infection, showing that M. 
tuberculosis requires the SenX3-RegX3 two component signal transduction system to be 
active during the early stages of infection. This allows us to conclude that the SenX3- 
RegX3 two component signal transduction system is responding to at least some of the 
environmental changes that occur during macrophage infection, such as the oxidative 
burst or nutrient starvation, although it is not possible to rule out involvement of this 
system to later stages during infection, such as those that occur in the granuloma.
In an effort to try and understand if  a specific single agent was responsible for the 
attenuation of the senX3 and regX3 null mutants, these strains were exposed to a number 
of different agents in vitro. The mutants appeared to be more resistant than the wild-type 
to killing by high concentrations of superoxide ions, and organic hydroperoxides that 
would normally form in vivo as a breakdown product of the superoxide ions. No 
difference was seen in viability between the mutants and the wild-type after nitrosative 
stress, nutrient starvation or growth in acidic conditions. From these data it may be 
possible to conclude that the SenX3-RegX3 two component signal transduction system 
may play a role in repression of genes that are involved in the defence of the bacterium to 
superoxide stress and its breakdown products, or metabolic stress as a result o f oxygen 
limitation. In the absence of the SenX3-RegX3 two component signal transduction
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system these genes may be constitutively produced, which would provide a selective 
advantage to the mutant strains under superoxide stress conditions.
In conditions o f in vitro oxygen or nutrient starvation M. tuberculosis would be 
likely to encounter internal oxidative stress as the free radicals produced by aerobic 
metabolism progressively damage the cellular machinery unless these processes were 
shut down. In E. coli this function is performed by ArcB, to which the SenX3-RegX3 
two component signal transduction system has homology. Although no difference in 
viability between the mutant strains and the wild-type was seen here after growth in low- 
oxygen conditions or in the absence of a carbon source, it may be that the time-frame for 
this phenotype to become apparent in M. tuberculosis is greater than that assessed in 
those experiments.
7.2 Microarray examination of the responses of senX3 and regX3 null mutants to
environmental stimuli
Previous work has shown no great differences in the transcriptome between the 
mutants and the wild-type after growth in rolling bottles (Rickman 2002). This is in 
agreement with the hypothesis that the SenX3-RegX3 two component signal transduction 
system is not active during normal growth in vitro. In the presence of a stimulus for the 
SenX3-RegX3 two component signal transduction system it would be possible to analyse 
differences in the ratios of gene transcripts between the mutants and the wild-type and 
thus deduce a role for the system based on the identity and function of the differentially 
regulated genes.
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No differences in the transcriptome between the wild-type and the mutants were 
seen after superoxide stress or growth in sealed cultures containing very little air. This 
suggests that these conditions were not sufficient to cause activation of the SenX3-RegX3 
two component signal transduction system. Initial experiments with a standing 
‘microaerobic’ model of M. tuberculosis growth showed a number of operons to be 
differentially regulated between the wild-type and the senX3 null mutant; however the 
differentially expressed gene list varied between experiments. It is likely that the bacteria 
are being subjected to reduced oxygen levels since cultures enter stationary phase before 
reaching a high enough OD600 to be indicative of nutrient limitation in aerobic cultures.
Refinement of this model allowed examination of the low-oxygen transcriptomes 
of the senX3 and regX3 null mutants and another regX3 null mutant, Tame 15, to be 
compared to the wild-type. A number of genes were common to the lists of differentially 
regulated genes o f all three mutants, suggesting that there are subtle differences in the 
regulatory behaviour o f the three strains. A ferridoxin gene, fdxA, is seen to be 
apparently regulated by the SenX3-RegX3 two component signal transduction system in 
the senX3 null mutant and Tame 15, as is tiarX, a nitroreductase, which is also associated 
with the DosR regulon. A number of mycobactin genes are upregulated in the regX3 null 
mutant. These point to a possible role for the SenX3-RegX3 two component signal 
transduction system in the pathogenesis of M. tuberculosis, since genes of these types are 
often associated with virulence in other organisms.
With respect to the variation in gene lists between the three strains grown under 
microaerobic conditions, it is possible that the SenX3-RegX3 two component signal 
transduction system is very sensitive to slight variation in the culture environment, and
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that slight variations in the handling of the strains accounts for the differences in the 
transcriptomes between the three strains.
Another method of analysing genes controlled by a regulatory system is to 
overexpress the regulator in a null mutant strain of M. tuberculosis and compare the 
transcriptional profile of this strain to the mutant carrying the overexpression vector 
without the coding sequence o f the regulator. The high levels of expression of the 
regulator may be able to make the system constitutively active, even in the absence of the 
specific signal for the system.
Expression of regX3 driven by a strong constitutive Hsp60 promoter showed high 
levels of regX3 transcript being produced in the overexpressing strain. Comparison of 
microarray data for this strain against a regX3 null mutant that did not appear to express 
any regX3 transcript showed 199 genes that were differentially regulated between the two 
strains. A number of these genes also appear in the published data for the Tame 15 
mutant o f regX3, as could be expected. Another group of genes also appear in the 
published data for the nutrient starvation stimulon of the wild-type M. tuberculosis, 
indicating that the SenX3-RegX3 two component signal transduction system is playing a 
role in the adaptation of nutrient starvation. Other genes in the list code for other 
regulatory genes, and genes known to be involved in the response of M. tuberculosis to 
components o f the oxidative burst of the macrophage.
Given i) the environments in which it is possible to see transcriptional differences 
between mutants in the SenX3-RegX3 two component signal transduction system and the 
wild-type, ii) the genes that are differentially regulated between these strains and the 
wild-type, and iii) the similarity of the lists of differentially-regulated genes to published
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data, it is possible to conclude that the SenX3-RegX3 two component signal transduction 
system may be acting as a global regulator, sensing redox levels or metabolic states and 
co-ordinating expression of pathogenicity factors that interact with the host and gene 
products that adapt the metabolism of the bacillus to an environment that it may 
encounter within a granuloma. Although the senX3 and regX3 null mutants were no 
more sensitive than the wild-type after incubation in nutrient starvation conditions (see 
section 3.2.1.3), it may be that the mutant bacteria were lacking critical components of 
the response to the host, but in the absence of any exogenous damaging compounds in 
vitro the mutants did not show any difference in viability. It is, however, possible to 
hypothesise that these mutants would be more attenuated in infection models after growth 
in nutrient starvation conditions.
7.3 Protein-DNA interactions of RegX3
A previous report (Himpens et al. 2000) studied the interaction between renatured, 
recombinant RegX3 and a 42 bp region upstream of senX3. Our study shows that 
recombinant polyhistidine-tagged RegX3 can be expressed and purified in soluble form 
that is more likely to be folded correctly and display the DNA-binding activity of the 
protein in vivo.
We have been able to confirm, by a more direct method, the interaction between 
RegX3 and the 42bp region upstream of senX3 reported in Himpens et al. (2000). This 
interaction implicates RegX3 in regulating its own expression. Further to the confirming 
the results in Himpens et al. (2000), the region upstream of senX3 has been mapped using 
overlapping oligonucleotides; contrary to expectation RegX3 appears to bind a number of
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sites in this region, suggesting that this region may form secondary structure that interacts 
with RegX3 at a number of sites along its length. An alignment of the upstream region of 
senX3 with that o f two related mycobacterial species showed a large degree of homology, 
which does not preclude the promoter-binding region being scattered throughout this 
region.
One potential promoter region from a gene suggested to be regulated by RegX3 in 
Parish et al. (2003), and two from genes in this study that appeared to be differentially 
regulated in a senX3 null mutant after growth in low oxygen conditions, were assayed for 
their ability to bind RegX3. RegX3 appeared to bind all three promoters, the 
electrophoretic mobility shift of which altered when RegX3 was phosphorylated. These 
results suggested that the phosphorylation state of RegX3 alters its ability to bind to 
promoters. The interactions specifically with the upstream regions of the gene encoding 
a probably transcriptional regulatory protein Rvl460 again suggests that RegX3 may be 
controlling other transcriptional regulators, and the interaction of the upstream region of 
Rv2780 (alanine dehydrogenase, encoded by aid) with RegX3 confirms that the SenX3- 
RegX3 two component signal transduction system has a role in regulating the metabolic 
state of M. tuberculosis.
1A Initial study of other genes that may be affecting the responses of M.
tuberculosis to oxidative stress
Rv0465c and Rvl049 are potential regulatory genes that were implicated in the 
oxidative stress response by their upregulation in the wild-type following organic 
hydroperoxide stress. Rvl049, a MarR-type regulator, also bears homology to genes in
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other organisms, namely B. subtilis and X  campestris, which are involved in the 
resistance of those organisms to oxidative stress.
Null mutants o f these genes have been created in this study, and it has been 
possible to demonstrate that these genes are not essential for the growth of M. 
tuberculosis in vitro as shown by their growth rate in rolling culture being similar to that 
of the wild-type. The Rvl049 null mutant is significantly more susceptible to killing by 
intermediate, but not high, levels o f terf-butyl hydroperoxide, an organic hydroperoxide. 
These results suggest that Rvl049 is necessary for the proper response of M. tuberculosis 
to components of the oxidative burst produced during infection. The lack of a reduced 
viability of the Rvl049 null mutant compared to the wild-type after exposure to high 
levels of tert-butyl hydroperoxide suggests that Rvl049 may be part of a generalised 
stress response o f the bacterium, as has been reported for other MarR-type regulatory 
genes, or may simply be a case o f the bacteria being overwhelmed by high doses of 
damaging agent to which they are unable to respond.
Neither the Rv0465c or the Rvl049 null mutants were significantly attenuated in a 
macrophage model o f infection, suggesting either that these genes do not play a role in 
the growth of M. tuberculosis in macrophages or that the macrophage model of infection 
used did not provide the stimulus to which these potential regulators would react in vivo. 
Growth of the Rv0465c and Rvl049 null mutants, and potential complementing strains, 
in an intravenous mouse model of infection showed that the Rv0465c null mutant was 
present at significantly higher numbers than the wild-type at day 63 in the spleen. This 
may represent a subtle in vivo growth phenotype for the Rv0465c null mutant.
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7.5 Future work
The interaction of RegX3 with a number of the promoters seen to be differentially 
regulated in the strain overexpressing the regX3 transcript (section 4.2.3) could be 
confirmed with electrophoretic mobility shift assay and DNA footprinting using the 
purified recombinant RegX3 protein. The microarray results could also be confirmed by 
quantitative PCR.
To further investigate the role of the SenX3-RegX3 two component signal 
transduction system in sensing low levels of oxygen, two collaborations have been set up 
in order to better control the oxygen levels in cultures of the senX3 and regX3 null 
mutants. Dr. J. Bacon (HPA, Porton Down) has grown the senX3 null mutant in a 
chemostat and subjected it to decreasing levels of oxygen. Future microarray analysis of 
samples of the culture at defined oxygen tensions and comparison to the wild-type data 
previously generated at CAMR should provide a definitive analysis of the low-oxygen 
regulon of the SenX3-RegX3 two component signal transduction system and suggest the 
oxygen concentration at which the system becomes active. Dr. T. Parish (St. Barts, 
London) is currently growing both the senX3 and regX3 null mutants in the well- 
documented ‘Wayne’ model of anaerobic shutdown (Wayne & Hayes 1996).
The role of SenX3 and RegX3 during infection could be analysed by assessing the 
growth of the senX3 and regX3 null mutants in mice deficient in aspects of the innate 
immune defence, such as iNOS and phox mice, which are unable to produce inducible 
nitric oxide synthase and phagocyte oxidase, respectively. The senX3 and regX3 null 
strains could also be grown in models of infection, such as the guinea pig model, that 
produce a granulatomous response to infection. Furthermore, the viability model used
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throughout chapter 3 (see 2.2.1.1) could be used with a variety of different superoxide 
generating agents not tested in this work to more thoroughly examine the promising in 
vitro results seen here. If the PAS domain of SenX3 contains a haem prosthetic group, 
then it may be able to conduct experiments using cyanide to inhibit the activity of the 
haem group and further study the system in in vitro models where a phenotype can be 
observed for the senX3 and regX3 null mutants.
To further investigate the role of Rv0465c and Rvl049 in the response of M. 
tuberculosis to reactive oxygen intermediates, the growth of these strains is currently 
being assessed in a mouse model of infection. Further work could include microarray or 
proteomic analysis o f the Rv0465c and Rvl049 null mutant strains and their 
complementing strains, or assessment in other models of infection.
7.6 Conclusion
Overall, the results of this study show that the SenX3-RegX3 two component signal 
transduction system is essential for the full virulence of M. tuberculosis in mice and 
macrophages. Null mutants in this system are more resistant than the wild-type to killing 
by superoxide and organic hydroperoxide stress in vitro, suggesting that SenX3 and 
RegX3 are involved in responding to oxidative stress during infection. Microarray and 
protein-DNA interaction studies build on homology data suggesting that SenX3 may be 
sensing oxygen, indicating that the SenX3-RegX3 two component signal transduction 
system is active under low oxygen conditions and regulates a number of other regulatory 
genes, as well as sets o f genes known to be involved in oxidative stress defence and 
survival in conditions thought to occur within granulatomous lesions. A collaboration
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has been set up to enable a more controlled examination of the low-oxygen regulon of the 
SenX3-RegX3 two component signal transduction system.
Creation and analysis o f other genes that may be involved in the oxidative stress 
response of M. tuberculosis has shown that null mutants o f both Rv0465c and Rvl049 
grow normally in vitro aerobically, and that the Rvl049 gene product is likely to be 
involved in the resistance of M. tuberculosis to killing by organic hydroperoxides. 
Neither the Rv0465c nor the Rvl049 null mutants were attenuated in a macrophage 
model of infection, suggesting that these genes are not crucial of the survival of M  
tuberculosis in the early stages o f infection when they encounter the oxidative burst of 
the macrophage. It may be that the protein encoded by Rvl049 is acting like some other 
regulators to which it has homology and forms part of a generalised stress response of M  
tuberculosis,; alternatively Rvl049 or Rv0465c may be acting like previously described 
proteins that have a function in the oxidative stress response of E. coli. Further data on 
these two mutants will provide a clearer picture of their potential role in the oxidative 
stress response of M. tuberculosis.
This study has increased our knowledge of the oxidative stress responses of M. 
tuberculosis, which form part of the interaction between M. tuberculosis and the host. 
Understanding of this relationship may allow further development of antimycobacterial 
drugs and identification of potential vaccine targets, which is particularly relevant for the 
SenX3-RegX3 two component signal transduction system since two component signal 
transduction systems represent a promising target for potential drug design (Stephenson 
& Hoch 2004). Furthermore, mutations in the SenX3-RegX3 two component signal
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transduction system such as those described here could be used a component of a future 
live attenuated vaccine strain.
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Appendix 1: Genes differentially regulated in null mutants of the SenX3-RegX3 two 
component signal transduction system after growth in low oxygen conditions
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senX3 null mutant vs. H37Rv after microaerobic growth
negative fold change values are upregulated in the mutant
Rv number fold change p value common i
Rv0042c 0.416 0.00201 Rv0042c
R vO lll 0.19 0.0436 R vO lll
Rv0174 0.605 0.00797 Rv0174
Rv0232 30.21 0.0483 Rv0232
Rv0297 0.33 0.013 PEPGRS
Rv0343 0.484 0.0395 Rv0343
Rv0383c 0.313 0.042 Rv0383c
Rv0408 376.4 0.00342 pta
Rv0483 0.613 0.011 Rv0483
Rv0490 107.8 0.0228 senX3
Rv0491 157.5 0.0265 regX3
Rv0637 0.287 0.000775 Rv0637
Rv0883c 0.542 0.0426 Rv0883c
Rv0896 0.575 0.0111 gltA2
Rv0932c 072 7 0.0233 pstS
Rv0968 0.34 0.00513 Rv0968
R v ll0 4 0207 0.0303 R v ll0 4
R v ll4 1 c 0.192 0.0453 echA ll
R v ll7 2 c 0.299 0.00748 PE
Rvl347c 0.48 0.05 Rvl347c
Rvl398c 0.391 0.0308 Rvl398c
R vl460 0.54 0.0429 Rvl460
Rvl471 0.396 0.0284 trxB
RvlS18 22.12 0.0254 Rvl518
Rv1632c 0.679 0.00293 Rvl632c
Rvl642 0.151 0.0211 rpml
Rvl736c 62.84 0.0216 narX
Rvl894c 0.461 0.027 Rvl894c
R vl952 39.88 0.0138 Rvl952
Rvl955 0.48 0.0101 Rvl955
Rv1980c 0.576 0.0281 mpt64
Rvl988 0.0303 0.0332 Rvl988
Rv2007c 0.481 0.000621 fdxA
Rv2094c 0.454 0.0497 Rv2094c
Rv2116 0.444 0.00544 IppK
Rv2197c 0.3 0.0219 Rv2197c
Rv2461c 0.524 0.0121 clpP
Rv2626c 0.595 0.0425 Rv2626c
Rv2658c 0.291 0.0157 Rv2658c
Rv2706c 0.548 0.0246 Rv2706c
Rv2820c 0.194 0.0194 Rv2820c
Rv2954c 0.363 0.0435 Rv2954c
Rv3049c 0.498 0.0129 Rv3049c
Rv3051c 0.525 0.0317 nrdE
Rv3089 0.301 0.0194 fadD13
Rv3301c 8.757 0.00551 phoYl
Rv3409c 0.545 0.00469 choD
Rv3585 0.351 0.0442 radA
Rv3679 0.56 0.022 Rv3679
Rv3680 0.478 0.00818 Rv3680
Rv3682 0.498 0.0106 ponA'
Rv3741c 0.0884 0.0318 Rv3741c
Rv3750c 0.357 0.0238 Rv3750c
Rv3853 0.343 0.031 menG
Rv3854c 0.431 0.0255 Rv3854c
Rv3857c 0.428 0.0242 Rv3857c
Rv3886c 0.343 0.0285 Rv3886c
Rv3893c 0.521 0.0218 PE
Rv3924c 0.233 0.0181 rpmH
regX3 null mutant vs. H37Rv after microaerobic growth
negative fold change values are upregulated in the mutant
R v number fold change p value common
Rv0064 7.367 0.0429 RvO064
Rv0065 0.418 0.0119 Rv0065
Rv0332 0.201 0.0133 Rv0332
Rv0410c 4.821 0.0242 pknG
Rv0489 0.195 0.046 gpm
Rv0497 0.21 0.027 Rv0497
Rv0511 4.337 0.00188 cysG
Rv0637 0.578 0.0437 Rv0637
Rv0654 0.362 0.00191 Rv0654
Rv0678 0.516 0.0178 Rv0678
Rv0715 0.156 0.0259 rplX
Rv0748 0.144 0.0485 Rv0748
Rv0790c 0.232 0.0423 Rv0790c
Rv0823c 4.97 0.0138 Rv0823c
R v ll6 5 2.746 0.00801 R vl 165
Rvl327c 4.611 0.0218 Rvl327c
R vl382 3.215 0.0223 R v l382
Rvl493 3.768 0.00244 mutB
Rv1566c 0.429 0.0287 Rvl566c
Rvl584c 0.273 0.0489 Rvl584c
Rvl594 10 14 0.0214 nadA
R v l595 6.948 0.0076 nadB
Rvl599 3.326 0.0372 hisD
R vl600 3.134 0.0386 hisC
Rvl601 2.26 0.00105 hisB
R v l602 2.261 0.012 hisH
Rvl632c 0.297 0.00799 Rvl632c
R vl654 57.84 0.0485 argB
Rvl655 3.569 0.00119 argD
R vl 658 3.747 0.0184 argG
R vl736c 75.55 0.0325 narX
Rvl952 30.28 0.0151 R vl 952
R vl966 19.6 0.0354 mce3
R vl970 3.965 0.0353 IprM
R vl 996 16.96 0.0248 Rvl996
Rv2035 0.438 0.0433 Rv2035
Rv2318 0.0332 0.0215 uspC
Rv2378c 5.386 0.033 mbtG
Rv2381c 5.202 0.000271 mbtD
Rv2382c 5.9 0.00141 mbtC
Rv2383c 3.363 0.0251 mbtB
Rv2484c 2.974 0.0269 Rv2484c
Rv2496c 5.111 0.0401 pdhB
Rv2498c 2.241 0.0382 citE
Rv2499c 6.953 0.0382 Rv2499c
Rv2500c 2.865 0.00146 fadE19
Rv2504c 3.297 0.00626 scoA
Rv2553c 3.149 0.0329 Rv2553c
Rv2628 42.24 0.0107 Rv2628
Rv2630 6.399 0.0019 Rv2630
Rv2631 7.444 0.00212 Rv2631
Rv2658c 0.525 0.0383 Rv26S8c
Rv2706c 0.327 0.0028 Rv2706c
Rv2895c 0.0768 0.039 viuB
Rv2935 0.152 0.00591 ppsE
Rv3042c 0.471 0.0459 serB2
Rv3205c 0.575 0.0459 Rv3205c
Rv3206c 0.256 0.0178 moeZ
Rv3248c 4.98 0.0137 sahH
Rv3301c 18.73 0.026 phoYl
Rv3329 0.623 0.0491 Rv3329
Rv3551 8.455 0.0241 Rv3551
Rv3736 00834 0.0252 Rv3736
Rv3785 0.567 0.0374 Rv3785
Rv3800c 6.244 0.000756 pksl3
Tamel S mutant vs. H37Rv after microaerobic growth
negative fold change values are upregulated in the mutant
Rv number fold change p value common name
Rv0174 0.617 0.0405 Rv0174
Rv0275c 0.455 0.000596 fadD27
Rv0283 0.374 0.00553 Rv0283
Rv0289 0.512 0.0123 Rv0289
Rv0297 0.457 0.0438 PEPGRS
Rv0343 0.559 0.0166 Rv0343
Rv0352 0.589 0.0173 dnaJ
Rv0393 0.622 0.0229 Rv0393
Rv0407 2.064 0.00889 Rv0407
Rv0483 0.517 0.0408 Rv0483
Rv0491 160.7 0.00207 regX3
Rv0497 0.493 0.00128 Rv0497
Rv0502 0.633 0.049 Rv0502
Rv0569 0.459 0.0127 Rv0569
Rv0572c 0.258 0.00761 Rv0572c
Rv0637 0.356 0.0457 Rv0637
Rv0715 0.338 0.0169 rplX
Rv0757 0.44 0.0195 phoP
Rv0848 2.316 0.0445 cysM3
Rv0876c 0.527 0.00366 Rv0876c
Rv0883c 0.492 0.0294 Rv0883c
Rv0886 0.468 0.0163 fprB
Rv0932c 0 591 0.0478 pstS
Rv0996 0.668 0.0495 Rv0996
RvlOISc 0.476 0.00287 rplY
R vl 017c 0.547 0.0199 prsA
R vl026 2.159 0.0428 R vl 026
R vl078 0.507 0.0201 pra
R vl 130 0.152 0.00991 R v l130
Rvl148c 0.493 0.0201 R vl 148c
Rvl172c 0.312 0.00567 re
R v ll7 8 0.426 7.61E-05 R v l178
R vl237 0.353 0.0183 sugB
Rvl361c 0.436 0.00366 PPE
Rvl374c 0.445 0.0265 Rvl374c
Rvl387 0.508 0.00705 PPE
Rvl398c 0.28 0.0465 Rvl398c
Rvl428c 0.462 0.0224 Rvl428c
R vl462 0.68 0.0394 R vl 462
Rvl464 0.615 0.0243 Rvl464
R v l590 14.05 0.0499 R v l590
Rvl601 0.652 0.0389 hisB
Rvl639c 0.594 0.0134 Rvl639c
Rvl733c 0.438 0.00467 Rvl733c
Rvl736c 28.35 0.00164 narX
Rvl791 0.461 0.0396 PE
Rvl885c 0.416 0.0106 Rvl885c
R v l925 0.668 0.0393 fadD31
R vl952 47.77 0.0139 R vl 952
Rvl954c 0.387 0.00724 Rvl954c
Rvl955 0.231 0.00428 Rvl955
Rvl957 0.297 0.0481 R v l957
Rvl988 0.0448 0.043 Rvl 988
Rvl992c 0.722 0.038 d p G
Rv2004c 0.501 0.0233 Rv2004c
Rv2005c 0.469 0.0059 Rv2005c
Rv2007c 0333 0.00192 fdxA
Rv2031c 0.141 0.03 hspX
Rv2056c 0.423 0.0364 rpsN2
Rv2057c 0.204 0.0214 rpmG
Rv2116 0.488 0.0491 IppK
Rv2159c 0.507 0.0441 Rv2159c
Rv2193 0.671 0.0458 ctaE
Rv2197c 0.389 0.0498 Rv2197c
Rv2216 0.665 0.0438 Rv2216
Rv2243 0.418 0.000864 fabD
Rv2280 0.594 0.027 Rv2280
Rv2373c 0.628 0.0486 dnaJ2
Rv2461c 0.599 0.0383 clpP
Rv2462c 0.487 0.0317 tig
Rv2465c 0.532 0.0388 rpi
Rv2497c 0.631 0.0271 pdhA
Rv2569c 0.573 0.0174 Rv2569c
Rv2609c 0.58 0.0474 Rv2609c
Rv2623 0.592 0.0296 Rv2623
Rv2624c 0.645 0.022 Rv2624c
Rv2658c 0.336 0.00913 Rv2658c
Rv2706c 0.411 0.0021 Rv2706c
Rv2782c 2.542 0.0132 pepR
Rv2814c 0.258 0.0444 Rv2814c
Rv2820c 0.359 0.00621 Rv2820c
Rv2841c 0.62 0.00959 nusA
Rv2935 0.197 0.00943 ppsE
Rv2936 0.444 0.00233 drrA
Rv2940c 5.79 0.0212 mas
Rv2963 2.26 0.00797 Rv2963
Rv2990c 0.614 0.0387 Rv2990c
Rv3043c 0.59 0.0494 ctaD
Rv3069 6.484 0.0255 Rv3069
Rv3089 0.469 0.00755 fadD13
Rv3121 0.374 0.0279 Rv3121
Rv3133c 0.436 0.00513 Rv3133c
Rv3134c 0.553 0.0173 Rv3134c
Rv3150 0.52 0.0173 nuoF
Rv3239c 7442 0.0453 Rv3239c
Rv3270 1.973 0.0216 ctpC
Rv3271c 2.01 0.00242 Rv3271c
Rv3301c 12.02 0.00242 phoYl
Rv3371 0.582 0.0351 Rv3371
Rv3398c 200.2 0.0351 idsA
Rv3422c 3 821 0.0343 Rv3422c
Rv3479 0.51 0.0024 Rv3479
Rv36l5c 0.123 0.0068 Rv3615c
Rv3616c 0.551 0.033 Rv3616c
Rv3648c 0.222 0.0269 cspA
Rv3680 0.553 0.011 Rv3680
Rv3764c 0.559 0.0476 Rv3764c
Rv3801c 0.483 0.0169 fadD32
Rv3814c 0.386 0.0158 Rv3814c
Rv3853 0.282 0.0223 menG
Rv3854c 0.401 0.000926 Rv3854c
Rv3874 0.321 0.0323 Rv3874
Appendix 2: Genes differentially regulated between a AregX3/PhSp6(r^A'5+ strain 
and a AregX3/PhSP60“^ ^ ^  strain of M. tuberculosis.
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regX3 overexpression gene list
negative fold change values are upregulated in the overexpressing strain
Rv number fold change p valve cammofl ilame Rv number fold change p value common nam
RvOOgO 0.665 0.0149 RvOOSO Rvl372 35.88 0.000821 pksl8
Rv0093c 0.S21 0.0301 Rv0093c Rvl387 67.97 0.0375 PPE
Rv0094c 0.694 0.0139 RvO094c Rvl409 0.693 0.0366 ribG
RvOllO 8.225 0.0206 RvOllO Rvl491c 0.368 0.000486 Rvl491c
RvOllS 0.613 0.0493 RvOllS Rvl 556 12.7 0.0369 R v l556
Rv0127 0.398 0.0283 Rv0127 Rvl587c 0.717 0.0148 Rvl587c
Rv®160c 0.544 0.0403 RE Rvl 588c 0.702 0.00664 Rvl588c
Rv0161 0341 0.00553 Rv0161 R v l594 0.617 0.0403 rtadA
Rv0166 4.722 0.00208 fadD5 R vl610 0.017 0.0232 Rvl610
Rv0172 1.695 0.0351 Rv0172 Rvl622c 0.0857 0.0209 cydB *
Rv0173 1.927 0.0162 IprK Rvl623c 0.1 0.00407 appC
Rv0211 0.615 0.0117 pckA Rvl632c 0.76 0.0233 Rvl632c
Rv0222 9.548 0.00911 echAl Rvl731 16.54 0.0303 gabDl
Rv0250c 2.717 0.00957 Rv0250c Rvl732c 1.408 0.0343 Rvl732c
Rv4251c 2.314 0.00712 hap R v l775 2.713 0.0416 Rvl775
Rv0256c 0.363 0.0457 PPE Rvl 784 0.58 0.0188 Rvl784
Rv0296c 1.687 0.00448 atsG Rvl789 0.378 1.71E-06 PPE
Rv0308 1.72 0.0466 Rv0308 R vl 795 0.452 0.00411 Rvl795
Rv0344c 1.472 0.0283 lpql R v l797 0.36 0.0196 Rvl797
Rv0361 0.725 0.0143 Rv0361 Rvl813c 2.878 0.0312 Rvl813c
Rv0369c 0.386 0.00419 Rv0369c R vl 830 0.82 0.0483 Rvl830
Rv0377 0.454 0.0157 Rv0377 Rvl849 7.766 0.02 ureB
Rv0411c 0.199 0.00431 gfaiH R vl 857 7.092 0.028 modA
Rv0412c 0.368 1.15E-0S Rv0412c Rvl890c 0.229 0.0194 Rvl890c
Rv0438c 6.158 0.00186 moaA3 R vl 898 1.836 0.0186 Rvl898
Rv0479c 0.726 0.015 Rv0479c R vl 956 1.913 0.0387 Rvl956
Rv048S 0.588 0.00968 Rv0485 Rv2006 6.938 0.0431 otsB
Rv0490 0.492 0.00245 senX3 Rv2015c 0.789 0.0449 Rv2015c
Rv0491 2.94E-06 1.73E-08 regX3 * Rv2036 10.91 0.029 Rv2036
Rv0513 0.101 0.0328 Rv0513 Rv2056c 0.694 0.00629 rpsN2
Rv0516c 0.392 0.0064 Rv0516c * Rv2082 0.734 0.000917 Rv2082
Rv0557 0.0486 0.00557 Rv0557 Rv2148c 0.233 0.0443 Rv2148c
Rv0559c 1.31 0.0123 Rv0559c Rv2177c 0.559 0.0345 Rv2177c
Rv0561c 22.29 0.0484 Rv0561c Rv2193 0.568 0.0384 ctaE
RvOS78c 0.343 0.00198 PEPGRS Rv2202c 0.57 0.0412 cbhK
Rv0621 13.68 0.0127 Rv0621 Rv2234 10.78 0.0455 ptpA
Rv0650 0.6 0.0426 Rv0650 Rv2243 1.779 0.038 fabD
Rv0683 1.907 0.0197 rpsG Rv2276 0.633 0.00389 Rv2276
Rv0706 1.258 0.0124 rplV * Rv2419c 21.06 0.019 Rv2419c
Rv0749 0.535 0.0309 Rv0749 Rv2428 0.632 0.00153 ahpC *
Rv0784 0.025 0.000132 Rv0784 Rv2429 0.615 0.00256 ahpD *
Rv0823c 0.636 0.0205 Rv0823c Rv2430c 0.704 0.00306 PPE *
Rv0891c 0.548 0.0407 Rv0891c Rv2492 2.01 0.043 Rv2492
Rv090S 0.462 0.0256 echA6 Rv2493 7.488 0.0203 Rv2493
Rv0906 0.362 0.0236 Rv0906 Rv2495c 0.282 0.0348 pdhC
Rv0928 0.00356 0.00326 phoS2 Rv2510c 7.095 0.000933 Rv2510c
Rv0929 0.0205 0.00102 pstC2 Rv2543 0.135 0.0401 IppA
Rv0931c 0.731 0.0467 pknD Rv2577 0.0151 000613 Rv2577
R vl008 3.592 0.0361 R v l008 Rv2S82 1.499 0.00174 PPiB
R vlO ll 4.544 0.026 R vlO ll Rv2591 1.394 0.00532 PEPGRS
Rvl038c 0.67 0.015 R vl 038c Rv2594c 1.991 0 0186 nivC *
Rvl041c 1.543 0.00781 Rvl041c Rv2645 5.019 0.0309 Rv2645
Rvl067c 0.0301 0.0121 PEPGRS Rv2661c 2.46 0.0431 Rv2661c
Rvl102c 1.568 0.0277 R vl 102c Rv2692 66.55 0.0147 trkB
R v l130 0.351 0.0172 R v l130 Rv2693c 19.12 0.0118 Rv2693c
R v l147 1.43 0.00037 R vl 147 Rv2698 21.04 0.0236 Rv2698
R v l150 1.491 0.00458 R vl 150 Rv2711 1.291 0.0264 ideR
Rvl158c 2.064 0.000347 Rvl158c Rv2712c 20.13 0.0369 Rv2712c
R v l197 0.662 0.000337 R v l197 Rv2719c 1.942 0.0159 Rv2719c
Rvl 224 1.378 0.035 R vl 224 Rv2728c 6.429 0.0164 Rv2728c
R vl228 0.522 0.0395 lpqX Rv2739c 2.63 0.0277 Rv2739c
Rvl 230c 1.581 0.0165 Rvl230c Rv2757c 21.79 0.0073 Rv2757c *
Rvl 277 0.66 0.0102 R vl277 Rv2829c 2.176 0.0382 Rv2829c
Rvl 284 11.56 0.0286 Rvl284 * Rv2831 22.87 0.032 echAl 6
R vl295 0.68 0.0357 thrC Rv2832c 7.322 0.0037 ugpC
Rvl 297 0.782 0.011 rho Rv2838c 1.68 0.0171 rbfA
R v l300 0.636 0.0116 hemK Rv2840c 1.449 0.00617 Rv2840c
Rvl 304 0.652 0.0284 atpB Rv2864c 19.3 0.0152 Rv2864c
Rvl306 0.728 0.0201 atpF Rv2894c 10.39 0.00175 xerC
Rvl307 0.719 0.0153 atpH Rv2930 0.612 0.00268 fadD26
Rvl316c 1.319 0.0256 ogt Rv2934 0.572 0.0338 ppsD
Rvl320c 6.182 0.00582 Rvl320c Rv2935 0.725 0.00827 ppiE
R v l339 0.502 0.00389 R v l339 Rv2944 1.797 0.0455 Rv2944
R v l360 0.664 0.0262 R v l360 Rv2945c 0.738 0.0327 IppX
Rvl361c 3.418 0.0133 PPE Rv2984 0.496 0.0353 ppk
Rv u m b e r fold d i u p p u l s e com moa
Rv2990c 0.665 0.0429 Rv2990c
Rv3045 0.652 0.00203 adhC
Rv3062 19.55 0.0411 ligB
Rv3095 1.388 0.00661 Rv3095
Rv3147 1.613 0.0102 nuoC
Rv3165c 3.562 0.0489 Rv316Sc
Rv3175 11.77 0.0351 Rv3175
Rv3180c 15.41 0.043 Rv3180c
Rv3182 6.328 0.0272 Rv3182
Rv319lc 1383 0.0231 Rv3191c
Rv3192 2336 0.0161 Rv3192
Rv3195 4.153 0.0474 Rv3195
Rv3224 1.75 9.91E-05 Rv3224
Rv3229c 20.77 0.0123 desA3
Rv3248c 0.642 0.000566 sahH
Rv3285 1.511 0.0162 accA3
Rv3290c 0.232 6.07E-07 lat
Rv3305c 13.93 0.0299 amiA
Rv3355c 21.29 0.0338 Rv3355c
Rv3370c 0.0449 0.0059 dnaF.7.
Rv3381c 17.33 0.00292 Rv3381c
Rv3395c 2.822 0.043 Rv3395c
Rv3408 1.345 0.0482 Rv3408
Rv3418c 1.976 0.000761 groES
Rv3466 0.708 0.00554 Rv3466
Rv3467 0.714 0.00501 Rv3467
Rv3478 2.556 0.0399 PPE
Rv3479 26.22 0.00596 Rv3479
Rv3486 1.362 0.00571 Rv3486
Rv3524 0.512 0.00253 Rv3524
Rv3587c 1.386 0.00664 Rv3587c
Rv3619c 0.649 0.0149 Rv3619c
Rv3620c 0.66 0.00136 Rv3620c
Rv3634c 1.733 0.0174 rmIB2
Rv3640c 37.45 0.00673 Rv3640c
Rv3642c 2.025 0.0159 Rv3642c
Rv3707c 0.604 0.0247 Rv3707c
Rv3720 0.731 0.0238 Rv3720
Rv3745c 0.0521 0.0457 Rv3745c
Rv3750c 1.752 0.0384 Rv3750c
Rv3839 2.662 0.00237 Rv3839
Rv3840 5.009 0.0297 Rv3840
Rv3842c 0.779 0.0436 glpQl
Rv3867 0.623 0.0462 Rv3867
Rv3870 0.842 0.0369 Rv3870
Rv3873 0.699 0.0146 PPE
Rv3888c 0.575 0.0331 Rv3888c
Rv3914 1.611 0.0347 trxC
Rv3919c 0.677 0.0204 gkl
Appendix 3: Oligonucleotide primers
Restriction sites are underlined
primer sequence
104 cgacgagcgacccgagc
114 tetagagcagtcagttcagccagga
115 atcgataccagacagtcgccaaggtt
119 gcggccgcatatgtgtagttacacccaactg
122 gcggccgcgtgaccatcgaccggatcct
133 aattcgggatccacgccgatgtgtccaaggagat
134 aattcgggatcctgaaacaactatgaccggtcagaacg
135 aattaaggaaaaaagcggccgcgagcgtaccgggtgttgtgaaga
136 aattaaggaaaaaagcggccgcgctgcagtgcgttgttgatcc
137 aattcgggatccaagtcgagccgtcgcagtagtga
138 aattcgggatcccattactccagactcgtgtagctacacgtattt
139 acttggccgttctgacc
140 aatggcgtcttcacaacacc
147 ggctttgacgggtcttgaca
148 gatcaacaccacctggtcac
151 cgggatocatgaccagtgtgttgattgtggaggac
152 ccatcgatctagccctcgagtttgtagc
153 cgggatccaatgaccagtgtgttgattgtggaggac
156 ctgctcgccttcaccttcct
157 gcaggctcgcgtaggaatca
160 atgtgaacggtaaccgaacagctgtggcgtagtgtgtgactt
161 aagtcacacactacgccacagctgttcggttaccgttcacat
162 gatccgggctatcagtgcgtgggaaagcccggttgctgagcga
163 tcgctcagcaaccgggctttcccacgcactgatagcccggatc
168 ccatogatgctagccctcgagtttgtagc
169 ttcgtggcggtcaggatcgt
170 tgaaggccatctacctgtcg
177 ctcgtatcgtcgtcacagtc
178 gtgcgagtcgctatgtc
179 acggcgttgacgtgaccatc
180 cagttctccaccgaagtatc
181 aagctgttcggcgagcactg
182 aagtcctcggtccgcttcca
183 gttcgacgaatgcgcttgct
184 tcagctcgatgcgcttgcac
185 taggtgtggccgcagtattc
186 gccagcaggtgttcaagatg
189 aattggatccgtcgcgtggtgttattgctg
190 aattggatcctgaccgatgtcctggatgtg
191 ttccagcgcactcac
192 gagatgatcggcgttcc
237 ctgacaaagagcgccccgctgat
238 ccatatcgtggccgccagga
241 agctcggtagtggtcagcgg
397
242 tgacaaaattccgttgatcg
243 gccatgcagcaagctcagga
244 gattacccctctcgatactg
PMV306-4 ccagcaacgcggcctttttacg 
dl53 ggtcagcgaaccaatca
Appendix 4: Media and solutions
Media
Dubos broth
k2h po4 lg
Na2HPO4.12H20 6.25g
Na3 citrate 1.25g
MgS04.7H20 0.6g
Asparagine 2g
10% Tween 80 5ml
Casamino acids (Difco) 2g
pH to 7.2 (NaOH), make up to 960ml with dH20 , autoclave 121°C for 15 min. Add 40ml 
albumin supplement (Difco) once cool.
Freezing medium 
K2HP04 
Na3 citrate 
MgS04.7H20  
(NH4)2S04
kh2po4
glycerol 
dH20
Autoclave 121°C 15 min.
Luria-Bertani agar (L-agar)
Tryptone (Difco)
Yeast extract 
NaCl
Agar (Difco) 
dH20
Autoclave 121°C 15 min.
Luria-Bertani broth (L-broth)
Tryptone (Difco)
Yeast extract 
NaCl
pH to 7.5 (NaOH), make up to 1 litre with dH20, autoclave 121°C for 15 min.
Middlebrook 7H11 agar
Glycerol 5ml
Tween 80 0.05% w/v
7H11 medium powder (Difco) 21 g
12.6g
0.9g
0.18g 
1.8g
3.6g
96g
to 1 litre
10g
5g
10g
15g
to  1 litre
10g
5g
10g
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Autoclave 121°C for 15 min. Add 100ml OADC (olaeic acid, albumin, dextrose and 
catalase) supplement (Difco) once cool.
Solutions
TBE buffer (1 Ox)
Tris base 
Boric acid 
EDTA 
pH to 8.0 (HC1), make
TE buffer
Tris-HCl, pH8.0 lOmM
EDTA ImM
GSE solution
Guanidinium chloride 6M
N-lauroylsarcosine 1% v/v
EDTA 20mM
SET solution
Sucrose 0.3M
Tris-Chloride pH8 50mM
121g
61.83g
18.612g
up to 1 litre with dH2 0
PBS
Sodium phosphate 
Sodium chloride
lOmM
0.8%
Appendix 5: Raw data for stress experiments
«<r m  H37Rv, hstnXJ, £r*gX3
•part paraquat
(M M atettii 5QnM
rtme 2 hwis
cuhxn Mwibic
raw data.___________________ log value*_____________________
jtap i uittwi55ad *tw**ad log 10ui»te«ffid log lOstawad
m m r 3.45E+07 5.Q5E+07 7.54E+00 7.7QE+00
H37Rv 9.7QE+07 1.30E+08 7.99E+00 8.18E+00
H37Kir 1.38E+C6 1.29E+08 8.14E+CD
ts*rX3 1.20E+O8 6.2DE+0? 8.08E+00 7.79E+00
£s*rX3 1.78E+08 1.04E+08 8.25E+00 8.02E+00
AunXS 1.93E+08 1.99E+08 8.29E+0D 8.3QE+00
£n& 3 8.65E+07 7.90E+O7 7.94E+00 7.9QE+00
tn t fS 1.22E+08 8.60E+07 8.08E+00 7.93E+00
tn t fS 1.4SE+C6 1.46E+08 8.16E+00 8.161+00
log cheap
-1.65E01
-1.89E-01 Stud«rf* T-test
canpexioncf log chug**
2.87E-01 2 tailed houmicedaf tic, equal variance
2.3GE01
-1.33E-02 H37Rv btnXS ixtgXS
3.94E-Q2 H37Hv 0.062767315 0.02833629
1.5CE01 turQB 0.357314703
4.49E03 fr ig E
fining H37Rv, hsanXS, tttgXS
apart paraquat
nmnteAn StUd
f a e  24 hours
cuhra M iobic
raw data.___________________ log values
uwtwssed *t»»«d lcc lOvuslnsnd loC 10 s biassed
H37Rv 1.01E+08 6.30E+05 8.00E-H30 5.80E-H30
H37Rv- 5.73E+07 2.40E-K35 7.76E+00 5.38E+00
H37Rv 9.82E+07 7.99E+00
ta*rX3 1.29E+08 5 .44E-KJ6 8.11E+00 6.74E+00
bsnXS 1.35E+08 7.29E-KJ6 8.13E+00 6.86E-H3Q
burdtS 1.37E+08 8.90E-KJ5 8.14E+00 5.95E-KJ0
tn& 3 2.32E+08 2.55E-H36 8.37E-KJ0 6.41E-KJ0
tn& 3 1.42E+08 3.77E-HJ7 8.15E+00 7.58E-H30
tn& 3 1.87E+08 8.74E-KJ7 8.27E400 7.94E-KJQ
be chirp
2.20E+00
2.38E+00 Stud arifs T-tast
camparis anoflag chaises
1.37E+00 2 tailed kxmajcedastic, equal variance
1.27E+00
2.19E+00 H37Rsr £**nX3 trtgXi
1.96E+00 H37Kv 0.1710196 0.1331226
5.77E-G1 tsstnXS 0.325488
3.30E-01 b'tfXS
itnfav H37Rv, bstnXS, £rtgX3
apart sifrerntrife
concm tntin 3btM
f m  24 hours
cuhuc aazobic, pHS.5
raw data
Stan
log values
U»t»5Md strass ad lc* 10 uns trass ad log lOstrassad
H37Rv 1.18E+08 1.06E-KJ8 8.Q7E+00 8.03E+00
H37Rv 1.41E+08 1.01E408 8.15E+00 8.01E-KJ0
H37Rr 1.34E+08 1.08E-HD8 8.13E-KJ0
tttnXS 1.77E+08 1J2E408 8.25E-HJ0 8.18E-KJ0
&s4nX3 1.91E+08 1.58E-KJ8 8.28E+00 8.20E400
ta*rX3 1.91E+08 1.39E-KJ8 8.28E+00 8.14E-HJ0
tr*4R 1.58E+08 1.31E408 8.20E400 8.12E+00
t**&5 1.72E+08 1.47E+08 8.24E400 8.17E-KJ0
£n&3 1.71E+08 1.60E-+08 8.23E-H30 8.20E+00
bi clFy
4.64E-02
1.43E-01 Studcnfs T-test
carqpan an of k* charges
6.4QE-02 2 failad homoscedwtic, equal variance
8.09E-02
1.36E-01 H37Rv tUnXS brtgXS
8.3 IE-02 H37Hv- 0.9880464 0.4707302
6.82E-02 AitnJB 0.2851766
3.05E-02 irtgXS
concentetim
4m
cuhm
stam
H37Rr
H37Rv
i W 3
turiCS
£r*&S
b*cX3
kgyilns
H37Rv, b u r iB , ttugX3 
filler nitrite
M
24 hours
naciDMxoibic, pH5.5
rmrdaU 
u n  teased______ sbessad
5.90E+07 
4.85E+07 
7.20E+07 
5.75E+07 
5.65E+07 
1.28E+08
1.70E-KJ7 
1.75E407 
1.6QE+07 
2.70E-KJ7 
1.85E-KJ7 
455E-KJ7
b|JOuwtnM std__
7.77E+00 
7.69E-KJ0 
7.86E-KJQ 
7.76E-+00 
7.75E-HJ0 
8.11E+00
log lOstnwwA
7.23E+00
7.24E-+00
7.20E+00
7.43E-KJ0
7.27E-KJ0
7.69E400
be clang
5.40E-01
4 .43E -01 S tudatf s T-tet
6.55E-01 canptriscnaflocclnxfes
3 .28E -01 2 trikd hamosctdutic, tqual viriencc
4.85E-01
4.13E-01  H37Rv buries
H37Rv> 0.9995206
buriCS
togXS
0.5540622
0.8221876
ftrdhn H37Rv, b stn S , tirtgXS
«??-butyl hydropeiDxide 
m co d iaA n  2nM
i n  24 boon
a d l m  M » b ic
raw d*ti_________________  log vtluti
uwtnssed stesscd log 10umfct$s«d log lOstnssed
H37for 7.80E+07 1.86E-HJ6 7.89E-KJ0 6.27E-KJ0
H37Rr 1.04E+08 5.72E+06 8.02E-HOO 6.76E400
H37ftr 9.00E+07 1.64E+06 7.95E-H30 6.21E4C0
burXS 1.34E+08 4.51E+06 8.13E 400 6.65E400
hurXS 1.12E+08 6.15E-HJ6 8.05E-KI0 6.79E400
ts*rXS 1.30E+08 2.64E-H36 8.11E400 6.42E400
hre&3 8.40E+07 1.33E407 7.92E-HJ0 7.12E-KJ0
tn& 3 7.64E+07 3.51E-KJ7 7.88E+00 7.55E+00
fa g K3 1.06E+08 2.88E+07 8.03E-KJ0 7.46E+00
bgchmg
1.62E+00
1.26E+00 Studntfj T-twt
1.74E+00 caiqpawanaflag chug**
1.47E+00 2 taibd katcfctdutic, tqail vtriur*
1.26E+00
1.69E+00 H37Rr btnXS begX3
8.02E-01 H37R7 0.7493036 0.0078501
3.38E-01 taerdB 0.00774
5.66E-01 bnfXS
rtrrim H37Rv, M65c, ZRvl049
apart tirt -butyl hydzopciDxide
ODKcntadm 23CbM
fm  24kurt
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u» tossed s toss ad be 10 uw tossed be 10 s tossed
H37Rv’ 1.09E+08 2.02E+07 8.04E+00 7.31E+00
H37Rr 1.66E+08 1.90E-KJ7 8.22E+00 7.28E-+00
H37Rv 1.71E+08 2.42E407 8.23E+00 7.38E-KJ0
QtoWSc 1.19E+08 1.40E-K37 8.08E-KJ0 7.15E+00
iSbAMSc 1.51E+08 1.38E-KJ7 8.18E+00 7.14E-KJ0
£i£MM5c 1.62E+08 1J8E+07 8.21E-KJ0 7.20E+00
tftv-1049 1.21E+08 6.80E-HD6 8.08E-+00 6.83E+00
fltvl049 1.46E+08 6.00E+06 8.16E+00 6.78E400
^Rvl049 1.30E+08 6.60E-HD6 8.12E-«)0 6.82E-KJ0
bg chirp
7.32E-01
9 .42E-01 Slud«rtfj T-tet
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•p a t tart-butyl fydroperoxide
a n o ta t iM  2nM
im  24 loirs
a d t a  aerobic
raw date___________________ log values
ur* tressed stressed kg 10 unstressed kg 10 stressed
H37Rv 7.80E+07 1.86E+06 7.89E400 6.27E+00
« m r 1.04E+08 5.72E406 8.02E+00 6.76E-KJ0
ESTBy 9.00E+07 1.64E-H36 7.95E+00 6.21E+00
ARv0465c 1.38E+08 1.14E-H36 8.14E-H30 6.06E+00
4Rv0465c 7.60E+07 1.04E-KJ6 7.88E-K30 6.02E-KJ0
iRv0465c 1.12E+08 2.26E-HJ6 8.05E400 6.35E+Q0
ZRvlCMS 1.48E+08 3.64E-K16 8.17E-H30 6.56E-KJ0
ZRvl049 1.34E+08 1.52E-K36 8.13E-KJ0 6.18E+00
R^v-1049 4.02E+08 2.2QE-KJ6 8.60E+00 6.34E400
log charge 
1.62E+0Q
1.26E+00 Student's T-test
1.74E+00 cantpaw on of kg charges
2.08E+00 2 tailed honrnscedestic, equal variance
1.86E+00
1.70E+00  H37Rv &v0465c
1.61E+00 H37Rv 0.136579324
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2.26E+00 iRvl049
ZRvdD49
0.168810985
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